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Abstract 
Methylation of lysine residues in histone tails is an intensively studied 
epigenetic signal that regulates transcription throughout development. 
Methylation of histone 3 lysine 4 (H3K4) is usually associated with promoters 
of actively transcribed genes whereas H3K27 or H3K9 methylation silences 
genes. Yeast possess only one H3K4 methyltransferase, Set1. In contrast, 
there are six enzymes capable of catalyzing this modification in mammals 
implying a certain specialization or division of labor. The present study 
examined the functions of the mouse H3K4 methyltransferase paralogs, 
Mixed Lineage Leukemia 1 (Mll1) and Mll2, during neural differentiation and 
reprogramming of neural stem (NS) cells to induced pluripotency.  
We could show that Mll2 is required for differentiation of embryonic stem 
(ES) cells to neural progenitors and identified Nuclear transport factor 2-like 
export factor 2 (Nxt2) as essential target gene. Mll2 trimethylated the Nxt2 
promoter in ES cells in order to allow for transcriptional upregulation during 
subsequent neural differentiation. Additionally, Mll2 prevented apoptosis of 
differentiating cells by regulating B cell leukemia/lymphoma 2 (Bcl2) levels.  
Mll1 could replace Mll2 after the first steps of cell commitment towards 
epiblast stem (EpiS) cells. While Mll2 activity was only required briefly when 
ES cells started to differentiate, the influence of Mll1 seemed to increase with 
developmental progression. It stabilized the NS cell state by regulating 
expression of the neural transcription factor Orthodenticle homolog 2 (Otx2). 
Thereby, Mll1 impeded early steps of reprogramming to induced pluripotency 
and its inactivation increased the efficiency. 
Besides their specificity for certain target genes, both enzymes also differed 
in their activity. The major function of Mll1 was to prevent silencing by H3K27 
methylation and possibly recruitment of transcription factors. In contrast, Mll2 
conducted H3K4 trimethylation of its target genes. Importantly, once 
established in NS cells, the expression of Nxt2 became independent of 
promoter H3K4 methylation. Thus, Mll2 and its target gene Nxt2 represent an 
example for H3K4 methylation functioning as priming mechanism rather than 
for fine-tuning or maintenance of transcription levels. 
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1 Introduction 
1.1 Stem cells 
Higher multicellular organisms like mammals consist mainly of terminally 
differentiated cells that are specialized for a certain function and cannot 
divide any more. This postmitotic state of most somatic cells might be 
necessary as protection against uncontrolled cellular growth that might 
otherwise lead to cancer. Due to the finite life span of most differentiated 
cells that varies from an average of 5 days for neutrophiles (Pillay et al., 
2010) to decades for other cell types there is a constant need for cell 
replacement. To maintain homeostasis almost every tissue harbors adult 
somatic stem cells that are less specialized. They are able to divide 
asymmetrically and give rise to one stem cell and a more committed 
progenitor. Progenitor cells are then amplifying, usually by several cell 
divisions and undergo differentiation to generate the specialized cells of the 
respective tissue. In contrast somatic stem cells that reside in the adult body, 
embryonic stem (ES) cells only exist in the early embryo. They can be 
derived and maintained in vitro while keeping the universal property to 
differentiate to all cell types of the organism, including somatic stem cells. 
 
1.1.1 Criteria and developmental potential of stem cells 
Stem cells have to fulfill certain criteria to be termed as such. First, they are 
undifferentiated and able to divide. Second, they have a broad 
developmental potential being able to generate several different cell types 
under appropriate conditions. Third, they have the ability to self-renew. Each 
cell division results in either two identical daughter cells with the same 
potential as the original cell (symmetric division) or one alike the original 
stem cell and a second cell with more restricted developmental potential 
(asymmetric division). Thus, stem cells are theoretically immortal if or when 
cultured under defined conditions and can be clonally expanded without 
compromising their developmental potential. Despite these similarities 
different stem cell types can be distinguished by their developmental 
potential. It decreases with progressing development from totipotency to 
pluripotency, multipotency and finally unipotency. 
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After fertilization the zygote divides three times producing eight cells named 
blastomeres (Fig. 1). They are identical to each other and thus still harbor the 
full developmental potential. If separated each single blastomere can 
produce an embryo. Monozygotic twins with separate placentas develop 
when an embryo splits at this time point. The zygote and the blastomeres are 
the only cell types that are totipotent. They are capable of generating all cell 
types of the embryo as well as the extra-embryonic tissues.  
Further cell divisions of the embryo produce a morula and then the blastocyst 
where the first step of cell differentiation already occurred (Fig. 1). The outer 
trophectoderm cells of the blastocyst will generate extra-embryonic tissues 
like the trophoblast giant cells forming part of the placenta. The inner cell 
mass further diverges into the epiblast and the primitive endoderm that will 
mainly generate the yolk sac and other extra-embryonic tissues. The early 
epiblast gives rise to the embryo proper and is the source of ES cells. During 
gastrulation the pluripotent epiblast specializes into the three germ layers - 
ectoderm, endoderm and mesoderm – as well as the germ cell lineage.  
Fetal somatic stem cells produce the cells of each organ during further 
development. Their potential is restricted to the respective tissue, termed 
multipotency. Examples are fetal neural stem (NS) cells that can be isolated 
from fetal brain like in the present study. A small fraction of fetal stem cells 
remain multipotent after fetal development is completed to form adult stem 
cell pools in most tissues that are needed for homeostasis or regeneration. 
The best-studied example for adult stem cells are hematopoietic stem cells 
that can produce all cell types of the blood. Progenitor cells that are restricted 
to few or only one cellular subtype are oligopotent or unipotent. 
The developmental potential of stem cells can be tested in vivo by 
transplantation studies. Pluripotency can be proven by injection of mouse ES 
cells into blastocysts where they integrate into the inner cell mass. Bona fide 
pluripotent ES cells thereby generate chimeras contributing to tissues of all 
three germ layers and the germ cell lineage. Even more stringent is the 
tetraploid complementation assay since blastocysts with four sets of 
homologous chromosomes can only form extra-embryonic tissues 
(Tarkowski et al., 1977). Therefore, the embryo proper is derived from the 
injected diploid ES cells only. 




Figure 1 Initial stages of mouse embryogenesis. The zygote divides into 8 blastomeres. 
Following compaction of cells and further cell divisions the blastocyst is formed. There, the 
first separation between trophoblast and the inner cell mass is established. The inner cell 
mass further differentiates into primitive endoderm and the epiblast. After implantation the 
epiblast gives rise to all three embryonic germ layers during gastrulation and to the germ cell 
lineage. The red arrow indicates the direction of the primitive streak from posterior to 
anterior. Adjusted from Tam and Rossant, 2003; Takaoka and Hamada, 2012. 
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The multipotency of hematopoietic stem cells can be proven by injecting 
them into the blood stream of mice that were irradiated to extinguish their 
own hematopoietic stem and progenitor cells. The transplanted 
hematopoietic stem cells will migrate into the empty niche in the bone 
marrow and repopulate it. After several weeks all blood cells will be derived 
from these transplanted cells. If the self-renewal or differentiation capacity of 
the transplanted cells is compromised, the resulting depletion of the 
hematopoietic system will be lethal. The principle of hematopoietic stem cell 
transplantation is the basis for the sole standard clinical therapy with stem 
cells so far. Combined with irradiation, it is used to cure leukemia by 
replacing the malignant hematopoietic cells with stem cells from healthy 
donors. Additionally, the hematopoietic system of other cancer patients after 
chemotherapy can be reconstituted by transplanting their own (autologous) 
hematopoietic stem cells that were isolated prior to the treatment. 
Similar attempts exist for other somatic stem cells with diverse success. 
Neural stem cells are usually able to differentiate into some neuronal 
subtypes and glia upon injection into the brain. However, the engraftment 
and synaptic connections of the produced neurons are often suboptimal and 
long-distance migration of new axons in adult brains is hindered (reviewed in 
Bonfanti, 2011). This might be also due to general mechanisms restricting 
regeneration in the mammalian brain and is not necessarily a sign for 
compromised potential of the neural stem cells. 
 
1.1.2 Origin, culture and characteristics of pluripotent stem cells 
ES cells are derived from the inner cell mass of the blastocyst, in particular 
the early epiblast, and stay pluripotent in vitro under defined culture 
conditions. Their isolation from mouse embryos was first achieved in 1981 
(Evans and Kaufman, 1981; Martin, 1981). However, it took 17 years until the 
first human ES cell lines could be established (Thomson et al., 1998). 
Besides the ethical concerns and the very limited availability of surplus in 
vitro fertilized human embryos, the different growth factor requirements of 
mouse and human ES cells accounted for this delay. Mouse ES cells grow 
on mouse embryonic fibroblasts (MEFs) or without them if provided with 
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Leukemia inhibitory factor (LIF). Additionally, they require Bone morphogenic 
protein 4 (BMP4) that can be supplied with serum. When cultured in serum 
and LIF, ES cells seem to switch between a naive and a differentiation-
permissive (“primed”) state as reflected by fluctuations of their transcription 
factor expression levels (Chambers et al., 2007). Recently, it was shown that 
mouse ES cells can be kept in the naive state under more defined growth 
conditions with only two inhibitors (2i) blocking Mitogen-activated protein 
kinase kinase (MEK) and Glycogen synthase kinase 3 (GSK3) (Ying et al., 
2008; Marks et al., 2012).  
Similar like mouse ES cells that are derived at E3.5, cells from the late 
mouse epiblast (E5.75) can be isolated and cultured in vitro as epiblast stem 
(EpiS) cells (Brons et al., 2007). They grow under serum-free conditions 
when supplied with Activin A (ActA) and FGF2 on Fibronectin. Alternatively, 
murine EpiS cells can be derived from ES cells by transferring them to these 
growth conditions and passaging them.  
Human ES cells, despite being derived from blastocysts are supposedly 
closer related to mouse epiblast cells than mouse ES cells as deduced from 
their growth conditions, expression profile and morphology (reviewed in 
Schnerch et al., 2010; Nichols and Smith, 2011). They require Fibroblast 
growth factor 2 (FGF2), serum replacement and feeder cells or conditioned 
medium and an appropriate matrix for their growth. 
All three pluripotent cell types discussed here express the markers Octamer 
binding transcription factor 4 (Oct4, official name Pou5f1) and Nanog that are 
transcription factors of the core pluripotency network. Reduced expression 1 
(Rex1, official name Zfp42) and Kruppel-like factor 4 (Klf4) transcription is 
restricted to mouse ES cells while Fgf5 is expressed in EpiS cells but not in 
ES cells. While mouse ES cells grow in round three-dimensional compact 
colonies, human ES and mouse EpiS cell colonies are flat but compact and 
consist of small epithelial-like cells. This probably reflects the in vivo 
morphology because the mouse early epiblast is cup-shaped while the 
epiblast of humans resembles a disk. Another important difference is the 
inactivation of one of the X chromosomes in female mouse EpiS cells and 
most human ES cell lines while female mouse ES cells have two active X 
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chromosomes reflecting their earlier developmental state (reviewed in 
Nichols and Smith, 2011). Accordingly, mouse EpiS cells display low levels 
of chimera contribution and cannot contribute to the germ cell lineage when 
injected into blastocysts (Brons et al., 2007). Since human ES cells cannot 
be tested for germ line compatibility, the only way to test their in vivo 
differentiation potential is the formation of teratomas when injected into 
immunodeficient mice.  
So far it was not possible to convert human ES cell lines to a naive state 
resembling mouse ES cells without the use of transgenes. Mouse embryos 
can undergo diapause and are thus predisposed for a stabilization of the 
naive state while human embryos lack this ability. Mouse blastocysts stay in 
this dormancy-like state that relies on LIF signaling if the mother is still 
nursing the previous litter (reviewed in Nichols and Smith 2011). 
 
1.1.3 Murine embryonic stem cells for studying development in vitro 
The ability of mouse ES cells to contribute to the germ line when injected into 
blastocysts can be used to generate knockout mice from genetically modified 
ES cells. However, understanding the function of a certain gene or protein 
only by utilizing mouse models can be a challenge. The complex interplay of 
numerous cell types that might be differentially affected by a certain 
treatment or loss-of-function and influence each other complicates the 
interpretation of results. Thus, the use of cell cultures that can mimic the in 
vivo situation reliably but in a much more accessible manner is one solution 
to approach this problem. Focusing on one relatively homogeneous 
population of cells once at a time can help to relate phenotypes to molecular 
functions.  
Mouse ES cells are optimal model systems for studying development in vitro 
for several reasons. First, mouse ES cells are amenable to genetic 
manipulation not only by plasmid and bacterial artificial chromosome (BAC) 
transgenesis but also gene targeting. This feature is due to their preferred 
use of homologous recombination for DNA repair as opposed to non-
homologous end joining that is prevalent in somatic cells (Tichy et al., 2010). 
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Secondly, mouse ES cells are close to the in vivo situation because they are 
in vitro equivalents of the early epiblast as proven by their contribution to 
chimeras and germ-line competency. Third, mouse ES cells are comparably 
easier to culture than human ones or ES cells from other mammals and can 
be indefinitely expanded. Thus, they represent an abundant starting 
population to generate almost any conceivable cell type. With increasing 
knowledge of the growth factor requirements for each lineage numerous well-
established protocols have been developed.  
When LIF is withdrawn from mouse ES cells they spontaneously differentiate 
in vitro into various cell types of the three germ lineages. This bulk 
differentiation is relatively undirected and results in mixed cell populations 
where some cell types are easily generated while others cannot be produced 
at all since they require specific growth factors or environments. In these 
experiments all-trans retinoic acid is often added to the ES cells to accelerate 
differentiation because retinoic acid was shown to activate expression of 
developmental homeobox (Hox) genes in embryonic carcinoma cells 
(Boncinelli et al., 1991). 
In order to provide a three-dimensional environment that is closer to the in 
vivo situation one can culture the cells in suspension where they aggregate 
spontaneously into so called embryoid bodies. Controlling the size of 
embryoid bodies by letting a defined number of cells aggregate in hanging 
drops that are subsequently seeded onto gelatine facilitates differentiation of 
contracting cardiomyocytes. Directed differentiation to one specific cell type 
with high yield and accuracy is possible by applying certain growth factors 
under defined conditions in an orchestrated manner. One example is the 
differentiation to neural stem (NS) cells that will be discussed in the following 
chapter. 
 
1.1.4 Neural stem cells of different origin 
Neural stem (NS) cells are multipotent somatic stem cells that can 
differentiate into neurons, astrocytes and oligodendrocytes. Due to the very 
limited regeneration potential of mammalian brains, the existence and 
identity of adult NS cells was under debate for many decades. Nowadays it is 
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established that adult NS cells exist in mammals in the subventricular zone 
and the dentate gyrus (for review see Ming and Song, 2011). However, their 
neurogenic potential is largely restricted to generating dentate granule cells 
or interneurons that migrate into the olfactory bulb.  
Weiss and Reynolds were the first ones to show that cells from the adult 
mouse brain can generate neurons and astrocytes in vitro (Reynolds and 
Weiss, 1992). They established suspension cultures supplemented with 
epidermal growth factor (EGF) where the cells grew in round aggregates 
called neurospheres. They contained a mixture of stem and progenitor cells 
with differentiated cells that provided the niche for self-renewal of the stem 
cells. However, cells from these neurospheres appeared to have a more 
restricted potential because they differentiated preferably to astrocytes and 
less neurons (Winkler et al., 1998). This might depend on the developmental 
time point of isolation because the potential of most neural stem and 
progenitor cells in vivo switches from neurogenesis to gliogenesis at around 
E17 in mice (reviewed in Guillemot, 2007). In 2005 Smith and colleagues 
showed that NS cells are able to self-renew in adherent cultures without a 
niche provided by neurospheres if supplemented with FGF2 in addition to 
EGF (Conti et al., 2005). These fetal NS cells can be isolated from the 
developing mammalian forebrain. Their in vivo counterparts are the bipolar 
radial glia cells that generate all cells of the cortex during development. In 
contrast to adult neural stem cells, they still possess the full developmental 
potential. 
Another source for NS cells is their generation from ES or EpiS cells in vitro 
(Fig. 2). After withdrawal of growth factors pluripotent stem cells can be 
differentiated under serum-free conditions in neural medium (N2B27) for 5-7 
days to generate neural rosettes (Ying and Smith, 2003; Pollard et al., 2006). 
These cells resemble the neuroepithelial cells of the neural plate and express 
the transcription factor SRY (sex determining region Y)-box 1 (Sox1) as well 
as neural precursor markers Paired box 6 (Pax6) and Nestin (Nes). Like in 
the neural tube the rosette cells are connected to each other with tight 
junctions to form an inner lumen at the apical site. This epithelial feature is 
lost during further transition to radial glia-like cells. Addition of EGF and 
FGF2 prevents further differentiation of the resulting bipolar cells that can be 
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indefinitely propagated as adherent monolayer NS cells. These in vitro 
differentiated NS cells retain Pax6 and Nestin expression, but lost the 
neuroepithelial marker Sox1 (Pollard et al., 2006). 
ES cell-derived NS cells and NS cells isolated from fetal telencephalon share 
many common features like the bipolar morphology, marker expression and 
their dependence on EGF and FGF2 for self-renewal (Conti et al., 2005). 
Both can be differentiated to Glial fibrillary acidic protein (Gfap)-positive 
astrocytes by addition of BMP4 or serum and to beta III tubulin (TuJ1) 
expressing neurons by the sequential removal of first EGF and then FGF2 
(Fig. 2).  However, there are slight differences as well. While ES cell-derived 
NS cells are able to grow on gelatine, NS cells from telencephalon tend to 
detach as neurospheres if they are seeded to gelatine, which can be 





Figure 2 Schematic representation of sequential in vitro differentiation of embryonic stem 
(ES) cells over epiblast stem (EpiS) cells to neural rosettes and neural stem (NS) cells and 
finally neurons or astrocytes. The in vivo counterparts, growth factor requirements for each 
cell type or transition as well as marker expression are also depicted. ActA, Activin A; FGF2, 
Fibroblast growth factor 2; EGF, Epidermal growth factor, N2B27, neural medium with N2 
and B27 supplements; BMP4, Bone morphogenic protein 4; Oct4 (Pou5f1), Octamer binding 
transcription factor 4; Rex1 (Zfp42), Reduced expression 1; Sox1, SRY (sex determining 
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1.2 Epigenetics 
Mammals consist of approximately 400 different cell types (Vickaryous and 
Hall ,2006) that all originate from one single cell and thus contain – with few 
exceptions – the same genetic information. In order to achieve such a high 
level of cellular specialization, multiple mechanisms and layers of gene 
regulation evolved in multicellular organisms. The term epigenetics 
summarizes all changes in gene expression that can be inherited without 
changing the underlying DNA sequence. Epigenetic mechanisms stabilize 
cell identity during development by allowing only the expression of genes 
required and appropriate for a certain stage. Thereby, the developmental 
potential of a cell is restricted the further it differentiates. This is reflected in 
the model of an epigenetic landscape that was suggested by Conrad Hal 
Waddington already in 1957 without concrete knowledge of the molecular 





1.2.1 Chromatin structure 
The huge genome of eukaryotes is compacted into a tightly packed 
chromatin structure in order to fit into the cell nucleus. First, the DNA double 
helix is wrapped around histones to form nucleosomes. Each single 
nucleosome consists of 146 base pairs (bp) of DNA wrapped almost twice 
(1.65 times) around the histone core (Luger et al., 1997) and connected to 
Figure 3 Waddington’s 
model of the epigenetic 
landscape. From 
Waddington, C.H. 
(1957) The Strategy of 
the Genes; a Dis-
cussion of some 
Aspects of Theoretical 
Biology. London, Allen 
& Unwin. 
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the next nucleosome by approximately 50 bp of linker DNA. The histone core 
is an octamer of two pairs each of histones H2A, H2B, H3 and H4. The core 
histone is formed by assembly of an H3-H4 tetramer with two H2A-H2B 
dimers. The linker histone H1 binds where the DNA emerges from the 
nucleosome in order to stabilize the structure. The beads-on-a-string 
structure that is formed by the nucleosomes can be compacted further into 
more dense structures, the 30 nm fiber often reported as heterochromatin. 
Dense packaging into chromatin fibers impedes access of transcription 
factors and therefore genes in these regions are usually silenced. In contrast, 
the more open structure of euchromatin allows transcription. Thus, enzymes 
remodeling the chromatin structure play a major role in gene regulation. 
Additionally, certain histone variants convey another level of regulation and 
organization. For instance, they can mark the transcriptional start sites 
(H2A.Z), double strand breaks (H2A.X) or they have structural relevance like 
the centromeric CenpA (for review see Maze et al., 2014). Other epigenetic 
signals are DNA methylation and post-translational histone modifications. 
 
1.2.2 DNA methylation  
In mammals, most of the DNA methylation occurs on cytosine-phosphate-
guanine (CpG) dinucleotides. DNA methyltransferases (DNMTs) methylate 
the 5-position of cytosine thereby creating 5-methyl-cytosine. While CpG 
dinucleotides are underrepresented throughout the mammalian genome in 
statistical means, around 70 % of genes are preceded by an unexpected 
accumulation of CpG dinucleotides (Saxonov et al., 2006). These so-called 
CpG island promoters are usually controlling actively transcribed genes like 
house keeping genes if they are unmethylated. DNA methylation of CpG 
islands leads to transcriptional silencing of the corresponding gene because 
it can prevent transcription factor binding. Additionally, methyl-CpG binding 
proteins recruit histone modifying enzymes and chromatin remodelers 
promoting heterochromatin formation. Conversely, some histone 
modifications are signals for de novo DNA methylation (reviewed in Jaenisch 
and Bird, 2003). Therefore, it is not clear whether DNA methylation is an 
initial step in gene silencing or rather a terminal event. DNA methylation is 
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especially involved in X chromosome inactivation, imprinting of genes in 
germ cells, silencing of repetitive elements and developmental genes. 
Alterations in the DNA methylation profile of cells are implicated in cancer 
where hypomethylation can lead to the expression of usually silenced 
oncogenes while hypermethylation of promoters may silence tumor 
suppressors. 
During replication the newly synthesized DNA strand can be distinguished 
from the old one as it is still unmethylated allowing correction of replication 
errors by proofreading. In order to be inherited from mother to daughter cells, 
the DNA methylation pattern of the old strand is then copied to the newly 
synthesized strand by DNA methyltransferase 1 (DNMT1). This enzyme 
binds hemimethylated double strands and converts yet unmodified cysteins 
to 5-methyl-cysteins. Besides this maintaining methyltransferase, there are 
also de novo methyltransferases (DNMT3a and DNMT3b) that establish 
methylation patterns in embryonic development. DNMT3L is catalytically 
inactive but can recruit DNMT3a and DNMT3b (reviewed in Jaenisch and 
Bird, 2003). Once a cell is committed to a certain lineage, genes that are no 
longer needed will often be silenced by DNA methylation and other chromatin 
modifications. DNA methylation is not essential for viability and self-renewal 
of undifferentiated ES cells because they can grow without any 5-methyl-
cytosine after inactivation of all three DNMTs (Tsumura et al., 2006). These 
triple knockout ES cells are even able to differentiate but fail to fully maintain 
silencing of Oct4 and Nanog transcription (Schmidt et al., 2012). 
For a long time DNA methylation was thought to be a final step of gene 
silencing that cannot be actively reversed, but only passively diluted during 
replication if DNMTs are not active at certain loci. This was negated by the 
discovery of Ten-eleven translocation (Tet) proteins that hydroxylate 5-
methyl-cytosine (Tahiliani et al., 2009). It is still under debate whether 5-
hydroxymethyl-cytosine represents an epigenetic mark itself or if it is merely 
an intermediate during active DNA demethylation. It can be converted to 5-
formylcytosine and 5-carboxycytosine that can then be reverted to an 
unmodified cytosine by base excision repair (for review see Kohli and Zhang, 
2014). 
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1.2.3 Post-translational histone modifications 
The N-terminal parts of histones protrude from the nucleosome and are 
easily accessible for modifying enzymes. Therefore, most post-translational 
histone modifications take place in these histone tails. Phosphorylation, 
acetylation, methylation and ubiquitination of amino acid residues in histones 
are the best-studied cases (reviewed in Bannister and Kouzarides, 2011), but 
many new modifications were recently identified with yet unknown functions 
(Tan et al., 2011). The role of histone modifications and the consequences 
for the underlying genomic region are dependent on the type of modification 
and its position. Thus, in correspondence to the DNA code, a so-called 
histone code was proposed (Fig. 4). Readers of this code are proteins that 
bind to the specific modifications and exert their functions that range from 
chromatin remodeling over DNA repair, transcriptional regulation and DNA 
methylation to the addition or removal of other histone modifications. 
Some histone marks directly influence the biochemical properties of histones 
like the introduction of negatively charged phosphate groups. Extensive 
histone phosphorylation by kinases might open the chromatin structure due 
to electrostatic repulsion from the equally negatively charged phosphate 
backbone of DNA. However, this histone modification can also exert more 
subtle functions similar to signals exerted by other phosphorylated proteins. 
Serine 139 phosphorylation of H2A.X for instance marks double-strand 
breaks (Rogakou et al., 1998). 
Acetylation of lysine residues in histone tails by histone acetyltransferases 
(HATs) removes their positive charge and thus weakens the interaction 
between histone and negatively charged DNA. Thus, histone acetylation 
enables transcription factor binding and can be found in euchromatin. In 
contrast, histone deacetylases (HDACs) are implicated in gene silencing 
(reviewed in Bannister and Kouzarides, 2011). Many HATs and HDACs are 
associated with other histone modifiers and chromatin remodelers in huge 
enzyme complexes.  
While histone phosphorylation and acetylation are thought to have a fast 
turnover, methylation and ubiquitination are supposedly more stable 
epigenetic marks that can be inherited for several cell divisions and during 
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development. Methyl groups can be added to several lysine and arginine 
residues. While arginine can be mono- or dimethylated (symmetrically or 
asymmetrically), lysine residues can carry up to three methyl groups. The 
degree of the modification influences binding of effector proteins and thus the 
implications. Mammals usually have several histone methyltransferases and 
demethylases specific for one or more sites adding another layer of 
complexity. For simplification we will concentrate on the impact of histone 
lysine methylation on transcription (reviewed in Dambacher et al., 2010). 
Histone 3 lysine 36 (H3K36) trimethylation can be found on the promoter and 
the open reading frame (ORF) of actively transcribed genes, increasing 
towards the 3’ end. It is associated with transcription elongation (Bannister et 
al., 2005). H3K4 trimethylation is also a mark for active genes, but it is mainly 
concentrated at the promoter and the transcriptional start site (TSS). It was 
suggested to be important for transcription factor binding, recruitment of the 
transcription machinery, transcription initiation or maintenance and splicing. 
In contrast to active promoters, active enhancers are marked by H3K4 
monomethylation and H3K27 acetylation (Creyghton et al., 2010). 
H3K9 and H3K27 methylation are repressive marks. Trimethylation of H3K27 
can usually be found around the promoters of developmental genes that are 
not transcribed. H3K9 and H4K20 trimethylation is generally linked to 
heterochromatin and can be found in pericentric and telomeric regions, on 
the inactivated X chromosome in females and at repetitive elements 
(reviewed in Dambacher et al., 2010). However, while H3K27 trimethylation 
seems to be more common for inactivation of developmental genes, some 
promoters were reported to be silenced by H3K9 trimethylation in certain 
lineages like androgen receptor-dependent genes (Wissmann et al., 2007) 
and Oct4 (Feldman et al., 2006). H3K9 trimethylation is also prevalent in 
imprinting control regions of the inactive allele (Mikkelsen et al., 2007). 
Additionally, large H3K9 dimethylated chromatin blocks can be found in 
silenced genomic regions in differentiated cells (Wen et al., 2009). 
Like other proteins histones can get polyubiquitinated for proteosomal 
degradation. However, monoubiquitination serves as specific histone mark. 
H2A lysine 119 monoubiquitination is involved in gene silencing. In 
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mammals, this histone mark is mainly catalyzed by Ring finger protein 2 
(Rnf2 or Ring1B), that is one component of the Polycomb Repressive 
Complex 1 (PRC1) and two other repressive chromatin modifying complexes 
(reviewed in Weake and Workman, 2008). In contrast, H2B lysine 120 
monoubiquitination is linked to transcription elongation since its deposition at 
the +1 nucleosome on active promoters in yeast is dependent on the RNA 
polymerase II-associated factor (PAF) complex (reviewed in Weake and 
Workman, 2008). Concordant with its role on active promoters, H2B 
ubiquitination stimulates methylation of H3K4 by Set1 in yeast (Kim et al., 





Figure 4 Post-translational histone modifications. Acetylation, methylation, phosphorylation 
and ubiquitination of certain amino acid residues in the tails of histones H2A, H2B, H3 and 
H4 act as epigenetic signals generating the histone code. Modified from Kato, S., Inoue, K., 
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1.2.4 Bivalency 
Chromatin regions that carry both the activating H3K4 and the repressing 
H3K27 methylation are termed bivalent (reviewed in Voigt et al., 2013). 
These domains can be found at promoters of developmental genes and were 
first discovered in ES cells (Bernstein et al., 2006). Initially, there were 
concerns whether bivalency is only a result of the chromatin 
immunoprecipitation (ChIP) method that relies on cell populations rather than 
single cells. This was especially due to the mixed population of ES cells in 
serum-containing medium that consists of naive and more primed cells. It 
was speculated that one population of cells is H3K4 and another H3K27 
methylated at developmental gene promoters depending on the lineage they 
are primed for. However, it was shown recently that H3K4 and H3K27 di- and 
trimethylation can indeed exist on the same nucleosome, but not on the 
same histone tail (Voigt et al., 2012). Additionally, by using more defined 
culture conditions with the two inhibitors (2i) more homogeneous ES cell 
populations can be achieved with a remarkable reduction of lineage priming 
(Ying et al., 2008). Bivalent promoters were identified even under these naive 
conditions although they appeared at a lower frequency due to a decrease in 
the overall H3K27 methylation level (Marks et al., 2012). 
Bivalent genes are not expressed or produce only very few transcripts in ES 
cells showing that the repressive mark is the dominant one in this 
combination. Nevertheless, bivalent genes are bound by RNA polymerase II 
that is paused at the promoters (Guenther et al., 2007). It is serine 5 
phosphorylated only, showing that transcription is initiated but no elongation 
takes place yet. This serine 5 phosphorylated RNA polymerase II associates 
with yeast Set1 (Ng et al., 2003) and mammalian Mll1 (Milne et al., 2005) 
H3K4 methyltransferase complexes. For transcription to start, RNA 
polymerase II gets serine 2 phosphorylated. This elongating RNA 
polymerase II interacts with Set2-type methyltransferases (Schaft et al., 
2003) that methylate H3K36 along the ORF. Methylated H3K36 in turn 
inhibits methylation of H3K27 (Yuan et al., 2011). Thus, the pausing of RNA 
polymerase II might cause the bivalent chromatin state because it recruits 
H3K4 methyltransferases while H3K27 methylation is not removed as long as 
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the gene is not actively transcribed. The opposite order of events could also 
be true - methylated H3K4 might recruit RNA polymerase II and allows 
transcription initiation but elongation is prevented by H3K27 methylation. 
Therefore, bivalency is thought to prime developmental promoters for fast 
activation or final silencing depending on the lineage choice. Indeed, most 
bivalent regions are resolved to either H3K4 or H3K27 trimethylation during 
stem cell differentiation (Mikkelsen et al., 2007). Other bivalent domains are 
maintained during differentiation of embryonic stem cells if the corresponding 
gene is required even later during development. Therefore, bivalent domains 
were also identified in lineage-restricted somatic stem cells like neural 
progenitors (Mikkelsen et al., 2007) and hematopoietic stem cells (Abraham 
et al., 2013). However, the number of bivalent promoters in these cells is 
lower which correlates with their more restricted differentiation potential. The 
more differentiated a cell type is, the fewer genes might be needed for 
subsequent differentiation steps. Nevertheless, some genes in these somatic 
stem cells acquired bivalent domains that were established de novo later 
during development as they were monovalent or carried no modifications in 
ES cells. 
Mikkelsen and colleagues also found a connection between promoter CpG 
content and H3K4 and H3K27 trimethylation. Promoters with a high CpG 
density are almost all H3K4 trimethylated in ES cells and around 22% (ca. 
2500) also carry H3K27 methylation rendering them bivalent. If the 
repressing H3K27 methylation is absent from high CpG promoters in ES or 
NS cells, they are usually highly expressed. Therefore, most CpG island 
promoters represent genes that would be active by default. However, not all 
of them are housekeeping genes, but some are expressed in a tissue-
specific manner. Those genes require silencing by Polycomb-mediated 
H3K27 methylation in tissues where they should not be expressed. In 
contrast to CpG island promoters, only few promoters with low CpG content 
are H3K4 methylated in ES cells and even less are bivalent. Promoters 
without CpG islands are usually tissue-specific genes that only acquire H3K4 
methylation in the lineage where they are expressed and otherwise are 
mostly unmethylated at H3K4 and H3K27 (Mikkelsen et al., 2007). 
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1.2.5 Histone 3 lysine methyltransferases and demethylases 
Histone methyltransferases were first discovered in Drosophila melanogaster 
as transcriptional repressors or activators of Hox genes without knowing that 
they conduct their role by post-translational modifications of histones and 
chromatin remodeling. Mutations of Polycomb group proteins caused 
homeotic transformations during embryonic development due to the failure to 
prevent the expression of certain Hox genes in some tissues while Trithorax 
(Trx) mutations led to transformations because expression of some Hox 
genes could not be maintained in the appropriate tissues (reviewed in 
Schuettengruber et al., 2007). Thus, Polycomb group proteins are epigenetic 
repressors while Trithorax group proteins are activators of gene expression. 
The molecular mechanisms of transcriptional regulation were unraveled later 
by the finding that constitutive heterochromatin is H3K9 methylated by 
Suppressor of variegation 3-9 homolog 1 (Suv39h1) (Rea et al., 2000). The 
catalytically active region is the SET (Su(var)3-9, Enhancer-of-zeste, 
Trithorax) domain that can be found in all lysine methyltransferases except 
for Dot1. It transfers methyl groups from S-adenosyl-L-methionine to the ε-
amino group of a lysine residue. An overview over the known histone 
methyltransferases for lysine residues of histone H3 can be found in Figure 
5.  
Suv39h1 and Suv39h2 are mainly responsible for heterochromatic H3K9 
trimethylation at pericentric and telomeric regions and at repetitive elements 
(Peters et al., 2001). The heterodimer of G9a together with G9a-like protein 
(Glp) mono- and dimethylates H3K9 (Tachibana et al., 2005) thus silencing 
genomic regions during development in large heterochromatic blocks (Wen 
et al., 2009). The fourth known H3K9-specific enzyme SET domain 
bifurcated 1 (Setdb1) might be involved in silencing of some gene promoters 
with H3K9 trimethylation during development (Schultz et al. 2002). 
Polycomb group action was linked to H3K27 methylation by the finding that 
D. melanogaster Enhancer-of-zeste E(Z)-ESC and the corresponding 
mammalian Ezh2-Eed complex can methylate H3K27 in vitro (Cao et al., 
2002; Czermin et al., 2002; Kuzmichev et al., 2002; Muller et al., 2002). This 
so-called Polycomb repressive complex 2 (PRC2) consists of Suppressor of 
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zeste homologue 12 (Suz12), Embryonic ectoderm development (Eed), 
Retinoblastoma binding protein 4 (Rbbp4) and the SET domain-containing 
proteins Ezh1 or Ezh2. While Ezh1 is mainly expressed in differentiated cells 
Ezh2 is prevalent in proliferating cells (Margueron et al., 2008) thus being 
mainly responsible for H3K27 trimethylation on bivalent domains in ES cells. 
Besides methylating H3K27 the complex can further recruit PRC1 that 
remodels the chromatin and ubiquitinates H2AK119 to create 





Figure 5 Histone lysine methyltransferases and demethylases specific for lysine residues in 
the histone H3 tail. Adjusted from Agger, K., Christensen, J., Cloos, P.A., and Helin, K. 
(2008). The emerging functions of histone demethylases. Curr Opin Genet Dev 18, 159-168. 
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The first H3K4 methyltransferase was discovered in yeast and termed Set1 
(Roguev et al., 2001). In Saccharomyces cerevisiae this is the only 
methyltransferase specific for H3K4. D. melanogaster has three H3K4 
methyltransferases and mammals have at least six of them organized in 
pairs that arose from gene duplications (Glaser et al., 2006). Setd1a and 
Setd1b are the mammalian orthologs to yeast Set1. Mixed-lineage leukemia 
1 (Mll1) and Mll2 are orthologs to D. melanogaster Trithorax (Trx) and Mll3 
and Mll4 are orthologs to Trithorax-related (Trr). Like most histone modifying 
enzymes Setd1 and Mll proteins reside in multiprotein complexes. They 
share the common subunits Ash2 (Absent, small, or homeotic)-like (Ash2l), 
Retinoblastoma binding protein 5 (Rbbp5), WD repeat domain 5 (Wdr5) and 
dpy-30 homolog (C. elegans) (Dpy30) and some subunits that are specific for 
the complexes formed by each pair of methyltransferases (see Table 1). 
Importantly, there is no evidence that the complexes contain both paralog 
methyltransferases simultaneously as no protein interactions between Mll1 
and Mll2, Mll3 and Mll4 or Setd1a and Setd1b were reported so far. Instead, 
each H3K4 methyltransferase seems to form its own complex. 
To avoid frequent confusions caused by incoherent naming of Mll2 and Mll4 
in the databases (Bogershausen et al., 2012), we want to clarify that this 
study refers to Mll2 (Wbp7, Kmt2b) located on mouse chromosome 7 and 
human chromosome 19. In contrast, Mll4 (Alr, Kmt2d) is located on mouse 
chromosome 15 and human chromosome 12. Mutations in Mll4 can be 
frequently found in patients with Kabuki syndrome (Ng et al., 2010). 
For a long time histone methylation was regarded as stable modification that 
could only be diluted from chromatin during cell divisions or when histones 
were replaced. Since the discovery of Lysine-specific histone demethylase 1 
(Lsd1) that is specific for mono- and dimethylated H3K4 (Shi et al., 2004) 
demethylases for most known histone methylation sites were identified and 
characterized (reviewed in Agger et al., 2008). Some of them can 
demethylate more than one position. Lsd1 itself was shown to harbor H3K9 
demethylase activity when it interacts with the androgen receptor (Metzger et 
al., 2005). 
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Table 1 Yeast and mammalian H3K4 methyltransferase complex subunits. Collected 
data from mass spectrometry analysis and immunoprecipitation. Adjusted from of Ciotta, 
G. (2011) Tagging methods as a tool to investigate histone H3 methylation dynamics in 
mouse embryonic stem cells. (doctoral dissertation). 
 
yeast mammals 
Set1 Setd1a or Setd1b Mll1 or Mll2 Mll3 or Mll4 
Bre2 Ash2l Ash2l Ash2l 
Swd1 Rbbp5 Rbbp5 Rbbp5 
Swd3 Wdr5 Wdr5 Wdr5 
Sdc1 Dpy30 Dpy30 Dpy30 
Swd2 Wdr82 - - 
Spp1 Cxxc1 (Cfp1) - - 
  Menin Ptip 
 Hcfc1 Hcfc1 and Hcfc2 Pa1 
   Ncoa6 
   Utx 
 
 
1.2.6 Recruitment and Interplay of epigenetic regulators on promoters 
Polycomb and Trithorax proteins in D. melanogaster were early found to 
counteract each other. Today one knows that the molecular basis of these 
opposing functions is the specificity of their methyltransferase and chromatin 
remodeling activities. While Polycomb group proteins silence target genes by 
methylating H3K27 (PRC2) or ubiquitinating H2A and causing chromatin 
compaction (PRC1), H3K4 methylation by Trithorax group proteins activates 
or maintains gene expression. Most methyltransferase proteins contain 
domains that bind to the respective modification that they catalyze thereby 
propagating and spreading the modification along chromatin. For Mll1 the 
respective domain is the third zinc finger called Plant homeo domain (PHD) 
that was shown to bind trimethylated H3K4 (Chang et al., 2010). As 
proposed by the polarization model (Jaenisch and Bird, 2003) this creates 
feed-forward loops of active and repressive chromatin states. Thus, 
chromatin domains should be either H3K4 or H3K27/H3K9 methylated since 
these modifications seem to exclude each other. Bivalent nucleosomes 
represent an exception because lysine 4 and lysine 27 are methylated on 
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different H3 tails (Voigt et al., 2012). H3K27 methylation by PRC2 is blocked 
if H3K4 is trimethylated on the same histone tail and to a lesser extend by 
mono- and dimethylated H3K4 (Schmitges et al., 2011). Conversely, the 
Cxxc1 (Cfp1) subunit of Setd1a/b complexes seems to be excluded from 
promoters with bound Polycomb group proteins (Vernimmen et al., 2011). 
Since Setd1a is the main H3K4 methyltransferase in ES cells (Bledau et al., 
2014) that is linked to the transcription machinery via its complex subunit 
Wdr82 (Lee and Skalnik, 2008), it must likely refrain from binding to bivalent 
genes to prevent their premature activation. Instead, Mll2 is the main H3K4 
methyltransferase responsible for bivalent promoters in ES cells (Hu et al., 
2013b; Denissov et al., 2014). 
In addition to the reciprocal repulsion of H3K4 and H3K27 methylation and 
their respective methyltransferase complexes, the recruitment of histone 
demethylases also helps to keep active and repressive marks apart. 
Demethylases of repressive methylation marks are often interacting with 
complexes of activating methyltransferases and vice versa. For instance, 
H3K27 demethylase Utx (Ubiquitously transcribed tetratricopeptide repeat, X 
chromosome) was shown to be part of the Mll3/Mll4 H3K4 methyltransferase 
complexes (Lee et al., 2007; see Table 1). And the H3K4 demethylase 
Jarid1a (Jumonji, AT rich interactive domain 1A) interacts with PRC2 that 
methylates H3K27 (Pasini et al., 2008). 
In contrast to D. melanogaster where Trithorax and Polycomb proteins are 
directed to their target genes by binding to certain DNA motifs, none such 
Trithorax or Polycomb responsive elements (TRE and PRE) could be 
identified in mammals. How methyltransferases are recruited to certain 
genes in a cell type-specific manner in mammals remains elusive. One 
possibility is that lineage-specific interactors recruit the complexes to certain 
genes. A more general mechanism might apply for genes with CpG islands. 
These are often housekeeping genes and can recruit proteins with CxxC 
domains that bind to unmethylated CpG islands (Voo et al., 2000). This 
domain can be found in a variety of chromatin modifying enzymes and 
complexes including DNA methylating and 5-hydroxymethylating enzymes 
(Dnmt1, Tet1, Tet3), H3K36 demethylases (Fbxl10, Fbxl11) and H3K4 
 Introduction  
 23 
methyltransferases or complex subunits (Mll1, Mll2, Cxxc1) (reviewed in 
Long et al., 2013). Therefore, it is likely that CxxC domain-containing Mll1 
and Mll2 as well as the Cxxc1 (Cfp1) protein-containing Setd1a or Setd1b 
complexes (Lee and Skalnik, 2005) are directed to unmethylated CpG island 
promoters explaining why these are mostly H3K4 trimethylated in ES cells 
(Mikkelsen et al., 2007). H3K4 methylation in turn can inhibit de novo CpG 
methylation of promoters (Ooi et al., 2007) to prevent silencing. This might be 
particularly important in the case of bivalent genes that could be especially 
susceptible to final silencing by heterochromatin formation due to their 
H3K27 methylation. The catalytically inactive Dnmt3L competes with 
Dnmt3a/3b for PRC2 binding on bivalent genes in ES cells and thus prevents 
silencing by DNA methylation (Neri et al., 2013). Thus, the open chromatin 
structure of CpG promoters in ES cells is ensured by multiple mechanisms 
that reinforce each other. This leads to the question how bivalency can be 
resolved when cells differentiate. Differentiation signals might tip the balance 
of H3K4 and H3K27 methylation and the corresponding activity of 
methyltransferase and demethylase complexes in one or the other direction. 
In order to activate expression of bivalent genes, their enhancers seem to 
play an essential role. For instance, the enhancer of the α-globin locus is 
required for the activation of its CpG island promoter that is probably H3K27 
demethylated by Jmjd3 (Vernimmen et al., 2011). Thus, it is reasonable that 
the Mll3/Mll4 complexes that were recently identified as enhancer H3K4 
monomethylases (Hu et al., 2013a) contain the H3K27 demethylase Utx (Lee 
et al., 2007). Utx might be required in the complex to remove H3K27 
trimethylation not only from the enhancer, but also from the promoter when 
the enhancer loops there in order to activate expression. 
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1.2.7 Mixed-Lineage Leukemia 1 (Mll1) and Mll2 
Mll1 was first identified in humans because chromosome translocations that 
fuse the Mll1 N-terminal part with a variety of other proteins cause leukemia 
(Ziemin-van der Poel et al., 1991). In contrast, its paralog Mll2 was not 
associated with any human disorder so far and fusion proteins generated 
with Mll2 instead of Mll1 are not able to transform hematopoietic cells (Bach 
et al., 2009). This implies a functional specialization despite the high degree 
of homology between the two sister genes that arose from a gene duplication 
(FitzGerald and Diaz, 1999). Both proteins share almost the same overall 
domain structure (Fig. 6) and participate in multiprotein complexes of the 
same composition (Table 1). They are proteolytically processed by Taspase 
1. While Mll1 has two adjacent recognition sites (Hsieh et al., 2003a and 
2003b), Mll2 harbors only one.  
Mll1 is important for the activation of certain Hox genes (Hoxa7, Hoxa9, 
Hoxa10 and Hoxb5; Ernst et al., 2004b) and has essential functions in fetal 
and adult hematopoiesis and hematopoietic stem cells (Jude et al., 2007; 
McMahon et al., 2007). It is required in vivo for self-renewal and proliferation 
of hematopoietic stem and progenitor cells, but not for terminal differentiation 
(Jude et al., 2007). Therefore, no hematopoietic cells can be differentiated 
from ES cells if Mll1 is inactivated in vitro (Ernst et al., 2004a).  
The expression of leukemic Mll1 fusion proteins usually leads to an 
overexpression of Hox target genes. The fusions contain only the N-terminal 
part of Mll1 that mediates target gene binding, but not the C-terminal SET 
domain. Thus, the transcriptional activating features are probably provided by 
the diverse fusion partners. Some of them are transcriptional activators or 
elongation factors or can recruit transcription factors or chromatin modifying 
enzymes (reviewed in Krivtsov and Armstrong, 2007). Overexpression of 
Mll1 target genes probably leads to accelerated proliferation of the 
transformed hematopoietic stem or progenitor cells creating the leukemic 
phenotype. Importantly, Mll1 fusion proteins are only tumorigenic in 
hematopoietic cells but no other cell types when ubiquitously expressed. 
Thus, Mll1 binding to target genes is probably highly cell type-specific. 




Figure 6 Schematic representation of mouse H3K4 methyltransferases Mll1-4 and Setd1a-
1b with respective protein domains and number of amino acids for each protein. SNL, 
speckled nuclear localization signals; zf-CxxC, zinc finger with CxxC motif; PHD, Plant 
Homeo Domain; ePHD, extended PHD; FYRN, FY-rich N-terminal domain; FYRC, FY-rich 
C-terminal domain; HMG, High Mobility Group box; RRM, RNA recognition motif, HDAC 




It is likely that Mll1 has functions apart from hematopoiesis that are 
concealed by the severe hematopoietic phenotype that leads to rapid 
lethality. Mll1 and Mll2 knockout mice die at embryonic day 13.5 (E13.5; Yagi 
et al., 1998) and E10.5 respectively, the Mll2 knockout phenotype being 
more severe with growth retardation from E7.5 on (Glaser et al., 2006). 
However, while Mll1 is also essential in adult mice due to its requirements for 
hematopoiesis, Mll2 can be inactivated after E11.5 without any obvious 
phenotypic effects except male and female infertility (Glaser et al., 2009). In 
adulthood, Mll2 seems to be only required in spermatogonia (Glaser et al., 
2009) and for bulk H3K4 di- and trimethylation in oocytes where it takes part 
in epigenetic reprogramming that is required for zygotic gene activation 
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(Andreu-Vieyra et al., 2010). However, it is also involved in memory 
formation as it methylates H3K4 on several genes in the dentate gyrus 
(Kerimoglu et al., 2013). In ES cells, inactivation of Mll2 causes no changes 
in bulk H3K4 methylation levels or severe transcriptional changes (Lubitz et 
al., 2007) because mainly bivalent and thus inactive genes are affected 
(Denissov et al., 2014). Very few genes depend upon Mll2 for their 
expression in ES cells with Magohb being the most affected one (Glaser et 
al., 2009; Ladopoulos et al., 2013). It looses H3K4 trimethylation, acquires 
trimethylation of H3K27 and CpG methylation at its promoter increases in 
absence of Mll2. Thus, Magohb represents a paradigm showing how 
silencing by Polycomb and DNA methylation prevails if Trithorax action fails. 
 
1.3 Induced pluripotency and reprogramming 
For a long time embryonic development was regarded as unidirectional 
process that cannot be reversed. The somatic cells of an organism would 
become more and more restricted in their potential by epigenetic 
mechanisms until reaching a fully differentiated state. Today we know that 
differentiated cells can be reversed to the pluripotent state by different 
techniques that remodel the epigenome of the cell, a process called 
reprogramming. Such induced pluripotent stem (iPS) cells hold great promise 
for potential stem cell therapies since they combine all advantages of ES 
cells like expandability, amenability to genetic manipulations and the full 
differentiation potential without the ethical issues generated by the derivation 
of ES cells from human embryos. Moreover, the derivation of iPS cells from 
patients opens the way for autologous cell transplantations that are superior 
to allogenic transplants that require constant suppression of the immune 
system. However, the process of reprogramming is usually very inefficient 
and takes a relatively long time and thus the risk of acquiring new genetic 
mutations is increased. Therefore, a better understanding molecular 
mechanisms involved in the reprogramming process is still required in order 
to improve this technique. Nevertheless, the first clinical trial with human iPS 
cell-derived retinal pigment epithelium cell sheets in patients with 
neovascular age-related macular degeneration started in Japan this year 
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(2014). Although there was no approved medical treatment that used iPS 
cells at that time, the two pioneers of the reprogramming field, sir John 
Gurdon and Shinya Yamanaka, were rewarded the Nobel prize in physiology 
or medicine in 2012.  
 
1.3.1 Somatic cell reprogramming to pluripotency 
The first prove that the epigenome of fully differentiated cells can be reverted 
to the state of an early embryo was provided by sir John Gurdon already in 
1962. He transplanted the nuclei of intestinal epithelium cells into enucleated 
Xenopus laevis oocytes and obtained some live and fertile animals (Gurdon, 
1962). A similar nuclear transplantation method was used for cloning the 
sheep Dolly which was the first live-born cloned mammal (Campbell et al., 
1996). Nuclear transfer is very inefficient, but if successful the 
reprogramming process is completed in 1-2 days. Enucleation and the 
derivation of intact nuclei provide technical challenges. Another problem is 
the need of large amounts of oocytes and the ethical issues if human 
sources are required, as it would be the case for stem cell therapies. 
Thus, a more feasible method to study reprogramming was introduced where 
a somatic cell is fused to an ES cell (Tada et al., 2001). The ES cell-specific 
factors reprogramm the somatic genome within 1-2 days, a time span 
comparable to nuclear transfer. However, the fusion of the two different cells 
is a rare event. Therefore, one needs to select or sort for fusion events or 
against non-fused cells. One possibility is the use of a pluripotency reporter 
integrated into the genome of the somatic cell. One can either fuse a 
fluorescent reporter or a selection marker to an endogenous pluripotency 
gene or drive their expression from the promoter of such a pluripotency gene 
(for instance Oct4). This reporter is not present in the ES cell genome and 
not expressed in the somatic cells, but gets activated in successfully 
reprogrammed cells after fusion. The limitation of this straightforward method 
is the tetraploid state of the resulting reprogrammed cells. Despite being 
useful for studying the basic principles of reprogramming, these cells cannot 
be used for potential stem cell therapies. In the case of fusion-derived 
pluripotent mouse cells proving their pluripotency in vivo by blastocyst 
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injection is also difficult as tetraploid cells hardly contribute to the embryo but 
mainly to extra-embryonic tissues (Tarkowski et al., 1977).  
In 2006 Takahashi and Yamanaka succeeded to reprogramm somatic cells 
to an ES cell-like state only by overexpression of four transcription factors. 
This most direct method of reprogramming by exogenous factors will be 
subject of the following paragraph. An overview over the three different 
techniques applied to artificially revert a somatic cell epigenome to an 








1.3.2 Reprogramming by exogenous factors 
Somatic cell nuclear transfer and fusion-induced reprogramming showed that 
the cytoplasm of oocytes and ES cells contains factors that are able to reset 
the epigenome. Various groups tried to identify the factors involved in this 
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process. Takahashi and Yamanaka finally succeeded by transducing mouse 
embryonic fibroblasts (MEFs) with retroviruses encoding 24 different 
transcription factors that were known to play an important role for 
pluripotency and self-renewal of ES cells (Takahashi and Yamanaka, 2006). 
They narrowed down the number of transcription factors needed to four that 
were essential to reprogramm at reasonable efficiencies – Oct4, SRY (Sex 
determining region Y)-box 2 (Sox2), Klf4 and Myelocytomatosis oncogene (c-
Myc). The induced pluripotent stem (iPS) cells they obtained showed many 
ES-like features, but were not fully reprogrammed. For instance, the 
endogenous Oct4 promoter was still partially CpG methylated and cells were 
not able to contribute to live chimeric mice when injected into blastocysts. 
This was probably due to selection of reprogrammed cells using a F-box 
protein 15 (Fbx15) reporter that rendered cells with Fbx15 expression 
resistant to G418. Fbx15 is expressed in ES cells but not essential for 
pluripotency (Tokuzawa et al., 2003). Thus, Takahashi and Yamanaka 
probably selected for partially reprogrammed cells in their first attempt. One 
year later, Yamanaka and colleagues could present the first fully 
reprogrammed germline-competent iPS cells that were obtained by the same 
method except for using Nanog instead of Fbx15 for selection (Okita et al., 
2007). In the same year the group around Thomson managed to reprogramm 
human fibroblasts to pluripotency with lentiviral transduction (Yu et al., 2007). 
Instead of the “four Yamanaka factors” (Oct4, Sox2, Klf4, c-Myc or short 
OSKM) they used Oct4, Sox2, Nanog and Lin-28 homolog A (Lin28a). Since 
then, almost every cell type available was reprogrammed from mouse, 
human and other species with different combination of factors, medium 
composition and supplements and inhibitors added.  
During the last years each of the original OSKM factors were shown to be 
replaceable with related factors and even some proteins that appeared 
completely unconnected to the original factor. The most remarkable finding 
was probably the achievement of reprogramming with lineage specifiers 
instead of the classical pluripotency genes Oct4 and Sox2 (Shu et al., 2013). 
It suggests that (induced) pluripotency might rather represent an equilibrium 
state where two signals directing cells towards different lineages might hold 
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pluripotent or reprogramming cells in balance because they mutually 
suppress each other. 
Reprogramming cells have to overcome several barriers on their way to 
induced pluripotency with several steps that happen during early, 
intermediate or late phases of the process (Fig. 8; reviewed in Apostolou and 
Hochedlinger, 2013). The earliest event is the silencing of genes that are 
specifically expressed in the somatic cell type used as source for iPS cells, 
often fibroblasts. The pluripotency factors Oct4, Sox2 and Klf4 can suppress 
their transcription almost immediately due to their open chromatin. Next, 
genes that are important for mesodermal-to-epithelial transition (MET) are 
activated. The endogenous pluripotency genes can only be activated during 
mid to late phases of reprogramming because they are silenced by different 
epigenetic modifications and thus not accessible earlier. Their reactivation is 
initiated by binding of the exogenous factors to the enhancers. Oct4 and 
Sox2 were shown to form heterodimers that bind to pluripotency gene 
enhancers including their own ones establishing a self-reinforching regulatory 
loop (Chew et al., 2005). Thereby, the forced expression of exogenous 
factors gradually reestablishes the transcriptional network of pluripotent cells 
during reprogramming. As final step after reactivation of the endogenous 
pluripotency genes, iPS cells have to silence the retroviral integrations in 
order to get independent of exogenous factor expression. The fully 
reprogrammed cells show all characteristics of ES cells, like reactivation of 
the second X chromosome in female cells and the expression of telomerase 
and they are germline-competent.  
While Oct4, Sox2 and Klf4 are needed during almost the whole 
reprogramming process until silencing of the transgenes, c-Myc is mainly 
required in early phases. It is not essential for reprogramming, but without c-
Myc the reprogramming process is significantly delayed and efficiency drops 
by one to two orders of magnitude (Wernig et al., 2008b). C-Myc might be 
required for efficient reprogramming to overcome the barrier of cellular 
senescence and stimulate growth of reprogramming intermediates. It is also 
involved in changing the metabolism from oxidative to glycolytic and to 
enhance transcription of target genes since it mediates pause release and 
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Figure 8 Dynamics of key molecular events during reprogramming of fibroblasts by 
exogenous factors. From Apostolou, E. and Hochedlinger, K. (2013) Chromatin dynamics 
during cellular reprogramming. Nature 502, 462–471. 
 
 
1.3.3 Methods for exogenous factor delivery 
Reprogramming by exogenous factors has a very low efficiency (usually 
around 0.1 - 1 %) and is slow compared to the other two methods with 
durations of 2 weeks for mouse and up to 4 weeks for human cells. Thus, at 
least some steps of the reprogramming process appear to be stochastic 
providing a window for improvements. First, it seems to be essential that the 
OSKM transcription factors are expressed at the right stoichiometry (Carey et 
al., 2011). Thus, the use of polycistronic vectors that express all factors in a 
predetermined convenient ratio is beneficial compared to the original 
approach with single viruses for each cDNA. Second, since retained 
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expression of exogenous factors leads to the growth of partially 
reprogrammed cells (Takahashi and Yamanaka, 2006) and hinders 
differentiation of obtained iPS cells, inducible expression of the transgenes 
(for example by the Tet-On system) offers the advantage of tightly controlling 
the factor expression in a temporal manner (Stadtfeld et al., 2008). 
Additionally, it allows the derivation of secondary iPS cells from mice that are 
generated from first generation iPS cells by blastocyst injection. Cells from 
these mice can be reprogrammed simply by inducing the expression of the 
already integrated reprogramming factors. The generation of such secondary 
iPS cells is much more efficient (25 - 50 times) because the integration site 
and expression level of transgenes already proved to be functional in the first 
reprogramming round (Wernig et al., 2008a). Another way to prevent residual 
factor expression and reactivation of transgenes (especially of c-Myc) that 
could lead to tumor formation (Okita et al., 2007) is to generate viruses or 
vectors that can be excised from the genome after reprogramming. 
Examples are lentiviruses flanked by loxP site that can be excised by 
transient transfection with Cre recombinase (Chang et al., 2009) or the use of 
transposon-based systems. Some transposable elements like the PiggyBac 
from the cabbage looper Trichoplusia ni have the advantage that they can be 
excised without leaving footprints (Fraser et al., 1996; Woltjen et al., 2009) 
and were therefore used to design reprogramming strategies (Kaji et al., 
2009; Woltjen et al., 2009; Yusa et al., 2009).  
Other systems prevent genetic manipulation of the host genome altogether in 
order to smooth the way for future therapies with iPS cells. One can express 
the reprogramming factors ectopically from non-integrating episomal vectors 
(Yu et al., 2009) or use RNA viruses like Sendai (Fusaki et al., 2009). One 
promising technique is reprogramming with synthetic mRNAs that appears to 
be faster (around 2 weeks for human fibroblasts) than classical 
reprogramming (Warren et al., 2010). Using poly-arginine fused 
reprogramming factors that can enter the cells and the nucleus, one can 
reprogramm cells with protein transduction albeit with high technical efforts 
and lower efficiencies (Zhou et al., 2009). 
In order to further improve the application of iPS cells for potential stem cell 
therapies, many laboratories attempted to gradually replace transcription 
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factors with inhibitors or other small molecules that are easier to produce 
than recombinant proteins or synthetic RNA. In 2013 Deng and colleagues 
managed to reprogramm MEFs with a combination of 7 small molecule 
compounds in the absence of any exogenously supplied transcription factors 
(Hou et al., 2013). However, this achievement could not be successfully 
repeated for human cells so far as they react differently to some of these 
molecules. Early in 2014 one group from the RIKEN Center for 
Developmental Biology in Kobe published two controversial reports claiming 
that pluripotency can be induced in cells simply by exposure to stress like low 
pH. However, other laboratories encountered problems when they attempted 
to reproduce the phenomenon called stimulus-triggered acquisition of 
pluripotency (STAP). Too many open questions and indications for image 
manipulation finally led to the retraction of both reports (Obokata et al., 
2014a; Obokata et al., 2014b). 
To generate cells for potential cell therapies does not necessarily involve a 
pluripotent intermediate. One can directly reprogramm one differentiated cell 
type into another by introducing the appropriate lineage-specific factors as it 
was shown by conversion of fibroblasts into cardiomyocytes (Ieda et al., 
2010) or neurons (Vierbuchen et al., 2010). However, having iPS cells as 
intermediates might still be beneficial in many cases in order to increase cells 
numbers or for genetic correction of mutations. 
 
1.3.4 Epigenetic changes during reprogramming 
Early after Takahashi’s and Yamanaka’s discovery small-molecule libraries 
were screened in order to identify compounds that improve the low efficiency 
of pluripotency induction. With reprogramming being a process that involves 
enormous epigenetic remodeling, inhibitors of chromatin modifiers were 
expected as leads. Indeed, the histone deacetylase (HDAC) inhibitor valproic 
acid (VPA) (Huangfu et al., 2008) and the G9a inhibitor BIX-01294 (Shi et al., 
2008) were shown to greatly improve reprogramming efficiency. Both 
compounds facilitate reactivation of silenced genes. While VPA might cause 
a general opening of chromatin due to increased histone acetylation, 
inhibition of the H3K9 mono- and dimethyltransferase G9a could help to 
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remove the blocks of dimethylated H3K9 that silence large genomic regions 
in differentiated cells (Wen et al., 2009).  
Other genes might be silenced by DNA methylation that has to be removed 
for efficient reprogramming. A triple knockout of all three Tet enzymes 
abolished MEF reprogramming due to a failure to activate the microRNA-200 
family that is essential for mesenchymal-to-epithelial transition (MET) during 
early reprogramming phases. These microRNA genes apparently require 
active DNA demethylation by Tets while the DNA methylated Oct4 promoter 
can also be passively demethylated during cell divisions in the late 
reprogramming phases (Hu et al., 2014).  
Besides H3K9 and DNA methylation, the removal of H3K27 methylation that 
silences other genes required for successful reprogramming seems to be 
important as well. The knockout of H3K27 demethylase Utx diminished the 
amount of iPS cells (Mansour et al., 2012 and Neumann, unpublished data). 
In contrast, the second H3K27 demethylase Jmjd3 inhibits reprogramming by 
demethylase-independent and -dependent roles, the latter by activating the 
INK4/Arf locus that promotes senescence (Zhao et al., 2013). Although both 
enzymes are H3K27 demethylases, Jmjd3 hinders reprogramming while Utx 
appears to promote it. Thus, not only the catalytic activity, but also the target 
gene specificity of chromatin modifiers decides whether they promote or 
inhibit the reprogramming process.  
While the roles of the repressive chromatin marks H3K9 and H3K27 
methylation and the respective methyltransferases and demethylases during 
different phases of pluripotency induction are relatively well established, the 
importance of H3K4 methylation for this process remained elusive so far. 
Wdr5 was shown to be important for reprogramming because it interacts with 
Oct4 to activate target genes (Ang et al., 2011). However, with Wdr5 being a 
core component of all six H3K4 methyltransferase complexes, it is not clear 
which of them is indeed required. The single catalytic Setd1 and Mll enzymes 
might have different roles during induction of pluripotency depending on their 
target gene specificity. 
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2 Aim of this work 
While yeast has only one H3K4 methyltransferase complex, namely 
Set1/COMPASS, mammals have six of them. Their catalytic subunits are 
organized in three pairs of sister genes – Setd1a and Setd1b, Mixed Lineage 
Leukemia 1 (Mll1) and Mll2 as well as Mll3 and Mll4. The single complexes 
might have distinct as well as redundant functions. In the present study we 
aimed to examine if the paralogs Mll1 and Mll2 have specific functions and if 
they cooperate during neural differentiation and reprogramming to induced 
pluripotency. 
Mll2 was recently identified as the major H3K4 methyltransferase on bivalent 
promoters in ES cells (Denissov et al., 2014; Hu et al., 2013b). Upon its 
knockout around 3000 promoters showed reduced levels of H3K4 
trimethylation, most of them being bivalent in the wild type situation 
(Denissov et al., 2014). The reasons why bivalent domains exist and if they 
are important for lineage choices or differentiation are not well understood so 
far. Therefore, we decided to examine the consequences of Mll2 inactivation 
during differentiation of mouse ES cells to neural progenitors. We determined 
the time point of essential protein function, crucial domains of Mll2, its 
interplay with Mll1 and potential target genes involved in this process.  
Additionally, we studied how the paralogs Mll1 and Mll2 are involved in the 
induction of pluripotency by reprogramming of neural stem cells. Being H3K4 
methyltransferases that play a role in neural differentiation we speculated 
that they might also have crucial functions for gene reactivation during the 
reverse process. 
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3 Materials and methods 
3.1 General materials 
3.1.1 Instrumentation     company  
CASY cell counter (model TTC)   Roche 
G:Box gel documentation system   Syngene 
Glomax 96 microplate luminometer  Promega 
ImageQuant LAS-3000 / LAS-4000   GE Healthcare 
LSR II Flow Cytometer    Becton Dickinson 
Mini Protean II vertical electrophoresis system Bio-Rad Laboratories 
Mx3000P / Mx3005P multiplex PCR instr. Agilent 
NanoDrop ND-1000 spectrophotometer  PeQLab 
Nucleofector II device    Lonza 
Protein Electrophosesis system   Bio-Rad Laboratories 
S2 sonicator      Covaris 
TCS SP5 I confocal system   Leica 
Thermocycler ep Gradient S   Eppendorf 
Thermomixer compact    Eppendorf 
XCell II blot module     Invitrogen 
 
3.1.2 Disposables      company (cat. number) 
1 ml CryoTube vials     Nunc (366656) 
10 cm and 15 cm tissue culture dishes  Nunc (172958 and 168381) 
15 ml low DNA binding polystyrene tubes  BD Falcon (352095) 
4-well plates      Nunc (176740) 
48-well plates     BD Falcon (353078) 
6-, 24- and 96-well plates Nunc (140675, 142475, 
167008) 
6 cm suspension culture dishes   Sigma-Aldrich (CLS430589) 
6 cm tissue culture dishes    VWR (734-2318) 
96-well qPCR plates and optical strip caps Agilent (401333 and 401425) 
Blotting paper (extra thick)    Bio-Rad Laborat. (170-3967) 
Cell scraper      BD Falcon (353085) 
DNA LoBind tubes 1.5 ml    Eppendorf (022431021) 
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FACS tubes      BD Falcon (352054) 
Glass coverslips (12 mm diameter, round) Menzel-Gläser 
(CB00120RA1) 
NuPAGE 3-8% Tris-acetate gradient gels Invitrogen (EA03752BOX) 
PVDF membrane     Roche (03010040001) 
 
3.1.3 Chemicals and reagents    company (cat. number) 
1-Naphthyl phosphate disodium salt  Sigma-Aldrich (N7255) 
2-Mercaptoethanol (β-Mercaptoethanol) Sigma-Aldrich (M6250) 
2-Propanol (isopropanol)    VWR (20842.330) 
4-(2-hydroxyethyl)-1-piperazineethane-  Sigma-Aldrich (54457) 
sulfonic acid (HEPES)     
4’,6-Diamidino-2-phenylindole hydrochloride Sigma-Aldrich (D8417) 
(DAPI) 
4-Hydroxytamoxifen  (4OHT)   Sigma-Aldrich (H7904) 
Acetic acid      VWR (20104) 
Acrylamide/bis-acrylamide 30%   Bio-Rad Laborat. (161-0156) 
Agarose      Serva (11404) 
Ammonium persulfate (APS)   Sigma-Aldrich (A3678) 
Bicine       Sigma-Aldrich (B3876) 
Bis-Tris      AppliChem (A1025) 
Bovine serum albumin (BSA)   Sigma-Aldrich (A7906) 
Bromphenol blue sodium salt   Sigma-Aldrich (B5525) 
Casyton      Omni Life Science (2501037) 
Chloroform       Merck Millipore (102445) 
D-glucose      Merck Millipore (108342) 
Diethylpyrocarbonate (DEPC)   Carl Roth (K028) 
Dimethyl sulfoxide (DMSO )   Sigma-Aldrich (D2650) 
di-Sodium hydrogen phosphate dihydrate  Merck Millipore (106580) 
(Na2HPO4 * 2 H2O)       
Disuccinimidyl glutarate (DSG)   Santa Cruz B. (sc-285455A) 
Dithiothreitol (DTT)     Sigma-Aldrich (D9779) 
Doxycyclin (Dox)     Sigma-Aldrich (D9891) 
Ethanol (EtOH)     VWR (20821) 
Ethidium bromide (EtBr)    Sigma-Aldrich (E8751) 
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Ethylene glycol-bis(2-aminoethylether)  Sigma-Aldrich (E3889) 
-N,N,N′,N′-tetraacetic acid (EGTA)    
Fast Red TR Salt hemi (zinc chloride) salt Sigma-Aldrich (F8764) 
Formaldehyde     Merck Millipore (104003) 
Formamide      Merck Millipore (109684)  
Gelatin from cold water fish skin   Sigma-Aldrich (G7041) 
Glycerol      Merck Millipore (104092) 
Glycine      AppliChem (A1067) 
Glycogen      Santa Cruz Biot. (sc-203976) 
Goat serum      Sigma-Aldrich (G9023) 
Hydrochloric acid (HCl)    VWR (20252) 
Igepal CA-630     Sigma-Aldrich (I7771) 
Isoamyl alcohol     Merck Millipore (100979) 
Lithium chloride (LiCl)    Sigma-Aldrich (L4408) 
Magnesium chloride (MgCl2)   Sigma-Aldrich (208337) 
Methanol      VWR (20847) 
N,N,N′,N′-Tetramethylethylenediamine  Sigma-Aldrich (T9281) 
(TEMED) 
Phenol/chloroform/isoamyl alcohol (25:24:1) Sigma-Aldrich (P2069) 
Poly (vinyl alcohol) 4-88 (Mowiol 4-88)  Sigma-Aldrich (81381) 
Ponceau S      Sigma-Aldrich (P3504) 
Potassium chloride (KCl)    Merck Millipore (529552) 
Potassium dihydrogen phosphate (KH2PO4) Merck Millipore (104873) 
Salmon sperm DNA (sonicated)   Agilent (201190) 
SDS sample buffer, Laemmli 2x   Sigma-Aldrich (S3401) 
Sodium acetate trihydrate    Sigma-Aldrich (S7670) 
Sodium chloride (NaCl)    VWR (27810) 
Sodium deoxycholate    Sigma-Aldrich (D6750) 
Sodium dodecyl sulfate (SDS)   Carl Roth (2326.2) 
Sodium hydrogen carbonate (NaHCO3)  Merck Millipore (106329) 
Thiodiethylenglycole / 2,2′-Thiodiethanol  Sigma-Aldrich (166782) 
(TDG) 
Titriplex III Ethylendinitrilotetraacetic acid  Merck Millipore (108418) 
(EDTA) 
TRI reagent      Sigma-Aldrich (T9424) 
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Tricine      AppliChem (A1085) 
Tris       Carl Roth (AE15) 
Tris-maleate (Trizma maleate)   Sigma-Aldrich (T3128) 
Triton X-100      Sigma-Aldrich (T8787) 
Tween 20      Sigma-Aldrich (P7949) 
Xylene cyanol FF     Sigma-Aldrich (X4126) 
 
3.1.4 Kits, enzymes, markers, inhibitors company (cat. number) 
100 bp DNA ladder     NEB (N3231) 
AffinityScript Multi-Temp cDNA synthesis kit   Agilent (200436) 
Benzonase      Merck Millipore (70746-3) 
BioLux Gaussian Luciferase assay kit  NEB (E3300) 
ColorPlus prestained protein ladder, broad r. NEB (P7711S) 
cOmplete protease inhibitor tablets  Roche (04693116001) 
Deoxynucleotide (dNTP) mix (10 mM each) NEB (N0447S) 
GoTaq qPCR master mix    Promega (A6002) 
HALT protease inhibitor cocktail   Thermo Scientific (87785) 
Luminata Classico Western HRP substrate Merck Millip. (WBLUC0500) 
Luminata Forte Western HRP substrate  Merck Millip. (WBLUF0100) 
MG-132 proteasome inhibitor   Merck Millipore (474790) 
Nucleofection kit for mouse NS cells  Lonza  (VVPG-1004) 
Proteinase K      Fischer Sc. (BP1700-100) 
Protein G Sepharose 4 Fast Flow beads  GE Healthcare (17-0618-01) 
Restriction enzymes (AhdI, EcoRV, SfiI, SpeI) NEB (R0584, R3195, R0123,  
       R0133) 
RNase-free DNase Set    Qiagen (79254) 
Sepharose CL-4B beads    Sigma-Aldrich (CL4B200) 
Taq DNA polymerase and buffer   5 prime (2200010) 
ZR RNA MiniPrep     Zymo Research (R1065) 
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3.1.5 Buffers and solutions 
Acrylamide running gel (12%, 20 ml for 4 gels, 1 mm spacers) 
        volume   final conc. 
ddH2O      6.5 ml    - 
30% acrylamide/bis-acrylamide  8 ml    12% 
1.5 M Tris-HCl (pH 8.8)   5 ml    375 mM 
10% SDS      200 µl   0.1% 
TDG       80 µl    0.4% 
10% APS      200 µl   0.1% 
TEMED      20 µl    0.1% 
 
Acrylamide running gel (15%, 20 ml for 4 gels, 1 mm spacers) 
        volume   final conc. 
ddH2O      4.5 ml    - 
30% acrylamide/bis-acrylamide  10 ml   15% 
1.5 M Tris-HCl (pH 8.8)   5 ml    375 mM 
10% SDS      200 µl   0.1% 
TDG       80 µl    0.4% 
10% APS      200 µl   0.1% 
TEMED      20 µl    0.1% 
 
Acrylamide stacking gel (4%, 8 ml for 4 gels, 1 mm spacers) 
        volume   final conc. 
ddH2O      4.8 ml    - 
30% acrylamide/bis-acrylamide  1.04 ml   4% 
1 M Tris-HCl (pH 6.8)   2 ml    250 mM 
10% SDS      80 µl    0.1% 
TDG       32 µl    0.4% 
10% APS      80 µl    0.1% 
TEMED      8 µl    0.1% 
 
Alkaline phosphatase staining solution 
        volume/amount  final conc. 
ddH2O      8.7 ml   - 
200 mM Tris-maleate (pH 9.0)  1.25 ml   25 mM 
1 M MgCl2     80 µl    8 mM 
1-Naphthyl phosphate   4 mg    0.04% (w/v) 
Fast Red TR salt    10 mg   0.1% (w/v) 
Always prepare fresh. After addition of 1-Naphthyl phosphate and Fast Red 
TR staining solution must be used within 5 min. 
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Antibody incubation solution 
        volume/amount  final conc. 
BSA       2.5 g    5% 
10% Tween 20     250 µl   0.05% 
Fill up to 50 ml with PBS. 
 
Benzonase buffer 
        volume   final conc. 
homogenization buffer   1 ml    1 x 
1 M MgCl2     3 µl    3 mM 
(additional) 
25 U/ml Benzonase    5 µl    125 U/ml 
 
ChIP buffer 
        volume   final conc. 
ddH2O      703 ml   - 
1 M Tris-HCl (pH 8.0)   16.7 ml   16.7 mM 
0.5 M EDTA (pH 8.0)   2.4 ml   1.2 mM 
10% SDS      1 ml    0.01% 
10% Triton X-100    110 ml   1.1% 
1 M NaCl      167 ml   167 mM 
Filter sterilize. Add fresh before use:  
10 mM MG-132    1 µl/ml   10 µM 
50x cOmplete protease inhibitor/PBS 20 µl/ml   1x 
(1 tablet in 1 ml PBS) 
 
ChIP elution buffer 
        volume/amount  final conc. 
10% SDS      500 µl   1% 
NaHCO3      0.42 g   0.1 M 
Fill up to 5 ml with ddH2O and filter sterilize. Always prepare fresh before 
use. 
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ChIP lysis buffer 
        volume   final conc. 
ddH2O      927 ml    - 
1 M Tris-HCl (pH 7.5)   10 ml   10 mM 
1 M NaCl      10 ml   10 mM 
1 M MgCl2     3 ml    3 mM 
10% Igepal CA-630    50 ml   0.5% 
Filter sterilize. Add fresh before use:  
10 mM MG-132    1 µl/ml   10 µM 
50x cOmplete protease inhibitor/PBS 20 µl/ml   1x 
(1 tablet in 1 ml PBS) 
 
ChIP sonication buffer 
        volume   final conc. 
ddH2O      987 ml    - 
1 M Tris-HCl (pH 8.0)   10 ml   10 mM 
0.5 M EDTA (pH 8.0)   2 ml    1 mM 
0.5 M EGTA (pH 8.0)   1 ml    0.5 mM 
Filter sterilize. Add fresh before use (per ml):  
10 mM MG-132    1 µl/ml   10 µM 
50x cOmplete protease inhibitor/PBS 20 µl/ml   1x 
(1 tablet in 1 ml PBS) 
 
DNA lysis buffer 
        volume   final conc. 
ddH2O      82.5 ml   -   
1 M Tris-HCl (pH 8.5)   10 ml   100 mM 
0.5 M EDTA     1 ml    5 mM 
5 M NaCl      4 ml    200 mM 
10% SDS      2 ml    0.2% 
Add fresh before use:  
20 mg/ml Proteinase K    5 µl/ml   100 µg/ml 
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High-salt protein lysis buffer 
        volume   final conc. 
ddH2O      28.7 ml   -   
1 M HEPES (pH 8.0)    800 µl   20 mM 
5 M NaCl      3.84 ml   420 mM 
1 M MgCl2     60 µl    1.5 mM 
0.5 M EDTA (pH 8.0)   16 µl    0.2 mM 
1 M DTT      20 µl    0.5 mM 
10% Igepal CA-630    2 ml    0.5% 
Glycerol      4 ml    10% 
Add fresh before use:  
10 mM MG-132    1 µl/ml   10 µM 
50x cOmplete protease inhibitor/PBS 20 µl/ml   1x 
(1 tablet in 1 ml PBS) 
 
Homogenization buffer 
        volume   final conc. 
ddH2O      3.37 ml   -   
1 M HEPES (pH 8.0)    100 µl   20 mM 
1 M NaCl      750 µl   150 mM 
1 M MgCl2     7.5 µl   1.5 mM 
Glycerol      500 µl   10% 
0.5 M EDTA (pH 8.0)   20 µl    2 mM 
10% Tween 20     250 µl   0.5% 
1 M DTT      5 µl    1 mM  
Add fresh before use (per ml):  
100x HALT protease inhibitor   10 µl /ml   1 x 
 
Immune complex wash buffer - High Salt 
        volume   final conc. 
ddH2O      366 ml   - 
1 M Tris-HCl (pH 8.0)   20 ml   20 mM 
0.5 M EDTA (pH 8.0)   4 ml    2 mM 
10% SDS      10 ml   0.1% 
10% Triton X-100    100 ml   1% 
1 M NaCl      500 ml   500 mM 
Filter sterilize. 
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Immune complex wash buffer - Low Salt 
        volume   final conc. 
ddH2O      716 ml   - 
1 M Tris-HCl (pH 8.0)   20 ml   20 mM 
0.5 M EDTA (pH 8.0)   4 ml    2 mM 
10% SDS      10 ml   0.1% 
10% Triton X-100    100 ml   1% 
1 M NaCl      150 ml   150 mM 
Filter sterilize. 
 
Immune complex wash buffer - LiCl 
        volume/amount  final conc. 
1 M Tris-HCl (pH 8.0)   10 ml   10 mM 
0.5 M EDTA (pH 8.0)   2 ml    1 mM 
10% Igepal CA-630    100 ml   1% 
Sodium deoxycholate   10 g    1% 
1 M LiCl      250 ml   0.25 M 
Fill up to 1000 ml with ddH2O and filter sterilize. 
 
Mowiol 
        volume/amount  final conc. 
ddH2O      6 ml    -   
Glycerol      6 g / 4.8 ml  20% 
Poly (vinyl alcohol) 4-88   2.4 g    3 M 
Stir 2 h at RT. Then add: 
0.2 M Tris (pH 8.5)    12 ml   0.1 M 
Stir over night at 50ºC, clarify by centrifugation at 3,400 xg for 20 min. Aliquot 
supernatant and freeze until use. 
 
Phosphate buffered saline (PBS) 
        amount   final conc. 
NaCl       10 g    171 mM 
KCl       0.25 g   3.4 mM 
Na2HPO4 * 2 H2O    1.78 g   10 mM 
KH2PO4      0.25 g   1.9 mM 
Fill up to 1000 ml with ddH2O. Adjust pH to 7.4 with HCl. 
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RNA loading buffer (2x) 
        volume   final conc. 
Formamide     950 µl   95% 
10% SDS      2.5 µl   0.025% 
2% Brom phenol blue   12.5 µl   0.025% 
10% Xylene cyanol FF   2.5 µl   0.025% 
1% EtBr      25 µl    0.025% 
0.5 M EDTA pH 8.0    1 µl    0.5 mM 
 
TBS-T 
        volume   final conc. 
ddH2O       412.5 ml   - 
1 M Tris-HCl (pH 7.4)   10 ml   20 mM 
1 M NaCl      75 ml   150 mM 
10% Tween 20     2.5 ml   0.05% 
 
TE buffer 
        volume   final conc. 
ddH2O      988 ml   -   
1 M Tris-HCl (pH 8.0)   10 ml   10 mM 
0.5 M EDTA (pH 8.0)   2 ml    1 mM 
 
Transfer buffer (20x) 
        volume/amount  final conc. (1x) 
Bis-Tris      52.4 g   25 mM 
Bicine      40.8 g   25 mM 
0.5 M EDTA     20 ml    1 ml 
Fill up to 500 ml with ddH2O.  
 
Transfer buffer (1x) 
        volume   final conc. 
ddH2O      850 ml   - 
20x Transfer buffer    50 ml   1x 
Methanol      100 ml   10% 
TDG       400 µl   0.04% 
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Tris-acetate SDS running buffer (20x) 
        amount   final conc. (1x) 
Tris       60.6 g   50 mM 
Tricine      89.5 g   50 mM 
SDS       10 g     0.1% 
Fill up to 500 ml with ddH2O. Dilute 1:20 with ddH2O for use. 
 
Tris-glycine SDS running buffer (10x) 
        amount   final conc. (1x) 
Tris       30.3 g   25 mM 
Glycine      144 g   192 mM 
SDS       10 g     0.1% 
Fill up to 1000 ml with ddH2O. Dilute 1:10 with ddH2O for use. 
 
Tris-maleate solution 
        amount   final conc. 
Tris       12.1 g   1 M 
Tris-maleate     4.74 g   200 mM 




3.1.6.1 Monoclonal primary antibodies  
company (cat. number) dilution 
mouse anti-Actin β     Sigma-Aldrich (A5441) 1:2500 WB 
mouse anti-class III β-tubulin (TuJ-1) Neuromics (MO15013)  1:100 IF 
mouse anti-Nestin (Rat-401)  DSHB (supernatant) 1:20 IF 
mouse anti-Oct4 (C-10)   Santa Cruz B. (sc-5279) 1:100 IF 
mouse anti-Pax6    DSHB (supernatant) 1:20 IF 
mouse anti-Ssea-1 (MC-480)  DSHB (supernatant) 1:20 IF 
rat anti-CD44-PE     BD Pharmingen (553134) 1:100 FC       
rat IgG-PE (isotype control)   BD Pharmingen (553989) 1:100 FC       
rabbit anti-Cleaved Caspase-3   Cell Signaling/NEB (9664)  1:200 IF 
(Asp175) (5A1E) 
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3.1.6.2 Polyclonal primary antibodies  
company (cat. number)   dilution 
rabbit anti-Bcl2     BD Pharmingen (554279) 1:2000 WB 
goat anti-GFP    MPI-CBG   1:2000 WB 
rabbit anti-Gfap IgG    DAKO  (M076101-2) 1:100 IF 
rabbit anti-H3    Abcam (ab1791)  1:5000 WB 
rabbit anti-H3K27me3   Merck Millipore (07-449) 1:2000 WB 
rabbit anti-H3K4me1   Diagenode (C15410037) 1:2000 WB 
rabbit anti-H3K4me2   Abcam (ab32356)  1:1000 WB 
rabbit anti-H3K4me3   Abcam (ab8580)  1:1000 WB 
rabbit anti-Mll2 IgG [#3853]  Glaser et al., 2006  1:1000 WB 
rabbit anti-Nanog    Calbiochem (sc1000) 1:200 IF 
rabbit anti-Sox1    Chemicon (AB5768) 1:100 IF 
rabbit anti-Zo-1    BD Bioscience (610966) 1:100 IF 
 
 
3.1.6.3 Secondary antibodies   
company (cat. number) dilution 
rabbit anti-goat IgG-HRP   Sigma-Aldrich (A5420) 1:10000 WB 
goat anti-mouse IgG-HRP   Thermo Scientific (32430) 1:10000 WB 
goat anti-rabbit IgG-HRP   Thermo Scientific (31460) 1:10000 WB 
goat anti-mouse IgG-TRITC  Santa Cruz Biot. (sc-2092) 1:500 IF 
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3.1.7 Primer sequences 
3.1.7.1 qRT-PCR primer pairs 
Table 2 Primer pairs used for qRT-PCR. All primers are designed to amplify mouse cDNA. 
*Otx2 primers amplify a 24 bp longer product from isoform a than from isoform b. 
 
primer name sense primer (5’ → 3’) antisense primer (5’ → 3’) product 
Actb CCAACACAGTGCTGTCTGGTGGT GCGCTCAGGAGGAGCAATGATCTTG 122 bp 
B3galnt1 TGACAGCCCCTGTGGTTAAG CACATTGTAGTGGGGGAGGC 183 bp 
Bcl2 CCCCTGGTGGACAACATCGCC GGTCGCATGCTGGGGCCATA 122 bp 
Dazl CTGGAAATGGCCCGCAAAAG AAGCACTGCCCGACTTCTTC 161 bp 
Fgf5 TGCTGTGTCTCAGGGGATTGTAGGA TTCTGTGGATCGCGGACGCA 170 bp 
Gapdh TCACCACCATGGAGAAGGC GCTAAGCAGTTGGTGGTGCA 169 bp 
Gstm5 GGTTCGCCTCTGCTACAATTC CTCATCCAGACACTTGGGCTC 199 bp 
Mael AGCAACAGTGTGACACCCAA GCCCGAAATTTTCACCCCAG 159 bp 
Nanog CCAAAGGATGAAGTGCAAGC GCAATGGATGCTGGGATACT 106 bp 
Nestin GCTTCTCTTGGCTTTCCTGA AGAGAAGGATGTTGGGCTGA 108 bp 
Nxt2 ex3-4 AGATGTTGCCTTCCAGCGAA ACGAGCACTGTAGTTTGGCA 91 bp 
Nxt2 ex1B-1 AGTGAGAGCTGACGGAGGAT GCTGGAAATGGTCTGCTCCA 188 bp 
Oct4 ex3-4 CGAGGCCTTGCAGCTCAGCC AGGGAGGGCTTCGGGCACTT 210 bp 
Oct4 endog. TGGAAGCCCCCACTTCACCACA AGCATCCCCAGGGAGGGCTG 131 bp 
Oct4 exog. TGGAAGCCCCCACTTCACCACA TCCTCCACGTCACCGCATGT 162 bp 
Otud6a TCACCCACCATTGTCATCGG AGCAACCTCAATGGGCTTCA 117 bp 
Otx2 ex1A2-2 TTCTAACGTCCAATGCGGCT GTCCTCTCCCTTCGCTGTTT 272/296 bp* 
Otx2 ex1B-2 GCGCTATCGCTATTTGCTCC GTCCTCTCCCTTCGCTGTTT 270/294 bp* 
Otx2 ex1C-2 CCCTCCGAAGCAGTAAACCA GTCCTCTCCCTTCGCTGTTT 300/324 bp* 
Otx2 ex2-3 TGCCAGAATCCAGGGTGCAGGTAT GGGGGACTGAACTGGCCACTTG 172 bp 
Pax6 GCTGAAGCGGAAGCTGCAAAGAA TTTCCCGGGCAAACACATCTGGAT 110 bp 
Pdgfrl CTAACAAAGTGAGGGGCGGT GTGTGTCCCAGTCCTCTGTG 163 bp 
Rex1 (Zfp42) AAGAGCTGGGACACGTGGCAA GGCAGCACAGTGAGGCGATCC 116 bp 
9330182L06Rik 
(Eig121l) CCATGAGATCGAGGGAGCCT AAAGCCACCAACAAAACGGC 186 bp 
Rnase4 TTCGCCATCCCAACAGGAAG TTCGATCCTGGCCATAGGAG 175 bp 
Rpl10l TGCACCCCTTCCATGTCATC CGTACCTTGTGGTTTCCCGA 104 bp 
Scml2 CTTCTGCGGGGCCATCTAAA CAGTCCGCTGGAGAATGACA 153 bp 
Slc39a8 TCCACTTCGACACTGTCAGC AAGCGTGATCATCCAGGCAA 122 bp 
Sohlh2 TTATTTGCCACCCACTGCAC CTGGTGATCCGAAGCTGACG 190 bp 
Taf7l CAGGAAAGTGGAAAACTTGACCC AGGCTGAGGCTTTCCTTACT 148 bp 
Tex11 AGCTGTGCAATCTGAGAAGGA ACACGTTTTCTGTGCAATCAGT 115 bp 
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3.1.7.2 ChIP-qPCR primer pairs 
Table 3 Primer pairs used for ChIP-qPCR. All primers are designed to amplify mouse 
genomic DNA. 
 
primer name sense primer (5’ → 3’) antisense primer (5’ → 3’) product 
Nxt2 GCGAGGTTCGTTTTGTTGCT GCTGGAAATGGTCTGCTCCA 111 bp 
Hoxc8 CCCCAAGAGCAGTCAAGAGACAAG GCCATCAGGTCAACTCAGGTTACC 264 bp 
Otx2 21 CpG CTAAAGCAACCGCCTTACGC GACTCACTTACCGGGGTAGC 96 bp 
Otx2 55 CpG GATAACCGAGGAGGCGACAG GGGCATTAAGCTTGGGGAGT 91 bp 
Scml2 GAGTGGCTGTGTCGGTTGT GGCACCAGACTTCACATTGC 83 bp 
Paf1 CCATGCCTTACCGACAGATT GCTCCGACTGCTACCAAGAC 243 bp 
 
 
3.1.7.3 Genotyping primer pairs 
Table 4 Primer pairs used for genotyping of Mll1 and Mll2 conditional alleles. All primers are 
designed to amplify mouse genomic DNA. See also section 3.4.1. 
 
primer name sense primer (5’ → 3’) antisense primer (5’ → 3’) product 
Mll1 int1-int2 GAGGTAAGGAGAGTTTTTGCT GTAGAAACCTACTTCCCATGCC F: 1.1 kb, wt: 0.9 kb, FC: 0.2 kb 
Mll1 int1-ex2 GCTCAGATGAAGAAGTCAGAG GTAGAAACCTACTTCCCATGCC F: 0.30 kb, wt: 0.25 kb 
Mll2 ex1-ex3 CGGAGGAAGAGAGCAGTGACG GGACAGGAGTCACATCTGCTAGG F: 1.6 kb, wt: 1.4 kb, FC: 0.75 kb 
Mll2 ex1-ex2 CGGAGGAAGAGAGCAGTGACG GGGACCGAAGCGCAGAGC F; 1.2 kb, wt: 1.1 kb 
 
 
3.1.8 Bacterial Artificial Chromosomes (BACs) 
Mll1 BAC (CHORI, RP23-217O17) was tagged with YPF and Mll2 BAC 
(Source Biosciences, bMQ-389B2) was tagged with eGFP internally on the 
N-terminal part 5’upstream of the Taspase cleavage sites by Helmut 
Hofemeister (Biotec, TU Dresden) using recombineering (Hofemeister et al., 
2011). For Mll1, a blasticidin S deaminase (BSD) selection marker was 
inserted into the backbone. On Mll2 BAC, an internal ribosomal entry side 
(IRES) followed by neomycin resistance gene was placed 3’ downstream of 
the open reading frame. Deletion of certain exons was carried out by Ashish 
Gupta and Davi Coe Torres (Biotec, TU Dresden) using recombineering.  
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3.1.9 Plasmids 
3.1.9.1 cDNA overexpression constructs 
The CAG-GFP-IRES-neo or -puro plasmids were designed by Konstantinos 
Anastassiadis (Biotec, TU Dresden) and Roberto Iacone (former lab member, 
Biotec, TU Dresden) using recombineering. They contain a GFP transgene 
under the control of a CAG promoter followed by an IRES and puromycin or 
neomycin resistance gene.  
Mouse cDNAs of Bcl2 (NM_009741.4), Nxt2 (NM_172782.3) and Scml2 
(NM_133194.3 with 4 additional amino acids, representing 
ENSMUST00000019101) were amplified from reverse transcribed RNA of 
mES cells, mEpiS cells or mNS cells and cloned into the CAG-GFP-IRES-
neo or -puro plasmid using recombineering. Bcl2 cDNA was inserted 3’ 
downstream of GFP (Helmut Hofemeister, Biotec, TU Dresden) creating a 
fusion protein (CAG-GFP-Bcl2-IRES-puro) while the other cDNAs replaced 
GFP in the vector (CAG-Nxt2-IRES-neo, CAG-Scml2-IRES-neo).  
 
3.1.9.2 Constructs for Tet-On system  
CAG-rtTA-IRES-neo and tetCMV-GLuc plasmids were engineered and 
provided by Roberto Iacone (former lab member, Biotec, TU Dresden) using 
recombineering. 
 
3.1.9.3 PiggyBac reprogramming plasmids 
The PB-CAG-OSKM-puro and CMV-PBase-neo plasmids were kindly 
provided by the laboratory of Allan Bradley and the Wellcome Trust Sanger 
Institute (Yusa et al., 2009). In order to create a Dox inducible PB 
reprogramming plasmid, the CAG promoter of PB-CAG-OSKM was replaced 
with tetCMV using recombineering. 
 
 Materials and methods  
 51 
3.1.10 esiRNA 
Endoribonuclease prepared siRNAs (esiRNAs) against mouse Mll1 
(ENSMUST00000114689) and Otx2 (ENSMUSG00000021848) were 
obtained from Eupheria Biotech GmbH. 
 
3.1.11 Mouse lines 
The Oct4-GFP reporter mouse line was kindly provided by the laboratory of 
Hans Schöler (Szabo et al., 2002). Mll2 conditional mice were generated 
using the multipurpose allele strategy as described elsewhere (Glaser et al., 
2006). Mll1 conditional mice were generated using the same strategy as for 
Mll2 (Denissov et al., 2014). 
 
3.1.12 Commercial cell culture media and supplements   
company (cat. number) 
21-Hydroxyprogesterone    Sigma-Aldrich (D6875) 
Accutase      PAA (L11-007) 
Activin A (ActA)      MPI-CBG protein facility 
Apo-Transferrin     Sigma-Aldrich (T1147) 
B27 supplement     Gibco/Invitrogen (17504-044) 
Blasticidin S      Gibco/Invitrogen (R210-01) 
Chicken serum     Invitrogen (16110082) 
DMEM/F12      Gibco/Invitrogen (31330-095) 
DMEM+GlutaMAX     Gibco/Invitrogen (61965-059) 
Epithelial growth factor (EGF)   Reprotec (AF-100-15) 
ESGRO leukemia inhibitory factor (LIF)  Merck Millipore (ESG1107) 
Euromed-N      Biozol  (ECL-ECM0883L) 
Fetal calf serum (FCS)    PAA (A15-101) 
Fibroblast growth factor 2 (FGF2)   MPI-CBG protein facility 
Fibronectin      Merck Millipore (FC010) 
Gelatine      Sigma-Aldrich (G2500) 
Geneticin (G418 sulfate)    Gibco/Invitrogen (11811-064) 
Insulin       Sigma-Aldrich (I1882) 
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Knockout DMEM     Gibco/Invitrogen (10829-018) 
KnockOut serum replacement   Gibco/Invitrogen (10828-028) 
Laminin      Roche  (11243217001) 
L-Glutamine      Gibco/Invitrogen (25030-024) 
Lipofectamine 2000 reagent   Invitrogen (11668-019) 
Lipofectamine LTX and Plus reagent  Invitrogen (15338-100) 
Mitomycin C      Sigma-Aldrich (M0503) 
Neurobasal medium    Gibco/Invitrogen (21103-049) 
Non-essential amino acids    Gibco/Invitrogen (11140-035) 
Opti-MEM with Glutamax    Gibco/Invitrogen (51985-026) 
PD0325901 (N-(2,3-Dihydroxypropoxy)-3,4- ABCR (CAS 391210-10-9) 
difluoro-2-(2-fluoro-4-iodophenylamino) 
benzamide)  
Penicillin/Streptomycin    Gibco/Invitrogen (15140-122) 
Puromycin dihydrochloride    Sigma-Aldrich (P8833) 
Putrescine dihydrochloride     Sigma-Aldrich (P5780) 
Sodium pyruvate     GIBCO/Invitrogen (11360-039) 
Sodium selenite     Sigma-Aldrich (S5261) 
Trypsin 2.5% (10x)     Gibco/Invitrogen (15090-046) 
Trypsin/EDTA 1x (0.05%)    Gibco/Invitrogen (25300-054) 
 
 
3.1.13 Self-made cell culture media and supplements 
0.1% Trypsin (for mouse ES and iPS cells) 
        volume/amount  final conc. 
PBS        500 ml   1x 
2.5% trypsin      20 ml   0.1% 
Chicken serum      5 ml    1% 
EDTA       0.1 g    0.2 mg/ml 
D-glucose       0.5g     1 mg/ml 
 
EpiS medium 
        volume   final conc. 
N2B27      100 ml   -   
100 ng/µl FGF2 (in 0.1% BSA/PBS) 12 µl 12 ng/ml 
100 ng/µl ActA (in 0.1% BSA/PBS) 20 µl 20 ng/ml 
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ES medium (FCS+LIF) 
        volume   final conc. 
DMEM+GlutaMAX    405 ml   -   
FCS       75 ml   15% 
10 mM 2-mercaptoethanol 5 ml 100 µM 
200 mM L-glutamine 5 ml 2 mM 
100 mM sodium pyruvate 5 ml 1 mM 
100x non-essential amino acids 5 ml 1x 
1x107 units/ml ESGRO LIF 10 µl 1000 units/ml 
or self-made recombinant LIF 1 ml - 
 
Knockout ES medium with serum replacement 
        volume   final conc. 
Knockout DMEM    81 ml   -   
KnockOut serum replacement  15 ml   15% 
10mM 2-mercaptoethanol 1 ml 100 µM 
200 mM L-glutamine 1 ml 2 mM 
100 mM sodium pyruvate 1 ml 1 mM 
100x non-essential amino acids 1 ml 1x 
1x107 units/ml ESGRO LIF 10 µl 1000 units/ml 
 
MEF medium 
        volume   final conc. 
DMEM+GlutaMAX    445 ml   -   
FCS       50 ml   10% 
200 mM L-glutamine 5 ml 2 mM 
 
N2 supplement 
        volume   final conc. 
DMEM/F12      13.7 ml   - 
75 mg/ml BSA/PBS     2 ml    7.5 mg/ml 
100 mg/ml apo-transferrin    2 ml    10 mg/ml 
160 mg/ml putrescine    200 µl   1.6 mg/ml 
0.6 mg/ml 21-hydroxyprogesterone/EtOH 66 µl    2 µg/ml 
3 mM sodium selenite    20 µl    3 µM 
25 mg/ml insulin (in 0.05 M HCl)  2 ml    2.5 mg/ml 
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N2B27 
        volume   final conc. 
DMEM/F12     241 ml   50%  
Neurobasal medium 241 ml 50% 
100x N2 supplement 2.5 ml 0.5 x 
50x B27 supplement 5 ml 0.5 x 
10 mM 2-mercaptoethanol 5 ml 100 µM 
200 mM L-glutamine 5 ml 2 mM 
100 mM sodium pyruvate 750 µl 150 µM 
 
Neuronal differentiation medium I 
        volume   final conc. 
Euromed-N     96 ml   -   
100x N2 supplement 1 ml 1 x 
50x B27 supplement 2 ml 1 x 
200 mM L-glutamine 1 ml 2 mM 
10,000 U/ml penicilin/streptomycin 1 ml 100 U/ml 
100 ng/µl FGF2 (in 0.1% BSA/PBS) 5 µl 5 ng/ml 
 
Neuronal differentiation medium II 
        volume   final conc. 
Euromed-N     48 ml   50% 
Neurobasal     48 ml   50% 
100x N2 supplement 250 µl 0.25 x 
50x B27 supplement 2 ml 1 x 
200 mM L-glutamine 1 ml 2 mM 
10,000 U/ml penicilin/streptomycin 1 ml 100 U/ml 
 
NSA (NS medium) 
        volume   final conc. 
Euromed-N     490 ml   -   
100x N2 supplement 5 ml 1 x 
200 mM L-glutamine 5 ml 2 mM 
100 ng/µl EGF (in 0.1% BSA/PBS) 50 µl 10 ng/ml 
100 ng/µl FGF2 (in 0.1% BSA/PBS) 50 µl 10 ng/ml 
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3.2 Conditional knockout strategy 
Mll1 and Mll2 were targeted using the multipurpose allele strategy (Testa et 
al., 2004). A selection cassette flanked by FRT sites was inserted into the 
intron preceding the first frame shifting exon (exon 2) that was flanked with 
loxP sites (Fig. 9). Besides conferring resistance via an internal ribosomal 
entry site (IRES) and neomycin, the cassette also contains a LacZ reporter. 
The splice acceptor (SA) in the targeting cassette captures Mll1 and Mll2 
transcripts and terminates them after the selection marker by a poly 
adenylation (pA) site thus creating a constitutive knockout (A) allele. Flp 
recombination removed the selection cassette leaving one FRT and two loxP 
sites in intronic positions. In this conditional Flp allele (F) the normal 
expression of Mll1 or Mll2 is restored.  
All conditional cell lines used in this study expressed Cre recombinase fused 
to a modified estrogen receptor (Cre-ERT2) (Feil et al., 1997) from the 
ubiquitous Rosa26 locus (Seibler et al., 2003). Chaperons keep the estrogen 
receptor fusion protein in the cytoplasm unless it binds 4-hydroxytamoxifen 
(4OHT). Upon treatment with the ligand Cre-ERT2 can enter the nucleus and 
mediate recombination between the loxP sites surrounding the second exon. 
The removal of exon 2 causes a frame shift and translation ends at a 
premature stop codon in exon three creating a conditional knockout. This Flp 
and Cre recombined allele will be named FC allele from now on. 
 
3.3 Cell culture methods 
3.3.1 Isolation and culture of mES cell lines from blastocysts 
Mll1F/F or Mll2F/F single and Mll1F/F; Mll2F/F double conditional ES cell 
lines carrying targeted Rosa26-Cre-ERT2 were established from blastocyst 
outgrowths. E3.5 pregnant mice were sacrificed and the uteri were flushed 
with 1 ml 0.2% BSA/PBS using blunt end syringes. The collected liquid was 
checked under the binocular and blastocysts were transferred to fresh 0.2% 
BSA/PBS using glass capillaries.  




Figure 9 Schematic representation of the conditional knockout strategy used for Mll1 and 
Mll2 alleles. SA, splice acceptor; IRES, internal ribosomal entry site; LacZ, β-Galactosidase 
gene; neo, neomycin; pA, polyadenylation signal; STOP, stop codon; FRT, Flp recombinase 
target site; loxP, Cre recombinase target site. 
 
 
Single blastocysts were placed in the middle of 4-well culture dishes with 
knockout ES medium containing serum replacement and 1000 units/ml 
commercial LIF. The cultures were incubated at 37ºC in 5% CO2. The inner 
cell mass of most blastocysts created outgrowths that were picked with 
capillaries after 3-5 days, placed into 50 µl drops of Accutase and incubated 
for 5 min. Cell clumps were then transferred to 48-well plates with Mitomycin 
C-treated (10 µg/ml, 4 h) mouse embryonic fibroblasts (MEFs) in knockout 
ES medium with 1 µM MEK inhibitor (PD0325901). After 3-6 days growing 
colonies were expanded to 24- and then 6-well plates by passaging as 
follows. Wells were washed with PBS, cells were detached with 0.1% Trypsin 
for 5 min at 37ºC, resuspended in fresh medium (9x volume of Trypsin) and 
transferred to new wells with Mitomycin C-treated MEFs. The MEK inhibitor 
was removed when reaching the 6-well format (passage 3), the medium was 
changed to FCS-based mES medium the following passage and commercial 
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LIF was replaced with self-made one at passage 5. ES cells were first 
cultured on Mitomycin C-treated MEFs and then adapted to feeder-free 
conditions on 0.1% gelatine and passaged every second day with Trypsin as 
described above by seeding approximately 1x106 ES cells per 10 cm dish.  
For cryopreservation cells in suspension were collected during passaging by 
centrifugation for 5 min at 215 xg and resuspended in cold freezing medium 
(25% FCS, 10% DMSO in DMEM+Glutamax). At least 2x106 cells were 
transferred to each cryovial and stored at -80ºC for 1 day to several weeks 
before being relocated to liquid nitrogen for long-term storage. 
The knockout of Mll1 or Mll2 conditional alleles in ES cells (4OHT-ES) was 
induced by supplementing the medium for 48 h with 10-7 M 4OHT (1:10,000 
diluted from 10-3 M stock in EtOH) following one passage (48 h) without 
4OHT before starting differentiation experiments or collecting samples. As 
control ES cells were left uninduced but treated with 0.01% EtOH. 
 
3.3.2 Lipofection of mES 
3.3.2.1 Lipofection of mES cells with plasmids for stable integration 
10 µg of plasmid DNA were linearized with two appropriate restriction 
enzymes to cut twice in the backbone: CAG-GFP-puro and CAG-GFP-Bcl2-
puro with SpeI and SfiI, CAG-Nxt2-neo and CAP-Scml2-neo with EcoRV and 
AhdI. Restrictions were incubated over night at 37ºC. The following day 
enzymes were heat inactivated (if possible) for 20 min at 80ºC and 1 µl of 
digests were checked for full restriction by gel electrophoresis (1% agarose). 
DNA was precipitated with 1/10 volume of 3 M sodium acetate, vortexed 5 
sec, 2.7 volume of EtOH was added and again vortexed 5 sec. DNA was 
pelleted by centrifugation at 17,000 xg for 20 min at 4ºC, washed once in 
70% EtOH and dried 2 min at RT after careful removal of all the liquid with a 
P10 pipette. 20 µl ddH2O were added and the pellet was dissolved on a 
thermomixer at highest speed for 1h at RT and stored over night at 4ºC 
before transfection.  
100 ng per kb of linearized plasmid DNA were lipofected to 1x105 mES cells 
per well seeded to gelatin-coated 6-well plates 24 h before. The DNA was 
diluted in 500 µl Opti-MEM with Glutamax, 2.5 µl of Plus Reagent were 
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added, incubated 5 min at RT. 6.25 µl of Lipofectamine LTX were added and 
the solution was carefully mixed by inversion. After 30 min incubation at RT 
the lipofection mix was added dropwise to the cells in 2 ml of fresh FCS-
based mES medium and incubated over night. Selection was started 24 h 
after lipofection with 1 µg/ml Puromycin (CAG-GFP-puro, CAG-GFP-Bcl2-
puro) or 200 µg/ml G418 (CAG-Scml2-neo, CAG-Nxt2-neo) and clones were 
picked, expanded under permanent selection and either analyzed by 
Western blot analysis (CAG-GFP-puro, CAG-GFP-Bcl2-puro) or qRT-PCR 
and positive clones or the bulk resistant population were used for following 
experiments. 
 
3.3.2.2 Lipofection of mES cells with BACs 
1 µg of purified BAC DNA was transfected into mES cells using 
Lipofectamine LTX and Plus reagent as described above. Cells were 
selected with 175 µg/ml G418 (Mll2 BACs) or 4 µg/ml Blasticidin S (Mll1 
BACs) starting 24 h after lipofection and picked clones were analyzed by 
Western blot analysis. 
 
3.3.2.3 Lipofection of mES cells with esiRNA 
Lipofectamine 2000 was used for esiRNA transfection to ES cells since 
Lipofectamine LTX was apparently ineffective for RNA transfection. 1x105 ES 
cells per well were seeded to gelatin-coated 6-well plates in 2 ml ES medium 
at the same day shortly before lipofection. 1000 ng of total esiRNA were 
diluted with 500 µl Opti-MEM with Glutamax and 4 µl of Lipofectamine 2000 
were added. The tube was carefully mixed by inversion, incubated 30 min at 
RT and added dropwise to the wells. ES cells were scraped from the wells 48 
h later in 1 ml of ice-cold PBS, pelleted by centrifugation at 600 xg for 5 min 
at 4ºC and stored at -80ºC until RNA extraction and reverse transcription for 
qRT-PCR. 
 
3.3.3 Differentiation of mES to NS cells 
Differentiation of mES cells to neural rosettes and NS cells was carried out 
either using a one-step protocol with a short initial culture of cells in EpiS 
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medium (section 3.3.3.1) or in two steps by first passaging cells in EpiS 
medium to establish a homogeneous population before proceeding to 
generate neural rosettes and finally NS cells (section 3.3.3.2). 
 
3.3.3.1 One-step differentiation of mES to NS cells 
For schematic overview see Figure 11. Cells in FCS-based ES medium were 
washed with PBS, detached using Accutase, resuspended and washed twice 
in DMEM/F12 and collected by centrifugation for 5 min at 215 xg. 6-well 
plates (Nunc) or glass cover slips in 24-well plates were coated with 10 ng/ml 
fibronectin/PBS for 1 - 8 h, before the supernatant was aspirated and cells 
were immediately seeded on top of the coating to avoid drying. 0.5-1x104 
cells per cm2 (1-2x104/cover slip, 0.5-1x105/well to 6-well plates) were 
seeded in EpiS medium consisting of N2B27 with ActA and FGF2. After 4 
days (only 2 days if cells overexpressed CAG-GFP-Bcl2-puro) wells were 
washed with DMEM/F12 and cells were cultured 7 days in N2B27 without 
growth factors. The medium was changed every other day and after 7 days 
in N2B27 cover slips were fixed and permeabilized for immunofluorescence. 
Neural rosettes from 6-well plates were dissociated with 0.5 ml Accutase for 
5 min at 37ºC, diluted and resuspended with 4.5 ml DMEM/F12, collected by 
centrifugation for 5 min at 215 xg and cultured on non-adhesive 6 cm 
suspension culture dishes in 4 ml NSA with 0.5x B27 for 2-4 days to allow 
formation of neurospheres. These were then transferred to centrifugation 
tubes, allowed to settle down for 5 min and the old medium was carefully 
aspirated. Spheres were resuspended in 3-4 ml fresh NSA with B27 and 
seeded to 6-well plates (Nunc) or 6 cm dishes (VWR) that were beforehand 
coated with 0.1% gelatine for at least 1 h at RT, aspirated and dried under 
the laminar flow hood with open lids for 10-20 min. Spheres were allowed to 
attach and grow out for 2 days without moving the dishes around before still 
unattached spheres were aspirated and medium was changed. When 
reaching near confluency (95%) at day 3-5 on gelatine, NS cells were 
passaged for the first time by aspirating the medium and detaching the cells 
with 0.5 ml Accutase for 5 min at 37ºC. Accutase was diluted with 4.5 ml 
DMEM/F12, cells were collected by centrifugation for 5 min at 215 xg, 
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resuspended in fresh NSA with B27 and seeded to gelatin coated dishes 
(Nunc or WVR) in a splitting ratio of 1:3 to 1:8. B27 was removed from the 
medium one day after the first passage und NS cells were regularly 
passaged every 3-5 days shortly before confluency was reached (95%) as 
described above.  
For cryopreservation cells were collected during passaging by centrifugation 
for 5 min at 215 xg and resuspended in cold freezing medium (10% DMSO in 
NSA). At least 2x106 cells were transferred to each cryo vial and stored at -
80ºC for 1 day to several weeks before being relocated to liquid nitrogen for 
long-term storage. The knockout of Mll1 or Mll2 conditional alleles was 
induced at the NS cell stage (4OHT-NS) by supplementing the medium for 48 
h with 10-7 M 4OHT (or 0.01% EtOH as control) following 48 h without 4OHT 
before starting differentiation experiments or collecting samples.  
 
3.3.3.2 Two-step differentiation of mES cells to stable EpiS and NS cells 
For schematic overview see Figure 20. ES cells were washed with PBS, 
detached using Accutase, resuspended and washed twice in DMEM/F12, 
collected by centrifugation for 5 min at 215 xg and 1x105 cells were seeded 
on fibronectin-coated 6 well-plates (Nunc) in EpiS medium. Medium was 
changed every other day and cells were passaged regularly every 3-5 days 
around 24 h after reaching full confluency. Therefor EpiS cells were detached 
from 6-well with 0.5 ml Accutase for 5 min at 37ºC, resuspended in 4.5 ml 
DMEM/F12, collected by centrifugation for 5 min at 215 xg and seeded at a 
splitting ratio of 1:4-1:10 on fibronectin-coated wells (Nunc). After 21-35 days 
the knockout of Mll1 or Mll2 conditional alleles was induced at the EpiS cell 
stage (4OHT-EpiS) by supplementing the medium for 48 h with 10-7 M 4OHT 
(or 0.01% EtOH as control) following 48 h without 4OHT before collecting 
samples or starting further differentiation to neural rosettes and NS cells. For 
the latter, 0.5-1x105 EpiS cells per cm2 (1-2x105/cover slip, 0.5-1x106/well to 
6-well plates) were seeded to fibronectin in N2B27 and cultured for 5-7 days 
with medium changes every other day. Cover slips were then fixed and 
permeabilized for immunofluorescence. Neural rosettes from 6-well plates 
were dissociated with Accutase, cultured in non-adhesive dishes for 
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neurosphere formation, seeded to gelatin and finally cultured as NS cells as 
described above. 
 
3.3.4 Isolation and culture of mNS cell lines from fetal telencephalon 
Mll1F/F or Mll2F/F single and Mll1F/F; Mll2F/F double conditional NS cell 
lines carrying targeted Rosa26-Cre-ERT2 and the respective heterozygous 
controls were established from E15.5 fetal telencephalon. Embryo tails were 
used for genotyping. After removing pia mater and olfactory bulbs the 
forebrains were triturated using a 27 G needle in 1 ml NSA supplemented 
with 0.5x B27. The cell suspension was incubated for 24 h in uncoated 24-
well plates at 37ºC in 5% CO2. The following day all cell lines carrying the 
desired genotype were transferred to non-adhesive 6 cm suspension culture 
dishes with 3 ml more medium and incubated for another 2 days. Formed 
neurospheres were then seeded to establish adherent NS cell lines, 
passaged and cryopreserved as described above for NS cells generated 
from ES cells (section 3.3.3.1). However, since NS cells isolated from 
telencephalon rarely attach on gelatine, they were kept on laminin for all 
experiments. Dishes and plates (VWR or Nunc) were coated with 2 µg/ml 
laminin/PBS for 1-8 h at 37ºC. Due to the high sensitivity of this coating, the 
laminin solution was always prepared fresh and in a sufficient amount to 
cover the culture area thoroughly (7 ml for 10 cm dishes, 1.5 ml/well for 6-
well plates, 0.5 ml/well for 24-well plates). It was aspirated only immediately 
before seeding of neurospheres or NS cells to prevent drying of the coating 
that would impair cell attachment. As laminin is prone to be washed away, 
the cell suspension was always slowly added by placing the pipette to the 
wall of culture dishes. 
If low cell densities were required (cloning), the medium was again 
supplemented with 0.5x B27 for several days to improve attachment and 
survival. For immunofluorescence, 1x105 cells per well were seeded to 
laminin-coated glass cover slips in 24-well plates in NSA with B27 and 1x 
Penicillin/Streptomycin and incubated for 2-4 days until fixation and 
permeabilization. 
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3.3.5 Differentiation of mNS cells to neurons and astrocytes 
NS cells were passaged using Accutase as described above and 5x104 cells 
per cm2 (1x105/cover slip) were seeded on laminin-coated glass cover slips 
in neuronal differentiation medium I. After 7 days medium was changed to 
neuronal differentiation medium II for 7 days before fixation and 
permeabilization for immunofluorescence. 
 
3.3.6 Isolation and culture of mouse embryonic fibroblasts (MEFs) 
Mll1F/F conditional MEFs carrying targeted Rosa26-Cre-ERT2 were 
established from E13.5 embryos. The head and all inner organs were 
removed and embryos were incubated in 500 µl 0.05% Trypsin/EDTA for 10 
min at 37ºC, passed 7 times through 20 G needles and transferred to 6-well 
plates coated with 0.1% gelatine in 3 ml MEF medium. The following day 
MEFs were passaged as follows. Cells were washed with PBS, detached 
with 0.05% Trypsin/EDTA for 10 min at 37ºC, resuspended in 10 ml MEF 
medium and seeded to gelatin-coated 10 cm dishes. MEFs were passaged 
twice within the following 7 days when they reached confluency at a splitting 
ratio of 1:5. For cryopreservation the cell suspension was pelleted during 
passaging by centrifugation for 5 min at 215 xg and resuspended in cold 
freezing medium (25% FCS, 10% DMSO in DMEM+Glutamax). At least 
2x106 cells were transferred to each cryo vial and stored at -80ºC for 1 day to 
several weeks before being relocated to liquid nitrogen for long-term storage. 
At passage 3 the knockout of Mll1 was induced by supplementing the 
medium for 48 h with 10-7 M 4OHT (or 0.01% EtOH as control) following 24 h 
without 4OHT before seeding cells for reprogramming (section 3.3.7.3). 
 
3.3.7 Reprogramming of mNS cells and MEFs into iPS cells 
The same time course of knockout induction was applied to all conditional 
cell lines in reprogramming experiments (see Fig. 33). Cells were either left 
uninduced as control or the knockout of conditional alleles was induced by 
treating cells for 2 days with 10-7 M 4OHT following 2 days recovery without 
4OHT one passage (P-1) before start of reprogramming. Additionally, the 
knockout was induced during iPS cell generation at early (d0-3), mid (d5-8) 
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or late (d10-13) stages by supplementing the medium with 10-7 M 4OHT for 3 
consecutive days. 
 
3.3.7.1 Reprogramming of mNS cells with constitutive factor expression 
One day before start of reprogramming, Mitomycin C-treated MEFs were 
thawn and 5x105 per well were seeded to gelatin-coated 6-well plates in MEF 
medium. The next day 8x106 NS cells from telencephalon were collected by 
centrifugation (215 xg, 5 min), the supernatant was completely removed 
using a P200 pipette and cells were resuspended in 100 µl of Nucleofection 
mix (2:9 mix of supplement 1 with Nucleofector solution) and 700 ng/kb of 
circular PB-CAG-OSKM-puro (9.3 µg) and CMV-PBase-neo (5.1 µg) 
plasmids (Yusa et al., 2009) were added. For knockdown experiments 500 
ng (250 ng per well) of total esiRNA were also added. The cell-DNA 
suspension was then transferred to nucleofection cuvettes (included in the 
kit) without creating air bubbles. Nucleofection was carried out using 
Nucleofector II device and program A-033 as recommended by the 
manufacturer for this cell type. NS cells from one nucleofection were 
resuspended in NSA with 0.5x B27 and equally distributed to two 6-wells with 
Mitomycin C-treated MEFs that were washed with PBS before to remove 
FCS. The next day the medium was changed to fresh NSA with B27 to 
remove death cells and debris left from nucleofection and from day 2 on it 
was replaced with FCS-based mES medium and changed every other day. In 
the case of conditional NS cell lines the 4OHT time course explained above 
(see 2.3.7) was applied.  
14 days after nucleofection the medium was removed and replaced with 
PBS. Two compact iPS cell colonies from each well were picked by 
scratching with a P20 pipette and 20 µl of PBS containing each colony were 
pipetted into 20 µl drops of 0.1% Trypsin, incubated 5 min, resuspended in 
200 µl of ES medium and transferred to 48-well plates with Mitomycin C-
treated MEFs. Residual colonies on reprogramming plates were stained for 
Alkaline phosphatase activity (section 3.4.3). The picked iPS cell clones were 
expanded, passaged and cryopreserved as described for ES cells (section 
3.3.1). Complete recombination of conditional alleles was confirmed by 
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genotyping and clones were analyzed by qRT-PCR and immunofluorescence 
staining for Nanog and Ssea-1.  
 
3.3.7.2 Reprogramming of mNS cells with inducible factor expression 
In order to establish the Tet-On system in NS cells 2 µg linearized (SpeI+SfiI) 
and precipitated (for details see section 3.3.2.1) CAG-rtTA-IRES-neo plasmid 
was nucleofected (for details see section 3.3.7.1) into 2.7x106 cells from 
telencephalon with conditional alleles. NS cells were resuspended in NSA 
with 0.5x B27 and seeded to laminin-coated 6-well plates. The next day 
selection was started with 200 µg/ml G418 and medium was changed every 
day. When resistant NS cells became almost confluent (day 7-10 after 
nucleofection), they were passaged and 1x104 and 5x104 cells were seeded 
to laminin-coated 10 cm culture dishes (Nunc) in NSA with B27 and G418 in 
order to establish colonies from single NS cells. These were picked 14 days 
later by scratching with a P200 pipette without enzymatic dissociation and 
transferred to laminin-coated 24-well plates. NS cell clones were expanded 
when almost confluent to 6-well plates using Accutase. B27 was removed 1 
day after passaging but G418 selection was permanently kept to prevent 
silencing of transgenes. Each clone was tested for functionality of rtTA by 
transient nucleofection of 3x106 NS cells with 5 µg circular tetCMV-GLuc 
plasmid, distributed equally to 2 wells of a 6-well plate in NSA with B27 with 
or without 1 µg/ml Doxycyclin (Dox). The medium was changed after 24 h 
and 48 h after nucleofection and the amount of secreted Gaussian luciferase 
was measured with the BioLux assay kit. Briefly, 10 µl culture supernatant 
from each well were pipetted into a white opaque 96-well plate. Substrate 
and buffer solution were mixed 1:100, 50 µl of the mix were added to each 
well either manually or using the injectors and luminescence was measured 
with a Glomax 96 microplate luminometer. Clones exhibiting high luciferase 
expression with Dox and little leakiness without Dox were selected for further 
experiments.  
In order to create a Dox inducible PB reprogramming plasmid, the CAG 
promoter of PB-CAG-OSKM-puro was replaced with tetCMV. 4x106 NS cells 
of each selected CAG-rtTA-IRES-neo clone were nucleofected with 350 
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ng/kb of circular PB-tetCMV-OSKM-puro (4.2 µg) and CMV-PBase-neo (2.5 
µg) plasmids and seeded to laminin-coated 6-well plates in NSA with 0.5x 
B27. The following day selection with 0.75 µg/ml Puromycin was started and 
after 3 days 150 µg/ml G418 was also added to avoid silencing the CAG- 
rtTA-IRES-neo transgene. The whole resistant population was expanded and 
used for reprogramming experiments. The knockout of conditional alleles 
was either induced by treatment with 10-7 M 4OHT for 2 days followed by 2 
days recovery without 4OHT or cells were left uninduced. To start the 
reprogramming (day 0) 3-10x105 NS cells per well were seeded to 6-well 
plates with Mitomycin C-treated MEFs (seeded 24 h before in MEF medium 
and PBS washed) in NSA with 0.5x B27 with or without 1 µg/ml Dox and the 
4OHT induction time course mentioned above was applied. The NS medium 
was replaced with FCS-based mES medium on the second day and medium 
was changed every day to keep the Dox concentration and thus the factor 
expression constant. At day 14 either 2 round iPS cell colonies per well were 
picked to 48-well plates for expansion and the residual colonies were stained 
for Alkaline Phosphatase activity or the whole population was passaged and 
one fifth of the cells were seeded to new 6-well plates. Picked colonies and 
the whole passaged population were incubated 3 more days in ES medium 
with 1 µg/ml Dox before it was withdrawn.  
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3.3.7.3 Reprogramming of MEFs with constitutive factor expression 
5x105 MEFs per well with conditional alleles (either uninduced or induced 
with 4OHT the previous passage) were seeded to gelatin-coated 6-well 
plates in MEF medium one day before start of reprogramming and the 
medium was changed at day 0 before lipofection (2 ml/well). For each well 
150 ng/kb of circular PB-CAG-OSKM-puro (2 µg) and CMV-PBase-neo (1.1 
µg) plasmids were diluted in 500 µl Opti-MEM with Glutamax and 4 µl of Plus 
Reagent were added. The tube was carefully mixed by inversion and 
incubated for 5 min at RT. 12 µl of Lipofectamine LTX were added, inverted 
and after 30 min incubation at RT, the lipofection mix was added dropwise to 
the cells. The 4OHT induction time course mentioned above was applied and 
medium was changed to ES medium from day 2 after lipofection and 
replaced every other day. 2 round iPS cell colonies per well were picked to 
48-well plates at day 14 after lipofection and expanded while the residual 
cells on the wells were stained for Alkaline phosphatase activity. 
 
3.4 Molecular biology methods 
3.4.1 Genotyping 
All cells were tested for full and successful recombination before the start of 
each experiment, usually 2 days after induction with 4OHT. In case of long-
term experiments (reprogramming, differentiation) the cells were also 
genotyped at the end to ensure that no unrecombined cells remained in the 
culture as they might have a growth advantage.  
Around 0.5-1x106 cells were collected during passaging by centrifugation and 
lysed for 1 h or over night at 55ºC in 300 µl DNA lysis buffer. 300 µl 
isopropanol were added, the tube was inverted 10 times and DNA was 
precipitated by centrifugation at 17,000 xg for 1 min and washed with 70% 
EtOH. The supernatant was completely removed using a P200 pipette and 
the pellet was air-dried for 2 min. 100-200 µl 1:10 diluted TE buffer were 
added and DNA was resuspended for 1 h on a thermomixer at highest 
speed. The PCR reactions (20 µl each) were mixed as follows and amplified 
with the thermal program indicated below. 
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        volume  final conc. 
ddH2O      16.24 µl   -   
10x Taq buffer (with 15 mM Mg2+) 2 µl    1x (1.5 mM Mg2+) 
10 mM dNTP mix    0.4 µl    200 µM 
100 µM primer se    0.08 µl    400 nM 
100 µM primer as    0.08 µl    400 nM 
Taq DNA polymerase (5 U/µl)  0.2 µl    0.05 U/µl 
genomic DNA     1 µl    - 
 
        temperature  time 
initial denaturation (hot start)  95ºC    5 min 
35 cycles denaturation   95ºC    30 sec 
annealing   58ºC    30 sec 
elongation   68ºC    70 sec 
final elongation    68ºC    7 min 
 
 
For each gene 3 primers were used to generate 2 primer pair combinations 
(Fig. 10 A, C, Table 4). One pair was designed to span over the frame-
shifting exon 2 and both loxP sites (Mll1 int1 se – int2 as, Mll2 ex1 se – ex3 
as) thus amplifying a larger product from the F allele than from wild type and 
a smaller product from the FC allele after excision of exon 2. The smallest FC 
product is favored during PCR thus potentially concealing small amounts of 
leftover F allele that escaped recombination. Therefore, a second primer pair 
was used with one primer being located in exon 2 (Mll1 ex2 se – int2 as, Mll2 
ex1 se – ex2 as). This primer combination can only amplify the wt allele and 
the bigger F allele, but gives no product from the FC allele. It can be used to 
detect even minimal amounts of unrecombined cells in the population. Figure 
10 B and D show examples of the PCR reactions separated on a 1% 
agarose gel. 
 
 Materials and methods  
 68 
 
Figure 10 Genotyping. (A, 
C) Schematic representation 
of Mll1 (A) and Mll2 (B) 
alleles and positions of 
primers (blue arrows) used 
for genotyping. Abbre-
viations: see also Figure 9. 
(B, D) PCR analysis of 
genomic DNA from Mll1 (B) 
and Mll2 (D) conditional cell 
lines with the indicated 
genotypes using two differ-
ent primer combinations for 
each gene. Product lengths 
in (B) Mll1 int1 se – int2 as: 
F: 1.1 kb, wt: 0.9 kb, FC: 0.2 
kb; Mll1 ex2 se – int2 as: F: 
0.30 kb, wt: 0.25 kb, FC: no 
product. Product lengths in 
(D) Mll2 ex1 se – ex2 as: F: 
1.2 kb, wt: 1.1 kb, FC: no 
product; Mll2 ex1 se – ex3 
as: F: 1.6 kb, wt: 1.4 kb, FC: 
0.75 kb. See also table 4. L,  
100 bp DNA ladder. 
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3.4.2 Protein extraction and Western blot analysis 
ES or NS cells from 10 cm dishes were collected by scraping in cold PBS 
with 1x cOmplete protease inhibitor (for analysis of Mll2 additionally with 10 
µM MG-132), pelleted by centrifugation with 600 xg for 5 min at 4ºC and 
frozen at -80ºC until further processing.  
 
3.4.2.1 SDS-PAGE analysis of small proteins 
Pellets were thawed on ice, resuspended in 50 µl high-salt protein lysis 
buffer, incubated for 5 min on ice and centrifuged with 17,000 xg for 1 min at 
4ºC. The supernatant was transferred to fresh tubes and protein content was 
determined by measuring the absorption of a 1:10 dilution (in 0.1% SDS) at 
280 nm with NanoDrop. 20 µg of each sample were diluted with high-salt 
protein lysis buffer to a total volume of 15 µl and 15 µl of 2x SDS sample 
buffer were added. The samples were cooked for 5 min at 95ºC, centrifuged 
1 min with 17,000 xg and loaded to Laemmli-SDS gels with 15% running and 
4% stacking gels. Proteins were separated by electrophoresis in 1x Tris-
glycine SDS running buffer at 120 V for approximately 90 min. 
 
3.4.2.2 SDS-PAGE analysis of Mll2 
Pellets were thawed on ice, resuspended in 100 µl high-salt protein lysis 
buffer, incubated for 5 min on ice and centrifuged at 17,000 xg for 1 min at 
4ºC. The supernatant was transferred to fresh tubes and protein content was 
determined by measuring the absorption of a 1:10 dilution (in 0.1% SDS) at 
280 nm with NanoDrop. 40 µg of each sample were diluted with high-salt 
protein lysis buffer to a total volume of 15 µl and 15 µl of 2x SDS sample 
buffer were added. The samples were cooked for 5 min at 85ºC, centrifuged 
1 min at 17,000 xg and loaded to 3-8% Tris-acetate gradient gels. Proteins 
were separated by electrophoresis in 1x Tris-acetate SDS running buffer at 
120 V for approximately 120 min. 
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3.4.2.3 SDS-PAGE analysis of histone modifications 
Pellets were thawed on ice, resuspended in 120 µl Benzonase buffer and 
incubated for 15 min at RT on a thermomixer (300 rpm). The insoluble 
fraction (cytoskeleton) was precipitated by centrifugation at 17,000 xg for 1 
min at 4ºC. The supernatant was transferred to fresh tubes and protein 
content was determined by measuring the absorption of a 1:10 dilution (in 
0.1% SDS) at 280 nm with NanoDrop. 80 µg of each sample (20 µg per lane) 
were diluted with homogenization buffer to a total volume of 40 µl and 40 µl 
of 2x SDS sample buffer were added. The samples were cooked for 5 min at 
95ºC, centrifuged 1 min at 17,000 xg and 20 µl per lane were loaded to 
Laemmli-SDS gels with 12% running and 4% stacking gels. Proteins were 
separated by electrophoresis in 1x Tris-glycine SDS running buffer at 120 V 
for approximately 80 min. 
 
3.4.2.4 Wet blotting and immunodetection 
PVDF membranes were activated for 2 min in Methanol and soaked in 1 x 
transfer buffer for 5 min. Blotting paper and sponges were equilibrated in the 
buffer, gels were dismantled after electrophoresis and the 2 stacks for wet 
blotting were assembled in the following order: anode plate, sponge, extra 
thick blotting paper, membrane, gel, extra thick blotting paper, sponge, extra 
thick blotting paper, membrane, gel, extra thick blotting paper, sponge, 
cathode plate. The proteins were transferred to the membranes in 1 x 
transfer buffer at 20 V for 2 or 4 h (2 h for small proteins and histones, 4 h for 
large proteins) at 4ºC. Membranes were stained with Ponceau S (0.1% in 5% 
acetic acid) for 2 min, washed several times with ddH2O, destained for 5 min 
with 0.05% Tween 20/PBS, dehydrated with methanol for 2 min and air dried 
for 10 min. Dry membranes were either stored at -20ºC until further analysis 
or immediately rehydrated for 15 min in 0.05% Tween 20/PBS and incubated 
over night at 4ºC with primary antibodies (section 3.1.6) diluted in incubation 
solution. The following day membranes were washed 3 times 5 min in 0.05% 
Tween 20/PBS, incubated for 1-2 h at 4ºC with HRP-coupled secondary 
antibodies in incubation solution and washed again 3 times 5 min in 0.05% 
Tween 20/PBS. Detection was carried out using Luminata Classico or Forte 
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(for Mll2) Western HRP substrate and images were taken with LAS-3000 or 
LAS-4000 image system. 
 
3.4.3 Alkaline phosphatase staining 
After picking 2 iPS cell colonies per well at day 14 of reprogramming, residual 
cells on plates were fixed for 5 min in 4% formaldehyde/PBS, washed once 
with PBS, permeabilized 10 min in 0.5% Triton X-100/PBS, washed twice 
with TBS-T and incubated for 5 min in Alkaline phosphatase staining solution 
at RT before stopping the reaction by washing with PBS. 
 
3.4.4 Immunofluorescence analysis 
Cells on glass cover slips were washed with PBS, fixed 10 min in 4% 
formaldehyde/PBS, washed with PBS, permeabilized 15 min in 0.5% Triton 
X-100/PBS, washed again with PBS and blocked 30 min with 3% BSA/PBS. 
The permeabilization step was omitted if the cover slips were intended for 
detection of the surface antigen Ssea-1. Cover slips were either stored in 3% 
BSA/PBS for up to 3 months at 4ºC or processed directly for 
immunofluorescence analysis as follows. Each cover slip was incubated in 25 
µl drops of primary antibodies diluted in 10% goat serum/PBS over night at 
4ºC in a humidified atmosphere. The following day cover slips were washed 
in PBS and incubated 1-4 h in 25 µl drops of appropriate secondary 
antibodies coupled to TRITC or Alexa488 diluted in 10% goat serum/PBS at 
4ºC in the dark. Cover slips were washed again in PBS and stained with 100 
ng/ml 4,6-diamidino-2-phenylindole (DAPI)/PBS for 2 min. After washing in 
PBS and then in ddH2O each cover slip was mounted to glass slides with 7 µl 
Mowiol and dried over night at RT before imaging with the TCS SP5 confocal 
system.  
 
3.4.5 Flow cytometry analysis 
1x106 NS cells were collected during passaging with Accutase, washed in 
DMEM/F12 and then 2% FCS/PBS, collected by centrifugation at 215 xg for 
5 min, resuspended in 1 ml 2% FCS/PBS and divided to two microcentrifuge 
tubes. After centrifugation at 600 xg for 5 min each pellet was resuspended 
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in 0.2 µg of PE-coupled CD44 antibody or isotype control in 100 µl 2% 
FCS/PBS and incubated for 30 min at 4ºC in the dark. After washing twice 
with 0.1% BSA/PBS the cell pellet was resuspended in 250 µl PBS, 
transferred to FACS tubes and 250 µl 4% formaldehyde/PBS were added 
while vortexing at middle speed to prevent agglutination of cells. Samples 
were stored at 4ºC in the dark for up to 2 days until analysis on LSR II flow 
cytometer. 
 
3.4.6 Chromatin immunoprecipitation (ChIP) 
Chromatin immunoprecipitation was used to determine binding affinities of 
Mll1 and Mll2 proteins to promoter regions of certain genes (section 3.4.6.1) 
and the histone methylation status at these binding sites (section 3.4.6.2). 
ChIPs were carried out as described elsewhere (Hofemeister et al., 2011) by 
Stefanie Weidlich or Isabell Kolbe (Biotec, TU Dresden).  
 
3.4.6.1 ChIP of tagged Mll1 and Mll2 proteins 
Since antibodies against Mll1 and Mll2 were not suitable for ChIP, the 
binding sites were analyzed using cell lines expressing YFP- or GFP-tagged 
Mll1 and Mll2 proteins from BAC transgenes (section 3.1.8) that could be 
immunoprecipitated with GFP antibody. A cell line without GFP tagged 
proteins was used as mock. Due to the size of both proteins the binding to 
chromatin during the ChIP procedure was improved by double crosslinking 
with DSG followed by formaldehyde. For each sample approximately 1.5x108 
cells on five 15 cm dishes were washed with PBS and fixed in 8 ml/dish 2 
mM DSG/PBS for 45 min at RT, washed with PBS and incubated in 10 
ml/dish 1% formaldehyde/DMEM+Glutamax for 20 min at RT. The 
formaldehyde was quenched by adding 500 µl/dish of 2.5 M glycine and the 
crosslinked cells were washed with cold PBS, scraped from the dishes in 
cold PBS, collected by centrifugation with 215 xg for 5 min at 4ºC and pellets 
were frozen at -80ºC until further processing.  
The pellets were thawed on ice, resuspended in 5 ml ChIP lysis buffer to 
solubilize the cell membranes. Nuclei were collected by centrifugation with 
215 xg for 3 min at 4ºC and resuspended in 3 ml ChIP sonication buffer. 
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Sonication was done using a Covaris S2 sonicator for 10 min with 20% duty 
cycles, intensity 8, 200 cycles per burst and frequency sweeping power 
mode in order to produce DNA fragments of 0.1 - 1 kb. Samples were then 
centrifuged at 17,000 xg for 5 min to remove cell debris and the cleared 
supernatant was transferred to fresh tubes.  
In order to check the fragment sizes, 50 µl aliquots of supernatant were 
incubated with 8 µl of 5 M NaCl (200 mM final concentration) at 98ºC for 15 
min to reverse the crosslinking. After cooling proteins were digested with 1 µl 
Proteinase K (20 mg/ml) at 55ºC for 30 - 60 min and samples were analyzed 
by electrophoresis on 1.5 – 2% agarose gels. 
200 µl sepharose beads (real bead volume) per sample were collected for 
preclearing by pipetting the double volume of beads-EtOH mix (∼1:1) with a 
cutoff pipette tip. Beads were pelleted by centrifugation with 1,500 xg for 2 
min, washed twice with PBS and resuspended in the same volume of ChIP 
buffer (200 µl/sample). 
The sonicated supernatant was transferred to fresh 15 ml low DNA binding 
polystyrene tubes, the sepharose beads for preclearing were added and the 
volume was adjusted to 9 ml by adding ChIP buffer. Samples were incubated 
for 1 h on a rotating wheel at 4ºC to remove proteins and DNA that bind 
unspecifically to beads. Beads were pelleted by centrifugation at 1,500 xg for 
2 min and discarded after transferring the supernatant to fresh 15 ml low 
DNA binding polystyrene tubes. 1 µl of pre-cleared supernatant was diluted 
1:100 with ddH2O and stored at -20ºC as input DNA control for ChIP-qPCR. 
37.5 µg goat anti-GFP antibody per sample were added and incubated over 
night on a rotating wheel at 4ºC. The following day 100 µl protein G 
sepharose 4 Fast Flow beads (real bead volume) per sample were collected 
and washed in PBS as described above. They were resuspended in 5 ml 
PBS with 200 µg/ml sonicated salmon sperm DNA and 1.5% gelatine from 
cold water fish skin and incubated on a rotating wheel at 4ºC for at least 2 h 
for pre-blocking. Beads were then collected by centrifugation at 1,500 xg for 
2 min, washed once with ChIP buffer and resuspended in 1 ml ChIP buffer. 
The pre-blocked beads were added to the supernatant-antibody mix and 
incubated on a rotating wheel at 4ºC for 2 - 3 h. Beads were collected by 
centrifugation at 1,500 xg for 2 min, the supernatant was discarded and 
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beads with bound proteins and DNA were carefully resuspended in 1 ml 
ChIP buffer and transferred to 1.5 ml DNA LoBind tubes. After centrifugation 
at 1,500 xg for 2 min, beads were washed 5 times on a rotating wheel for 1 
min at 4ºC with 1 ml of each ice-cold wash buffer in the following order: once 
with low salt, twice with high salt, once with LiCl immune complex wash 
buffer and then once with ice-cold TE buffer. The immune complexes were 
eluted by resuspending the beads in 250 µl freshly prepared ChIP elution 
buffer and incubating them 15 min at RT on a rotating wheel. After 
centrifugation for 2 min at 17,000 xg the supernatants were transferred to 
new 1.5 ml DNA LoBind tubes. Elution was repeated with 250 µl ChIP elution 
buffer and both eluates were combined. 20 µl 5 M NaCl were added to a final 
concentration of 200 mM and the crosslinking was reversed at 65ºC for at 
least 4 h or over night. 1 µl Proteinase K (20 µg/µl), 10 µl 0.5 M EDTA pH 8.0 
and 20 µl 1 M Tris-HCl pH 6.5 were added and proteins were digested for 1 h 
at 55ºC on a thermomixer at 800 rpm. Samples were allowed to cool down, 
500 µl phenol/chloroform/isoamyl alcohol (25:24:1) were added, mixed, 
incubated 5 min at RT and centrifuged at 17,000 xg for 5 min. The aqueous 
phase at the top was transferred to a new 1.5 ml DNA LoBind tube, 500 µl 
chloroform/isoamyl alcohol (24:1) were added, mixed, incubated 5 min at RT 
and centrifuged at 17,000 xg for 5 min. The aqueous phase at the top was 
transferred to a new 1.5 ml DNA LoBind tube, 500 µl isopropanol were added 
and 1 µl glycogen (20 µg/µl) for visualization of the pellet. The DNA was 
precipitated for at least 2 h or over night at -20ºC, centrifuged with 17,000 xg 
for 20 min at 4ºC and the pellet was washed with 70% EtOH. After air drying 
for 15 min the DNA was resuspended in 24 µl ddH2O and 2 µl were diluted 
1:100 for qPCR analysis while residual DNA samples were subjected to deep 
sequencing. 
 
3.4.6.2 ChIP of methylated histones 
For histone ChIPs 1.5x108 cells with Mll1 or Mll2 conditional knockout alleles 
on five 15 cm dishes were washed with PBS and crosslinked with 10 ml/dish 
1% formaldehyde/DMEM+Glutamax for 20 min at RT. The formaldehyde was 
quenched by adding 500 µl/dish of 2.5 M glycine and the crosslinked cells 
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were washed with cold PBS, scraped from the dishes in cold PBS, collected 
by centrifugation with 600 xg for 5 min at 4ºC and pellets were frozen at -
80ºC until further processing. The ChIP was performed as described above 
with the following adaptation: The sonicated supernatant (input DNA) was 
equally divided up into 3 to 5 separate tubes and incubated with 7 µg of 
H3K4me3, H3K4me2, H3K4me1 or H3K27me3–specific antibodies. To 
normalize histone ChIPs against the background binding of histones to 
beads, a control without antibodies was always performed in parallel. 
 
3.4.7 RNA extraction and reverse transcription 
ES or NS cells from 6-well plates or 10 cm dishes were collected by scraping 
in cold PBS, pelleted by centrifugation at 600 xg for 5 min at 4ºC and frozen 
at -80ºC until further processing. Total RNA was extracted using ZR RNA 
MiniPrep according to manufacturer’s instructions including on-column 
DNaseI digest. Cell pellets were resuspended in 400 µl lysis buffer at RT and 
passed several times through a 22 G needle for homogenization if 
necessary. The lysates were applied to Zymo-Spin IIIC columns placed in 
collection tubes and centrifuged at 8,000 xg for 30 s. The supernatant was 
mixed with 320 µl EtOH and transferred to Zymo-Spin IIC columns placed in 
collection tubes, centrifuged at 17,000 xg for 1 min and the flow-through was 
discarded. The columns were washed with 400 µl RNA Prep buffer, 
centrifuged at 17,000 xg for 1 min and the flow-through was discarded. 43.7 
µl RDD buffer and 6.25 µl of DNase I (2.7 Kunitz units/µl) from the RNase-
free DNase set were mixed and applied to the middle of each column. After 
digesting the DNA for 15 min at RT, columns were washed with 800 µl and 
then 400 µl RNA wash buffer, centrifuged at 17,000 xg for 1 min and the 
flow-through was discarded. The columns were dried by centrifugation at 
17,000 xg for 2 min, placed in RNase-free 1.5 ml microcentrifuge tubes and 
30 µl RNase-free ddH2O were added in the middle of each column. RNA was 
eluted after 2 min incubation by centrifugation at 10,000 xg for 1 min. The 
RNA concentration was determined using NanoDrop (absorption at 260 nm) 
and the RNA was either stored at -80ºC or immediately used for reverse 
transcription with AffinityScript Multi-Temp cDNA synthesis kit. A combination 
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of random primers and oligo(dT) primers was used to enrich not only for 
polyadenylated mRNAs, but to ensure efficient cDNA synthesis towards the 
5’ ends of long mRNAs. For each sample 2.5 µg total RNA were diluted with 
RNase-free ddH2O to a total volume of 13.7 µl. 1.5 µl random hexamer 
primers (0.1 µg/µl) and 0.5 µl oligo(dT) primers (0.5 µg/µl) were added. The 
RNA-primer mix was denatured at 65ºC for 5 min and slowly cooled down at 
RT for 10 min. 2 µl 10x Affinity Script buffer, 0.8 µl dNTP mix (25 mM) 0.5 µl 
RNase Block inhibitor (40 U/µl) and 1 µl of reverse transcriptase were added 
to each sample to a final volume of 20 µl. The reaction was incubated for 10 
min at RT, followed by 5 min at 42ºC, 60 min at 55ºC and finally inactivated 
at 70ºC for 15 min. The cDNA was diluted 1:10 by adding 180 µl ddH2O and 
stored at -20ºC until qRT-PCR analysis. 
 
3.4.8 Quantitative PCR (qPCR) 
Real time quantitative PCR was performed in 20 µl reactions mixed as 
described below. The amplification was done on Mx3000P or Mx3005P 
multiplex PCR instruments with the following thermal profile. 
 
     volume   final conc. 
ddH2O     8.2 µl   - 
2x GoTaq qPCR master mix  10 µl   1x 
5 µM primer se    0.4 µl   100 nM 
5 µM primer as    0.4 µl   100 nM 
diluted cDNA or ChIP sample  1 µl   - 
 
      temperature  time 
initial denaturation    95ºC    5 min 
40 cycles denaturation   95ºC    30 sec 
annealing   58ºC    1 min 
elongation   72ºC    1 min 
dissociation curve    95ºC   1 min 
      58ºC   30 sec 
0.5ºC steps   58ºC - 95ºC  30 sec 
 
If possible primers for qRT-PCR (Table 2) were designed to be exon-exon 
spanning or separated by at least one intron to further minimize the risk of 
amplification from contaminating genomic DNA. Analysis of qRT-PCRs was 
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done in triplicates and cycle threshold (Ct) values were normalized against 
average Ct of an internal control like Actb or Gapdh. Expression was 
calculated either relative to these housekeeping genes only:  
 
2 - ΔCt  
ΔCt = Ctgene – avg. Cthousekeeping 
 
or fold changes relative to control cells were calculated (according to (Livak 
and Schmittgen, 2001)): 
 
2 - ΔΔCt 
ΔΔCt = (Ctgene – avg. Cthousekeeping)sample - (avg. Ctgene – avg. Cthousekeeping)control 
 
Genomic promoter regions for designing ChIP-qPCR primers (Table 3) were 
selected considering peak regions detected by ChIP-sequencing analysis in 
mES cells (Denissov et al., 2014). ChIP-qPCRs were analyzed in triplicates 
and Ct values for tagged Mll1 and Mll2 proteins and mock were normalized 
to average Ct of input DNA amplified with the same primer pair and the 
values were adjusted according to dilution factors of ChIP samples and Input: 
 
2 - ΔCt * dilution factor (ChIP/Input) 
ΔCt = CtChIP – avg. CtInput 
 
qPCRs of histone ChIPs were additionally normalized to the average Ct of no 
antibody control and displayed as enrichment against this background 
binding: 
 
2 - ΔΔCt * dilution factor (ChIP/Input) 
ΔΔCt = (CtChIP – avg. CtInput)antibody - (avg. CtChIP – avg. CtInput)no antibody 
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3.4.9 RNA extraction and preparation for RNA-sequencing 
Approximately 3x107 cells with Mll1 or Mll2 conditional knockout alleles on 
one 15 cm dish per sample were washed with cold PBS, scraped from the 
dishes in cold PBS, collected by centrifugation at 600 xg for 5 min at 4ºC and 
pellets were frozen at -80ºC until further processing. For extraction of total 
RNA 4 ml TRI reagent were added to each sample and mixed by pipetting up 
and down several times. After 5 min incubation at RT 800 µl chloroform were 
added and tubes were shaken vigorously for 15 s, incubated 3 min at RT and 
centrifuged 15 min with 9,600 xg at 4ºC. The upper aqueous phase was 
transferred to new tubes, 2 ml isopropanol were added, mixed, incubated 10 
min at -20ºC and centrifuged 20 min with 17,000 xg at 4ºC. The supernatant 
was removed carefully and RNA pellets were washed with 70% EtOH, air 
dried for 5 min and dissolved in 50 µl DEPC-H2O. Aliquots of different sizes 
were stored at -80ºC until further processing. 1:10 dilutions of the RNA 
samples were used for measuring the concentration at the NanoDrop 
(absorption at 260 nm). 5 µg of each sample were diluted with DEPC-H2O to 
a total of 3.5 µl and 3.5 µl 2x RNA loading buffer were added. Samples were 
denatured at 65ºC for 4 min and separated by electrophoresis on 2% 
agarose gels to verify that the RNA is intact and not degraded.  
10 µl of total RNA were submitted to the deep sequencing facility of the 
Center for Regenerative Therapies Dresden (CRTD) where it was DNase 
digested, reverse transcribed and cDNA was sequenced using the Illumina 
Genome Analyzer II. Differential expression analysis of obtained raw reads 
from Mll2 conditional knockout cells was done by Federico De Masi 
(Technical University of Denmark) with DESeq2 using its default linear model 
and Wald test. DESeq2 used raw fragment counts obtained from cuffdiff, 
using cummerbund. Gene expression of Mll1 conditional knockout NS cells 
was analyzed by Sukhdeep Singh (Biotec, TU Dresden) using Tuxedo suite 
(Trapnell et al., 2012) with default values. 
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4 Results 
4.1 Interplay of Mll1 and Mll2 during neural differentiation 
4.1.1 Mll2 is essential for neural differentiation of mES cells 
Many developmental genes carry both the activating H3K4 and silencing 
H3K27 methylation mark on their promoters in pluripotent cells and were thus 
termed bivalent (Bernstein et al., 2006). The view of bivalency as priming 
mechanism was recently challenged by the finding that the H3K4 
trimethylation loss on most bivalent promoters in Mll2 knockout cells could be 
overcome by retinoic acid-induced differentiation (Denissov et al., 2014). The 
expression of all but 16 genes that were retinoic acid-responsive in wild type 
could be induced. Promoter H3K4 trimethylation was increased despite the 
absence of Mll2, probably due to compensation by other H3K4 
methyltransferases. Since retinoic acid differentiation produces a pool of 
different cell types, we aimed at analyzing the role of H3K4 methylation on 
bivalent promoters in a more controlled system by differentiating ES cells to 
NS cells. 
 
4.1.1.1 Differentiation of mES cells to neural rosettes and NS cells 
The neural differentiation method used here (Fig. 11 A) was adopted from 
the monolayer protocol for the derivation of neural progenitors (neural 
rosettes) and for the derivation of NS cells from any ES cell line (Pollard et 
al., 2006; Ying and Smith, 2003). In contrast to the original protocol, an 
additional step was included in which ES cells were first directed towards 
epiblast stem (EpiS) cells by seeding them on fibronectin and supplementing 
N2B27 with fibroblast growth factor 2 (FGF2) and Activin A (ActA) before 
neuroectodern differentiation was initiated. EpiS cells still expressed the 
pluripotency marker Oct4 (Fig. 11 B). This additional phase of proliferation 
under serum-free conditions greatly improved neural differentiation efficiency 
of ES cell lines derived from C57Bl/6 blastocysts which otherwise showed 
poor survival and attachment in N2B27 without growth factors. After 4 days 
ActA and FGF2 were removed to induce further differentiation to radially 
growing neural progenitors called neural rosettes. They expressed 
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transcription factors Pax6 and Sox1 (nuclear) and the intermediate filament 
Nestin (Fig. 11 C). The tight junction protein zonula occludens 1 (Zo-1, Tjp1) 
was organized in a rim around the inner lumen (Fig. 11 D). Neural rosettes 
started to appear in the culture at day five to seven in N2B27. The cells were 
then dissociated and aggregated to neurospheres in suspension culture (Fig. 
11 E). Subsequent seeding to gelatine-coated plastic allowed for the 
outgrowth of neural progenitor cells and stably growing homogenous cell 
lines could be generated by passaging. Neural progenitors generated by this 





Figure 11 Differentiation of mES cells to neural rosettes and NS cells. (A) Schematic 
representation of the differentiation protocol applied to generate neural stem cells from 
mouse ES cells. (B) EpiS cells stained for Oct4. Nuclei were counterstained with DAPI. 
Scale bar, 100 µm. (C) Neural rosettes stained for Nestin (left), Pax6 (middle) or Sox1 
(right). Nuclei were counterstained with DAPI. Scale bar, 100 µm. (D) Neural rosettes 
stained for Nestin and Zo-1. Nuclei were counterstained with DAPI. Scale bar, 25 µm. (E) 
Phase contrast images of neurospheres. Scale bar, 100 µm. (F) Phase contrast images of 
NS cells. Scale bar, 100 µm. 
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4.1.1.2 Inactivation of Mll2 impairs neural differentiation 
In order to examine the role of Mll1 and Mll2 in neural differentiation, ES cells 
with Mll1 or Mll2 conditional alleles were subjected to the differentiation 
protocol explained above. The knockout was induced by treating the ES cells 
with 4OHT (4OHT-ES) for 48 h followed by 48 h without 4OHT before the 
start of differentiation. Uninduced ES cells served as control for each cell line 
since the efficiency of differentiation can vary greatly between individual ES 
cell lines. Mll1 knockout ES cells (Fig. 12 A; Mll1FC/FC) readily formed 
Nestin- and Pax6-positive neural rosettes as their uninduced controls 
(Mll1F/F). However, when Mll2 was inactivated (Mll2FC/FC) the cells started 
to die shortly after activation of Pax6 expression and did not generate neural 
rosettes. Hence, no neurospheres could be formed (Fig. 12 B; Mll2FC/FC) 
and generation of NS cell lines failed (Fig. 12 C; Mll2FC/FC). In order to 
show that the Mll2 knockout effect is specific, we transfected the conditional 
ES cells with a bacterial artificial chromosome (BAC) containing the genomic 
region of the whole Mll2 gene. In most of the cases, BACs contain all 
regulatory sequences providing physiologic levels of expression. The second 
exon of Mll2 in the BAC was not flanked by loxP sites and thus, it was not 
affected when the endogenous alleles were inactivated. Indeed, the neural 
differentiation defect could be rescued by expressing a GFP-tagged version 
of Mll2 from the BAC transgene (Fig. 12; Mll2FC/FC + Mll2 BAC). If both Mll1 
and Mll2 were inactivated, ES cells recapitulated the Mll2 knockout 
phenotype in a more severe manner (Fig. 12; Mll1FC/FC Mll2FC/FC). Hence, 
Mll2 function is essential for the generation of NS cells from ES cells. 




Figure 12 Inactivation of Mll2 impairs neural differentiation. (A) Neural differentiation of Mll1, 
Mll2 and double knockout (FC/FC) and control (F/F) ES cells. Cells with the respective 
alleles were induced with 10-7 M 4OHT at the ES cell stage (4OHT-ES) or left uninduced as 
control. After 2 days of recovery they were differentiated to the neural rosette stage and 
stained for Nestin (upper panel) or Pax6 (lower panel). Nuclei were counterstained with 
DAPI. The endogenous knockout of Mll2 was rescued by expressing full-length Mll2 from a 
BAC transgene (Mll2-GFP). For the double knockout of Mll1 and Mll2 the starting cell 
number was increased 4-fold (*). (B) Neurospheres generated from neural rosettes depicted 
in (A). (C) NS cell lines established from neural rosettes depicted in (A). Mll2FC/FC and 
Mll1FC/FC Mll2FC/FC cells failed to generate NS cell lines. Scale bars, 100 µm.  
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4.1.1.3 Deletion of Mll2 protein domains 
Mll2 is a very big protein (295 kDa) with numerous domains whose particular 
functions are only partially known. Like its sister protein Mll1 it is cleaved by 
the protease Taspase 1 into a smaller C-terminus containing the catalytically 
active Set domain and a larger N-terminus (Fig. 13 A). Tagging the C-
terminal end of Mll2 abolished the methyltransferase activity and N-terminal 
tagging created a hypomorph (Andreu-Vieyra et al., 2010). Therefore, a GFP 
tag was introduced internally to the N-terminal part upstream of the Taspase 
1 cleavage site (Fig. 13 B). As shown above the tagged Mll2 BAC fully 
rescued the knockout of endogenous Mll2 proving its functionality (Fig. 12). 
In order to test which domains are essential for proper protein function, Mll2 
mutant BACs were generated by removing exons without causing frame 
shifts in the downstream mRNA (Fig. 13 B).  
All Mll2 mutants were expressed at reasonable levels (Fig. 13 C) in ES cells 
with conditional Mll2 alleles. The upper protein band corresponds to the full-
length (FL) protein while the lower one represents the N-terminal (NT) half 
after Taspase 1 cleavage. The sizes of the mutant BAC proteins varied 
according to the size of the mutation. Deletion of exons 3-5 (Δex3-5) caused 
the largest size reduction. When exons 30-37 were removed the size 
difference between full-length protein and N-terminal half was diminished. 
After knockout of endogenous Mll2 (FC/FC) only the expression from the 
BACs was left. While the GFP antibody could only recognize this tagged Mll2 
variant, the Mll2 antibody detected Mll2 expressed from the BAC as well as 
from the endogenous locus (Mll2F/F). Note that the Mll2 mutant lacking 
exons 3-5 was not recognized by the Mll2 antibody since it binds to an 
epitope in this region. In addition to the exon deletions we also generated a 
BAC where the Taspase 1 cleavage site was point mutated (Gly2059->Ala). 
In contrast to the other BACs this one was not tagged by GFP. Thus, it could 
only be detected by Mll2 antibody. After inactivation of endogenous Mll2 
expression, only this non-cleavable Mll2 variant was left while the N-terminal 
cleavage product was absent.  
  




Figure 13 Deletion of Mll2 protein domains. (A) Schematic representation of full-length (FL) 
Mll2 protein and the N-terminal (NT) and C-terminal (CT) parts after Taspase cleavage. The 
GFP tag of the BAC variants and regions of antibody binding are depicted. (B) Schematic 
representation of Mll2 protein domains, exon structure in mRNA and deletions generated 
from the full-length Mll2 BAC. Vertical lines in the Mll2 mRNA represent exon boundaries. A 
GFP tag was inserted upstream of the Taspase 1 cleavage site in all versions except for the 
Taspase 1 site mutant. For abbreviations see Fig. 6. (C) Western blot analysis of Mll2 
knockout (FC/FC) and control (F/F) ES cells expressing mutant Mll2 BAC transgenes using 
α-GFP (upper panel) or α-Mll2 (lower panel). The Mll2 antibody recognizes an epitope in 
exons 3-5 and thus the according domain deletion cannot be recognized by it. The Western 
Blot was done in cooperation with Helmut Hofemeister (Biotec, TU Dresden). 
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In contrast to cDNAs expressed from plasmids the expression of BAC 
transgenes is very similar to endogenous alleles. However, copy number 
variations and position effects can lead to expression differences between 
clones. Here, comparable mRNA levels from each mutant BAC were ensured 
by neomycin selection via an internal ribosomal entry side (IRES) placed 
downstream of the Mll2 ORF. Apparent differences in protein levels between 
the different mutants might thus be mainly accounted to structural differences 
influencing antibody binding or protein stability. 
 
4.1.1.4 PHD fingers, Bromo-like domain and Set domain of Mll2 are 
required for neural differentiation 
All ES cell lines carrying BAC transgenes expressing different Mll2 variants 
were tested for their neural differentiation efficiency to determine which 
domains are essential for this process. After inactivation of endogenous Mll2 
(4OHT-ES) the ES cells solely relied on Mll2 expression from the BAC. 
Deletion of exons 3-5 (Δex3-5) resulted in a Mll2 mutant lacking three AT 
hooks that are supposed to bind to the minor groove of AT-rich DNA and two 
speckled nuclear localization signals (SNL). When endogenous Mll2 was 
inactivated, ES cells expressing only this mutant BAC could still generate 
neural rosettes (Fig. 14 A, left panel) and further NS cells (Fig. 14 B). Thus, 
these conserved domains in the N-terminus were not essential for protein 
function in the applied assay.  
Two other BAC mutants could rescue the knockout of endogenous Mll2, but 
the efficiency of differentiation seemed to be slightly reduced since less 
neural rosettes were generated. The CxxC zinc finger domain (Δex6-8) was 
not essential for its function in neural differentiation. Similarly, deletion of 
exons 21-26 that code for the extended Plant Homeo Domain (ePHD) zinc 
finger and the FY-rich N-terminal domain (FYRN) reduced the efficiency of 
differentiation but did not abolish it. The FYRN domain is known to interact 
with the FY-rich C-terminal domain (FYRC) heterodimerizing the two protein 
parts after Taspase 1 cleavage. 
In contrast, the Mll2 BAC lacking three PHD fingers and the Bromo-like 
domain after deletion of exons 9-20 was not able to rescue the phenotype 
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observed after inactivation of endogenous Mll2. Bromo domains are 
supposed to bind to acetylated lysines in histone tails and PHD fingers 
accomplish protein-protein interactions, often binding to nucleosomes in 
coordination with an adjacent Bromo domain. Indeed, efficient binding of this 
Mll2 mutant protein to chromatin seemed to be disturbed. Its localization was 
not restricted to the cell nucleus, but could be also detected in the cytoplasm 
(data not shown). As expected, Mll2 without exons 30-37 lacking the 
catalytically active Su(var)3-9, Enhancer-of-zeste, Trithorax (SET) domain, 
post-Set and FYRC was also not able to rescue the knockout of endogenous 
Mll2.  
Surprisingly, cleavage of Mll2 does not seem to be important for neural 
differentiation since cells expressing only the noncleavable Mll2 variant are 
able to form Nestin-positive neural rosettes and NS cells without any obvious 
phenotype. Nevertheless, Taspase cleavage and the ability of Mll2 mutants 
to rescue seem to be correlated. There was mainly full-length protein present 
and much less of the cleaved N-terminal part from the two non-rescuing Mll2 
BAC variants (Fig. 13 C, α-Mll2, FC/FC, Δex9-20 and Δex30-37). Possible 
explanations will be addressed in the discussion. 
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Figure 14 PHD fingers, Bromo-like 
domain and Set domain of Mll2 are 
required for neural differentiation. (A) 
ES cells carrying the Mll2 mutant BACs 
displayed in Figure 13 A were 
differentiated to neural rosettes and 
stained for Nestin. Mll2 protein from the 
BACs could be detected in all cell lines 
due to the GFP tag except for the 
Taspase site mutant BAC that was not 
tagged. Due to the low expression of 
Mll2, the brightness and contrast of the 
GFP panel was enhanced equally for 
each clone after image recording to 
make the fusion proteins visible. Nuclei 
were counterstained with DAPI. The left 
panel shows cells with expression of 
endogenous Mll2 (F/F) as control while 
endogenous Mll2 was inactivated in ES 
cells (4OHT-ES) prior to differentiation 
in the right panel (Mll2FC/FC). Scale 
bars, 100 µm. (B) NS cell lines 
established from neural rosettes 
depicted in (A). Mll2FC/FC cells 
expressing BACs with deletions of 
exons 9-20 and 30-37 failed to generate 
NS cell lines. Scale bars, 100 µm. 
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4.1.2 Cooperation of Mll1 and Mll2 in the neural lineage 
In contrast to the severe phenotype caused by Mll2 inactivation, the absence 
of Mll1 did not impair neural differentiation. Despite its apparent 
dispensability the double knockout of Mll1 together with Mll2 (see Fig. 12; 
Mll1FC/FC Mll2FC/FC) caused a more severe phenotype hinting towards a 
certain compensation capacity or overlapping functions of both genes. In 
order to gain a better understanding of the interplay between both histone 
methyltransferases the knockout phenotypes in different cell types and 
stages of differentiation as well as timing effects were examined. 
 
4.1.2.1 Mll1 and Mll2 have redundant but indispensable functions in NS 
cells 
We analyzed Mll1 and Mll2 functions in established NS cell cultures that were 
isolated from mouse telencephalon at E15.5. The cells were expanded in 
adherent cultures on laminin and maintained multipotent by addition of 
epidermal growth factor (EGF) and FGF2. The knockout was induced by 
4OHT treatment of NS cells (4OHT-NS) with the respective conditional 
alleles. Surprisingly, the inactivation of Mll2 in cells with a stable NS cell 
identity did not cause any obvious effects. The inactivation of Mll1 or Mll2 did 
not alter expression of the NS cell marker Nestin (Fig. 15 A; Mll1FC/FC and 
Mll2FC/FC) or proliferation of NS cells (Fig. 15 B and C). However, if both 
Mll1 and Mll2 were simultaneously inactivated, the cells stopped proliferation 
(Fig. 15 D) and adopted a more elongated shape (Fig. 15 A; Mll1FC/FC 
Mll2FC/FC). Nevertheless, they still expressed Nestin and global H3K4 di- 
and trimethylation was unchanged (Fig. 15 E). The same phenotype could be 
observed in ES cell-derived NS cells in which the knockout of Mll1 and Mll2 
was induced at the NS cell stage (data not shown). Hence, either Mll1 or Mll2 
are needed for NS cell proliferation while inactivation of only one of the 
paralogs does not appear to have severe effects. 





Figure 15 Mll1 and Mll2 have redundant but indispensable functions in NS cells. (A) 
Conditional Mll1, Mll2 and double knockout Mll1 and Mll2 NS cells were isolated from fetal 
mouse brain and induced for the knockout for 2 days with 4OHT. 3 days after the treatment 
cells were stained for the NS cell marker Nestin. Nuclei were counterstained with DAPI. 
Scale bar 100 µm. (B-D) Cell counts of Mll1 (B), Mll2 (C) and double knockout Mll1 and Mll2 
(D) NS (FC/FC; dashed lines) induced with 4OHT on days 0-2 after seeding. Uninduced F/F 
NS cells (continuous lines) served as control. Cell counts were carried out daily starting from 
day 3 until day 7. Data is represented as mean of triplicate analysis +/- SD. (E) Western blot 
analysis of Mll1 and double knockout NS cells 5 days after 4OHT treatment for trimethylated 
(H3K4me3), dimethylated (H3K4me2) and total histone 3 (H3). 
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4.1.2.2 Neuronal differentiation of Mll1 and Mll2 knockout NS cells 
Despite being redundant in self-renewing NS cells, Mll1 or Mll2 might be 
needed for further differentiation when the epigenetic state of the cells is 
altered. Therefore, conditional NS cells were subjected to two weeks of 
differentiation by step-wise withdrawal of EFG and FGF. The differentiation 
capacity of NS cells was not impaired by single inactivation of Mll1 or Mll2. 
Both conditional knockout cells lines could generate glial fibrillary acidic 
protein (Gfap)-positive astrocytes and class III beta tubulin expressing 





Figure 16 Neuronal differentiation of Mll1 and Mll2 knockout NS cells. Conditional Mll1, Mll2 
and double knockout Mll1 and Mll2 NS cells from fetal brain were induced for 2 days with 
4OHT and after 2 days recovery differentiated for 14 days to neurons and astrocytes and 
stained for class III β-tubulin and Gfap. Nuclei were counterstained with DAPI. For 
Mll1FC/FC Mll2FC/FC NS cells the starting cell number was increased 4-fold (*) to 
compensate for the proliferation defect. Scale bar, 100 µm. 
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Also the double Mll1 and Mll2 knockout cells were able to activate Gfap and 
class III β-tubulin expression under neuronal differentiation conditions (Fig. 
16; Mll1FC/FC Mll2FC/FC) when the proliferation defect was overcome by 
increasing the starting cell number fourfold. However, all class III β-tubulin-
positive double knockout cells coexpressed Gfap and did not adopt the 
typical shape of mature neurons. Importantly, these two markers were 
mutually exclusive under wild type conditions and only appeared to be 
regularly coexpressed in the double knockout and in few cells of the Mll2 
single knockout. Thus, Mll1 and Mll2 have a redundant role in NS cell self-
renewal and neuronal differentiation. 
 
4.1.2.3 Temporal requirement of Mll1 and Mll2 during neural 
differentiation 
After establishing that Mll2 is essential for neural differentiation but 
dispensable in NS cells, we aimed to narrow down the window of essential 
protein function using a time course experiment. ES cells were induced with 
4OHT at 9 different time-points at 24 hours intervals during differentiation 
and for three consecutive days (Fig. 17 A). Uninduced Mll2F/F control cells 
readily formed neurospheres as did cells where the knockout was induced by 
4OHT starting after 3 days culture in EpiS medium (N2B27+ActA+FGF2) or 
later (Fig. 17 B). There were significantly less and smaller neurospheres 
formed when Mll2 was inactivated after only one or two days in EpiS medium 
und induction of the knockout with the start of differentiation (d0-3) 
completely abolished neurosphere formation. 
Mll2 protein is completely gone 96 h after start of 4OHT treatment (Glaser et 
al., 2009). Thus, Mll2 presence is only needed for early stages of ES cell 
differentiation, even though the effect of early removal becomes only obvious 
later when formation of neural rosettes fails.  
Considering the largely redundant functions of Mll1 and Mll2 in established 
NS cells, we speculated that Mll2 might be functionally replaceable with its 
sister gene already in earlier cell types. Indeed, applying this time course to 
Mll1 and Mll2 double knockout ES cells (Fig. 17 C) revealed a more severe 
phenotype. Inactivation as late as on day 5-8 still had an effect on the 
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number and size of neurospheres formed. But again, only the inactivation 
with the start of differentiation (d0-3) could completely prevent neurosphere 
formation. However, due to the fatal effect of the double knockout on 
proliferation of the resulting cell type, no NS cell lines could be established 





Figure 17 Temporal requirement of Mll1 and Mll2 during neural differentiation. (A) 
Schematic representation of the 4OHT-induction time course during neural differentiation. 
(B-C) Neurospheres generated from Mll2 (B) and double knockout Mll1 and Mll2 (C) ES cells 
by the 4OHT-induction time course outlined in (A). The knockout was induced by 4OHT 
addition on 3 consecutive days. Uninduced Mll2F/F and Mll1F/F Mll2F/F cells served as 
controls. (D) NS cell lines established from neurospheres depicted in (C). Scale bars, 100 
µm. 
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4.1.2.4 Timing of the neural differentiation defect 
To further analyze when the Mll2 knockout defect occurs, cell counts were 
carried out during differentiation of ES cells to neural rosettes. In contrast to 
Mll1 knockout cells that proliferated normally (Fig. 18 A), Mll2 knockout cells 
stopped proliferation when ActA and FGF2 were removed (Fig. 18 B). This 
proliferation defect in N2B27 could be rescued by the full-length Mll2 BAC 
transgene (Fig. 18 D). Again, the double knockout of Mll1 and Mll2 showed a 
more severe phenotype (Fig. 18 C) than the inactivation of Mll2 alone. Here, 








4.1.2.5 Mll1 and Mll2 are not essential for EpiS cell self-renewal 
To test whether the inactivation of both paralogous genes impairs EpiS cell 
formation, homogenous EpiS cell lines were generated from ES cells by 
passaging them in EpiS cell medium on fibronectin. The cell lines either 
expressed Mll1 and Mll2 or the knockout was induced in ES cells (4OHT-ES) 
Figure 18 Timing of the 
neural differentiation defect. 
(A-D) Cell counts of Mll1 
(A), Mll2 (B) and double 
knockout cells (C) and Mll2 
knockout cells expressing 
full-length Mll2 from a BAC 
transgene (D) during neural 
differentiation for 4 days in 
N2B27+ActA+FGF2 fol-
lowed by 7 days in N2B27 
only. ES cells were induced 
for the knockout (FC/FC; 
dashed lines) as ES cells 
(4OHT-ES) by 4OHT 
treatment for 2 days 
following 2 days recovery 
before seeding or left 
uninduced as control 
(continuous lines). Cell 
counts were carried out on 
day 4, 7, 9 and 11. Data is 
represented as mean of 
triplicate analysis +/- SD. 
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prior to differentiation or later at the EpiS cell state (4OHT-EpiS). Despite the 
substantially slower proliferation of the double knockout EpiS cells (data not 
shown) they displayed a morphology typical for EpiS cells with flat compact 
colonies composed of small cells (Fig. 19 A, Mll1FC/FC Mll2FC/FC). 
Additionally, the expression of marker genes was analyzed by qRT-PCR (Fig. 
19 B). Oct4 was slightly upregulated compared to ES cells while Nanog was 
expressed at a lower level in all EpiS cell lines examined. Further, the 
epiblast marker Fgf5 was highly expressed while the ES cell marker Rex1 
was downregulated. Thus, Mll2 single and Mll1 and Mll2 double knockout ES 
cells were able to generate epiblast-like cells as judged by morphology and 
marker expression. The defect that is caused by inactivation of Mll2 
apparently takes place after the EpiS cell state when cells are directed 





Figure 19 Mll1 and Mll2 are not essential for EpiS cell self-renewal. (A) Phase contrast 
images of EpiS cell lines established from ES cells by passaging 21-35 days in 
N2B27+ActA+FGF2. The knockout of Mll1, Mll2 or Mll1 and Mll2 was induced (2 days 4OHT, 
2 days recovery) either at the ES cell stage (4OHT-ES) prior to differentiation or as EpiS 
cells (4OHT-EpiS) or cells were left uninduced as control. Scale bar, 25 µm. (B) qRT-PCR 
analysis of EpiS cells depicted in (A) for Rex1, Oct4 ex3-4, Nanog, and Fgf5. Mll2F/F ES 
cells served as control. Expression levels were normalized to Actb and are plotted as fold 
change relative to the expression in ES cells for Rex1, Oct4 and Nanog and relative to 
Mll2F/F EpiS cells for Fgf5. Data is represented as mean of triplicate analysis +/- SD. 
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4.1.2.6 Mll1 can substitute for Mll2 from the EpiS cell state on 
Summarizing the previous experiments it becomes clear that the EpiS cell 
stage represents a transition state between Mll2 requirement and knockout 
phenotype. Neural differentiation was only impaired if Mll2 was inactivated 
before cells were for 4 days in EpiS cell medium (see Fig. 17 B). And the 
manifestation of the knockout effect occurred only after cells left the EpiS cell 
stage (see Fig. 18 B). To substantiate this observation, neural differentiation 
experiments were carried out starting with established EpiS cells lines rather 
than with ES cells. Two different knockout time points were now 
distinguished (Fig. 20 A): Either Mll1 or Mll2 were inactivated in ES cells 
(4OHT-ES) before they were differentiated to EpiS cells or the knockout was 
induced in already established EpiS cells (4OHT-EpiS). 
Indeed, when Mll2 was inactivated at the EpiS cell state, cells were able to 
form Nestin-positive neural rosettes without any obvious impairment (Fig. 20 
B, Mll2FC/FC 4OHT-EpiS) while their counterparts that lost Mll2 protein 
already earlier in the ES cell state (Mll2FC/FC 4OHT-ES) could not 
differentiate properly.  
If cells reach the EpiS cell stage with Mll2 being present it becomes 
dispensable for further differentiation. The sister gene Mll1 is clearly the best 
candidate for being able to substitute Mll2. Indeed, if both Mll1 and Mll2 were 
inactivated in EpiS cells, they failed to form neural rosettes (Fig. 20 C, 
Mll1FC/FC Mll2FC/FC 4OHT-EpiS). Thus, Mll1 is able to replace Mll2 from 
the EpiS cell state on. This observation is further supported by a full-length 
Mll1 BAC transgene being able to rescue the double knockout when it is 
induced in EpiS cells (Fig. 20 D, Mll1FC/FC Mll2FC/FC +Mll1 BAC 4OHT-
EpiS), but not if endogenous Mll1 and Mll2 are absent already from the ES 
cell state on (Fig. 20 D, Mll1FC/FC Mll2FC/FC +Mll1 BAC 4OHT-ES). 
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Figure 20 Mll1 can substitute for Mll2 from the EpiS cell state on. (A) Schematic 
representation of the establishment of EpiS cell lines from ES cells and subsequent neural 
differentiation. The knockout was induced by 4OHT either in ES cells prior to the 
differentiation to EpiS cells (4OHT-ES) or at the EpiS cell stage (4OHT-EpiS). Uninduced 
cells (F/F) served as control. (B-E) Neural rosettes generated from Mll2 knockout (B) or 
double knockout Mll1 and Mll2 (C) or double knockout Mll1 and Mll2 EpiS cells expressing 
full-length YFP tagged Mll1 from a BAC transgene (D) or Mll1 without exons 8-19 (E) using 
the protocol outlined in (A). The Mll1 BAC without exons 8-19 expresses a mutant protein 
missing the 3 PHD fingers and the Bromo-like domain accordant to the Mll2 mutant not being 
able to rescue (see Figure 14 B). Due to the low expression of Mll2, the brightness and 
contrast of the YFP panel was enhanced equally for each condition after image recording to 
make the fusion proteins visible. Neural rosettes were stained for the NS cell marker Nestin 
and nuclei were counterstained with DAPI. Scale bars, 100 µm. 
 
 
Moreover, we mutated exons 8-19 of the Mll1 BAC, which correspond to the 
same domains of the Mll2 mutant lacking three PHD fingers and the Bromo-
like domain that was not able to rescue the knockout of endogenous Mll2 
from the ES cell state on (see Fig. 14 A; Δex9-20). Like the corresponding 
Mll2 mutant, the Mll1 mutant was partially located in the cytoplasm (data not 
shown). Interestingly, this mutant BAC was able to partially rescue the 
proliferation defect of Mll1 and Mll2 double knockout in EpiS cells (data not 
shown) and during differentiation as indicated by more cells present after 7 
days in N2B27 (Fig. 20 E, Mll1FC/FC Mll2FC/FC +Mll1 BAC Δex8-19 4OHT-
EpiS). Despite that, the differentiation defect could not be rescued as no 
neural rosettes were formed. Thus, the capability of Mll1 to replace Mll2 from 
the EpiS cell state on depends on its PhD fingers and Bromo-like domain 
mediating appropriate chromatin binding. 
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4.1.3 Attempts to replace Mll2 during neural differentiation 
Evidence from this study and previous ones (Austenaa et al., 2012; Denissov 
et al., 2014; Glaser et al., 2009) suggests that H3K4 methyltransferases 
might indeed share most of their target genes and thus can compensate for 
the loss of each other with only few exceptions. If this hypothesis holds true, 
the neural Mll2 knockout phenotype described above could be caused by 
failed induction of only a few target genes. Thus, we aimed to identify, 
evaluate and characterize possible candidates and test if their forced 
expression might be able to replace Mll2 in our neural differentiation assay. 
 
4.1.3.1 Overexpression of Bcl2 prevents Mll2 knockout-induced 
apoptosis  
The apoptosis inhibitor B cell leukemia/lymphoma 2 (Bcl2) was shown to be 
a target gene of Mll2 in ES cells (Lubitz et al., 2007) and is known to regulate 
neural differentiation (Zhang et al., 1996). Its promoter is bound by Mll2 and 
shows reduced H3K4me3 in Mll2 constitutive knockout ES cells leading to 
decreased mRNA expression and slightly enhanced apoptosis rates (Lubitz 
et al., 2007). To test if apoptosis is also the reason of cell loss in our neural 
differentiation protocol, Mll2 conditional cells on day 7 of differentiation in 
N2B27 were stained for cleaved Caspase-3 that is only present in apoptotic 
but not necrotic cells. Due to the selective nature of the differentiation 
protocol a basal level of apoptosis could be already detected in control cells 
(Mll2F/F). The percentage of cleaved Caspase-3 positive cells was greatly 
increased in the Mll2 knockout situation (Fig. 21 A). 




Figure 21 Overexpression of Bcl2 prevents Mll2 knockout-induced apoptosis. (A) Mll2 
knockout (FC/FC) and control (F/F) ES cells differentiated to the neural rosette stage by the 
protocol outlined in Figure 11 A were stained for cleaved Caspase-3 (Cl. Casp.-3). Nuclei 
were counterstained with DAPI. Scale bar, 100 µm. (B) Western blot analysis of Mll2 
knockout (FC/FC) and control (F/F) ES cells expressing GFP (27 kDa) or GFP-Bcl2 (53 kDa) 
using α-Bcl2 (left panel) followed by α-GFP (middle panel) or α-Actin β (42 kDa) as loading 
control (right panel). Endogenous Bcl2 would be detected at 26 kDa. (C-D) Neural rosettes 
generated from Mll2 knockout ES cells overexpressing GFP-Bcl2 (C) or GFP (D) cDNA from 
stably integrated plasmids. Cells were stained for cleaved Caspase-3 and nuclei were 
counterstained with DAPI. For Mll2FC/FC + GFP ES cells the starting cell number was 
increased 4-fold (*) to compensate for the reduced proliferation. Scale bars, 100 µm. (E-F) 
Apertures of GFP channel images in (C-D) with 3.25x higher magnification and 50% more 
contrast. Scale bars, 20 µm. 
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We aimed to overcome this defect by expressing GFP-tagged Bcl2 from a 
stably integrated plasmid (GFP-Bcl2) or GFP alone as control (GFP). 
Western blot analysis confirmed the overexpression (Fig. 21 B). Note that no 
endogenous Bcl2 (26 kDa) could be detected due to very low protein levels 
in ES cells. Bcl2 overexpression during differentiation could indeed reduce 
the amount of apoptotic Mll2 knockout cells to similar levels like in the 
respective control (Fig. 21 C). In contrast, GFP expressing Mll2 knockout 
cells showed an enhanced rate of apoptosis as expected (Fig. 21 D). The 
overexpression and tagging of Bcl2 did apparently not disturb its cellular 
localization. As expected, GFP-Bcl2 was cytoplasmic and excluded from the 
nucleus (Fig. 21 E), while GFP alone was distributed evenly in the cells (Fig. 
21 F). 
 
4.1.3.2 Bcl2 cannot rescue the differentiation defect caused by Mll2 
inactivation 
Cell counts during differentiation showed that Bcl2 overexpression almost 
completely reverted the proliferation of Mll2 knockout cells in N2B27 
(Mll2FC/FC + GFP-Bcl2) to the rate of control cells (Fig. 22 A) while GFP 
expression did not influence the proliferation rate (Fig. 22 B). Despite 
preventing cell death by Bcl2 overexpression the Mll2 knockout cells were 
not able to form neural rosettes (Fig. 22 C). Similarly, increasing the starting 
cell number in an attempt to compensate for the extensive loss of cells in the 
GFP expressing Mll2 knockout had no supportive effect (Fig. 22 D). The 
residual Mll2 knockout cells expressing GFP died after dissociation in 
suspension culture (Fig. 22 F) while Bcl2 overexpression improved the 
survival. However, unlike the round neurospheres formed by Mll2F/F control 
cells, the apoptosis-rescued cells clumped together to irregular aggregates 
(Fig. 22 E) and no NS cells could be established (Fig. 22 G). This shows that 
the Mll2 knockout indeed affected the differentiation capacity of cells while 
apoptosis could also be a secondary effect. 
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Figure 22 Bcl2 cannot 
rescue the differen-
tiation defect caused 
by Mll2 inactivation. 
(A-B) Cell counts of 
Mll2 knockout ES cells 
overexpressing GFP-
Bcl2 (A) or GFP alone 
(B) during neural 
differentiation for 2 
days in N2B27+FGF2 
+ActA followed by 7 
days in N2B27 only. 
ES cells were induced 
for the knockout 
(FC/FC; dashed lines) 
as ES cells one 
passage prior to 
seeding (4OHT-ES) or 
left uninduced as 
control (continuous 
lines). Cell counts 
were carried out on 
day 2, 5, 7 and 9. Data 
is represented as 
mean of triplicate 
analysis +/- SD. (C-D) 
Neural rosettes gen-
erated from Mll2 
knockout ES cells 
overexpressing GFP-
Bcl2 (C) or GFP (D) 
cDNA from stably 
integrated plasmids. 
Cells were stained for  
the NS cell marker 
Nestin and nuclei were 
counterstained with 
DAPI. For Mll2FC/FC 
+ GFP ES cells the 
starting cell number 
was increased 4-fold 
(*) to compensate for 
the reduced pro-
liferation. (E-H) Phase 
contrast images of 
neurospheres (E-F) 
and neural stem cell 
lines (G-H) generated 
from GFP-Bcl2 (E, G) 
or GFP (F, H) 
overexpressing Mll2 
knockout and control 
neural rosettes de-
picted in (C-D). Scale 
bars, 100 µm. 
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4.1.3.3 Identification of Mll2 target genes during neural differentiation 
Being a H3K4 methyltransferase, Mll2 is thought to act as transcriptional 
activator. We speculated that the defect in neural differentiation might be 
caused by a failure to activate the expression of neural genes. Expression 
profiling by RNA-sequencing was utilized to identify Mll2 target genes that 
might be involved in this process. The knockout of Mll2 was induced in two 
independent conditional ES cell lines by 4OHT treatment or cells were left 
uninduced as controls. Then cells were differentiated for four days in EpiS 
medium followed by two days in N2B27 alone and RNA samples were 
collected at both differentiation stages (Fig. 23 A). The second time point was 
chosen before Mll2 knockout cells started to die extensively to reduce the 
influence of secondary effects on the analysis. Despite the reduced H3K4me3 
levels on many developmental genes in Mll2 knockout ES cells (Denissov et 
al., 2014) the start of the neural differentiation program was not completely 
abolished. Upon ActA and FGF2 removal both knockout and control cells 
commonly upregulated 39 genes more than twofold, including the brain-
specific transcription factor Pou3f2 (Brn2), and downregulated 33 genes, for 
example the epiblast marker Fgf5 (data not shown). Comparing Mll2 
knockout to control cells revealed only 22 genes downregulated by at least 
twofold in EpiS medium and 15 that were lower expressed two days later in 
N2B27 (Fig. 23 B and table 5 in appendix). Seven of these genes were 
significantly lower expressed in both conditions.  
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Figure 23 Identification of Mll2 
target genes during neural 
differentiation. (A) Schematic 
representation of samples 
collected for RNA-sequencing. The 
knockout of Mll2 (FC/FC) was 
induced in ES cells by 4OHT 
treatment for 2 days. Following 2 
days recovery knockout and 
control (F/F) ES cells were 
differentiated for 4 days in N2B27 
with ActA and FGF2 (EpiS cell 
medium) followed by 2 days in 
N2B27 alone. RNA samples were 
collected at both differentiation 
time points. (B) Venn diagram 
illustrating the number of genes 
significantly downregulated at least 
two fold in Mll2FC/FC cells. 
Differential expression analysis 
was carried out on 2 biological 
replicates representing 2 ES cell 
lines derived from blastocysts of 
different litters using DESeq2 
default linear model and Wald test. 
See table 5 (appendix) for details. 
(C) Flow chart explaining selection 
of Mll2 target genes that might be 
essential for neural differentiation. 
Numbers or gene names in 
brackets state how many or which 
genes fulfill each criterion. 
 Results  
 104 
4.1.3.4 Expression of Mll2 target genes during neural differentiation 
The number of Mll2 target genes that might be responsible for the neural 
differentiation defect was further reduced by applying certain criteria (Fig. 23 
C). First, they should have a reasonable expression level as defined by an 
FPKM (fragments per kilobase of exon per million) value of at least 4 in 
control cells. This significantly shortened the list to ten genes (Table 5 in 
appendix, grey background) whose expression level during neural 
differentiation with or without Mll2 was examined by qRT-PCR (Fig. 24). In 
addition, we tested five more Mll2 target genes with FPKM values below 4 
whose GO terms implied a possible involvement in differentiation processes 
(*). Interestingly, nine Mll2 target genes (Sohlh2, Taf7l, Tex11*, Dazl*, Rpl10l, 
Otud6a, Mael, Gstm5, Rnase4) appeared to be mainly expressed in ES cells 
and were almost completely silenced in EpiS and NS cells. Six of them 
(Sohlh2, Taf7l, Tex11*, Dazl*, Mael, Gstm5) are known to be involved in 
spermatogenesis which is consistent with the infertility that is caused by Mll2 
inactivation in adult mice (Glaser et al., 2009). In addition, Dazl was 
previously reported to be a Mll2 target in ES cells (Glaser et al., 2009). These 
ES cell and spermatogenesis-specific genes are probably not essential for 
neural differentiation. Their appearance in the RNA-sequencing data was 
likely due to leftover expression from the ES cell stage. All these ES or germ 
cell-specific genes showed another peak of expression in Mll2F/F N2B27 d7, 
suggesting that the applied differentiation protocol produced not only neural 
rosettes but also some cells with germ cell identity.  
In contrast to the expression profiling samples where ES cells were only 
differentiated for four days in EpiS medium, cells for this particular 
experiment (Fig. 24) were grown for several passages as EpiS cells after 
inducing the knockout at the ES cell stage. Prolonged culture without Mll2 
caused certain adaptations and the expression of most of the target genes 
(Taf7l, Tex11*, Dazl*, Otud6a, Mael, Gstm5, Rnase4, Pdgfrl*, B3galnt1, 
Eig121l*) was back to wild type levels in Mll2FC/FC EpiS cells or in N2B27. 
As these cells were still not able to generate NS cells (see Fig. 20 B, 
Mll2FC/FC 4OHT-ES) we also excluded these genes from further analysis.  




Figure 24 Expression of potential Mll2 target genes during neural differentiation. qRT-PCR 
analysis of potential Mll2 target genes in Mll2 knockout (dashed lines) and control 
(continuous lines) ES cells that were further differentiated to homogeneous EpiS cell lines by 
passaging before further differentiation in N2B27 for 2 or 7 days and finally to NS cells. Mll2 
knockout NS cells were obtained by inducing the knockout in established NS cells (4OHT-
NS, red dot) since Mll2 knockout ES cells cannot reach the NS cell stage. Expression levels 
are plotted relative to the expression of the housekeeping gene Actb. For Nxt2 ex3-4 primers 
were used. Data is represented as mean of triplicate analysis +/- SD. *Gene displayed 
FPKM < 4 in RNA-sequencing analysis in Mll2F/F cells (see Fig. 23 and table 5 in appendix).  
 Results  
 106 
Of two genes fulfilling all criteria so far, Slc39a8 seemed to be more specific 
for EpiS cells and thus we concentrated on nuclear transport factor 2-like 
export factor 2 (Nxt2). It was expressed at low levels in ES cells and 
upregulation of expression during neural differentiation failed if Mll2 was 
inactivated at the ES cell stage (4OHT-ES). The time point of expression 
upregulation between N2B27 d2 and d7 when Mll2 is present coincides with 
apoptosis of the knockout cells. In addition to Nxt2, another qRT-PCR tested 
gene fulfilled all criteria of a neural-specific Mll2 target gene except for having 
FPKM values below 4. Thus, sex comb on midleg-like 2 (Scml2) was also 
included in further experiments. 
As Mll2 knockout ES cells were not able to generate NS cells, the knockout 
was induced separately in NS cells (Fig. 24, red dot). At this stage the 
expression of Nxt2 and Scml2 was not dependent upon Mll2 anymore what is 
consistent with the absence of a severe Mll2 knockout phenotype in NS cells. 
 
4.1.3.5 Nxt2 and Bcl2 overexpression partially rescues the 
differentiation defect 
In order to determine whether loss of Nxt2 or Scml2 expression causes the 
observed neural differentiation defect, their cDNAs were cloned into 
eukaryotic expression plasmids. They were transfected and stably integrated 
into Mll2 conditional ES cells. The CAG promoter of these plasmids ensured 
high expression that is independent of Mll2. Compared to ES cells with a 
GFP plasmid as control the mRNAs of Nxt2 and Scml2 transfected ES cells 
were overexpressed 30-55 fold and 280-350 fold, respectively (Fig. 25 A). 
The overexpression from the Bcl2 plasmid used for previous experiments 
was even higher, namely 1000 fold. 
Nxt2 or Scml2 overexpression alone could not alter the observed neural 
phenotype upon Mll2 knockout (Fig. 25 B). Most cells still underwent 
apoptosis during differentiation. Aiming at preventing cell death, cells were 
co-transfected with the Bcl2 plasmid. Bcl2 together with Nxt2 overexpression 
could partially rescue the absence of Mll2. Approximately 20% of the cells 
survived and generated neural rosettes and finally NS cells (Fig. 25 B and 
C).  




Figure 25 Nxt2 and Bcl2 overexpression partially rescues the differentiation defect. (A) qRT-
PCR analysis of ES cells overexpressing GFP, Bcl2, Nxt2 or Nxt2 or Scml2 together with 
Bcl2. Expression levels were normalized to Actb and plotted as fold change relative to the 
expression in GFP overexpressing ES cells. For Nxt2 ex2-3 primers were used. Data is 
represented as mean of triplicate analysis +/- SD in logarithmic scale. (B) Neural rosettes 
generated from Mll2 knockout and control ES cells overexpressing Nxt2 or Scml2 cDNA with 
or without Bcl2 cDNA from stably integrated plasmids. Cells were stained for the NS cell 
marker Nestin and nuclei were counterstained with DAPI. For the Mll2 knockout the starting 
cell number was increased 2-fold (*). (C) Phase contrast images of NS cells generated from 
Bcl2 and Nxt2 overexpressing Mll2 knockout and control neural rosettes depicted in (B). 
Scale bars, 100 µm. 
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Overexpression of Scml2 and Bcl2 together also showed a certain 
improvement as more cells started to express Nestin after 7 days in N2B27. 
However, no distinct rosette structures were formed and cells died when 
dissociated for suspension culture (Fig. 25 B and data not shown). 
Unfortunately, simultaneous overexpression of all 3 cDNAs was not possible 
since Nxt2 and Scml2 plasmids both carry a neomycin resistance gene and 
cotransfection resulted in clones with either one or the other plasmid 
integrated, but never both. Thus, it remains unclear if forced expression of 
Nxt2 and Scml2 might have a cumulative effect further improving the rescue 
effect or not. 
 
4.1.3.6 Epigenetic regulation of the Nxt2 promoter 
Nxt2 has four different transcripts and three protein isoforms (Fig. 26 A). 
Isoform a is translated starting from an ATG in exon 1 and thus can be 
produced from two different transcript variants either with exon 1A in front of 
exon 1 as 5’UTR or without. The longer isoform b starts translation from the 
alternative exon 1B upstream of exon 1. The shortest isoform c is missing the 
otherwise common exon 1 and instead has exon 1C as 5’UTR and 
translation starts from an alternative ATG in exon 2. It was only very recently 
annotated and this could not be evaluated in the context of this study. We 
determined expression of the different isoforms using primers for qRT-PCR 
that were either placed to amplify a product from exon 3 to 4 capturing all 
transcript variants or with primers in exons 1B and 1 to only amplify a product 
from isoform b (Fig. 26 B). Isoform b was expressed at relatively low levels in 
ES cells, had its maximal expression in N2B27 d7, but was not expressed at 
all in NS cells. It remained unclear if this isoform was specifically expressed 
in neural rosettes or rather some other cell types that developed in N2B27 d7 
as well (like germ cell-like cells).  
Nxt2 has no CpG island complicating the identification of its promoter region. 
H3K4 trimethylation and Mll2 binding determined by ChIP-sequencing in ES 
cells (Denissov et al., 2014) revealed a single peak spread over exons 1A 
and 1, but not at exons 1B and 1C. In EpiS and NS cells the peak was more 
spread but still highest at this position (data not shown). Thus, we assumed 
 Results  
 109 
that isoform a is the prevalent one and the overexpression construct for the 
rescue experiment (see Fig. 25) was constructed accordingly with cDNA 
starting shortly before the ATG in exon 1 that will be translated into isoform a. 
The reduced expression of Nxt2 upon Mll2 inactivation could also be caused 
indirectly or by secondary effects. Chromatin immunoprecipitation (ChIP) of 
GFP-tagged Mll2 expressed from a BAC transgene was applied to prove that 
Nxt2 is indeed a direct target gene. The primers for ChIP-qPCR were 
designed to amplify a genomic region in exon 1 where ChIP-sequencing 
peaks in ES cells were highest and thus where the Nxt2 promoter was most 
likely located. The Nxt2 promoter was bound by Mll2 in ES cells and the 
binding decreased when cells differentiated to EpiS cells and NS cells (Fig. 
26 C). Simultaneously, Mll1 binding was very low in ES cells but gradually 
increased towards NS cells. This is consistent with our hypothesis that Mll1 
can replace Mll2 from the EpiS cell state on. 
We showed before that bivalent promoters in ES cells rely on Mll2 while 
active promoters are bound not only by Mll2, but also by the Set1 complex 
(Denissov et al., 2014) conferring protection by redundancy. However, 
despite Nxt2 being expressed at low levels in ES cells (see Fig. 24) it seems 
to represent an exception as it relies mainly on Mll2 for H3K4 methylation. 
Trimethylation (H3K4me3) on the Nxt2 promoter was reduced by 
approximately 70% in ES cells when Mll2 was inactivated (Fig. 26 D). H3K4 
dimethylation was only mildly decreased and monomethylation was even 
enhanced, probably due to accumulation as it was not converted to di- or 
trimethylation. In contrast, the H3K4 methylation profile on the Paf1 promoter 
(Fig. 26 E) serving as control was not changed except for a slight increase in 
H3K4me3. 
The H3K4me3 reduction at the Nxt2 promoter in ES cells was further 
inherited throughout differentiation to NS cells (Fig. 26 F). This might explain 
the failure of Mll2 knockout cells to increase Nxt2 transcription later in 
development. Surprisingly, H3K4me3 at the Nxt2 promoter was also reduced 
when Mll2 was inactivated in stable NS cells despite Mll1 binding to the 
promoter (Fig. 26 F, red dot). This reduction did not alter its expression level 
(see Fig. 24, red dot).  




Figure 26 Epigenetic regulation of the Nxt2 promoter. (A) Schematic representation of Nxt2 
genomic organization, transcripts and protein isoforms adjusted from Ensemble Genome 
Browser. Thin lines with arrows indicate introns and direction of transcription. Compact blue 
lines display exons with thicker areas between start and end of translation. (B) qRT-PCR 
analysis of different Nxt2 transcripts during differentiation of control (Mll2F/F) ES cells to NS 
cells. Values for Nxt2 exon 3-4 are the same like in Figure 24. Expression levels are plotted 
relative to the expression of the housekeeping gene Actb. Legend continues on page 112. 
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(C) ChIP-qPCR of the Nxt2 promoter in ES, EpiS and NS cells. Binding of Mll2-GFP or Mll1-
YFP was determined using a GFP antibody for ChIP from cells expressing full-length tagged 
Mll1 or Mll2 from a BAC transgene or in cells without a GFP tag (mock). Values are plotted 
relative to input DNA. (D-E) ChIP-qPCR of the Nxt2 (D) promoter and Paf1 (E) promoter 
(serving as control) in Mll2 knockout and control ES cells using H3K27me3, H3K4me3, 
H3K4me2 or H3K4me1 specific antibodies. ES cells were induced for 2 days with 4OHT 
following 6 days of recovery before analysis. Values are plotted as enrichment against no 
antibody control. (F-J) ChIP-qPCR of the Nxt2 (F, H) promoter and Paf1 (G, I) or Hoxc8 (J) 
promoters (serving as controls) in Mll2 knockout and control ES cells differentiated to 
homogenous EpiS cell lines and differentiated further in N2B27 for 2 and 7 days and finally 
to NS cells using H3K4me3 (F-G) or H3K27me3 (H-I) specific antibodies. ChIPs of Mll2 
knockout NS cells were performed after inducing the knockout in established NS cells 
(4OHT-NS, red dot). Please note that the values for Nxt2 and Paf1 in ES cells are identical 
to the ones in (D-E) because these are the same samples. Values are plotted as enrichment 
against no antibody control. Data is represented as mean of triplicate analysis +/- SD. 
 
 
H3K27me3 at the Nxt2 promoter was very low in control ES cells and 
elevated upon Mll2 knockout but was eventually reduced to a similar extent 
like in control cells during subsequent differentiation steps (Fig. 26 H). Thus, 
silencing by Polycomb repressive complex 2 was not the cause for 
transcriptional failure of Nxt2. The Hoxc8 promoter served as a control here 
as it is known to be H3K27 methylated in ES cells (Fig. 26 J). 
 
4.1.3.7 Nxt2 expression and epigenetic regulation in EpiS cells 
Since Mll1 could replace Mll2 only if Mll2 was present until the EpiS cell 
stage (see Fig. 20 D), we speculated that Mll1 binding to the Nxt2 promoter 
might depend upon Mll2. However, this was not the case as Mll1 binding was 
not altered when Mll2 was inactivated in EpiS cells (4OHT-EpiS) or in ES 
cells (4OHT-ES) prior to differentiation (Fig. 27 A). The consequences of 
different Mll2 knockout time points were reproduced in mRNA levels. Despite 
the still low Nxt2 expression in EpiS cells it was decreased mildly upon Mll2 
knockout in EpiS cells but more when Mll2 was removed already earlier in ES 
cells (Fig. 27 B). H3K4 trimethylation of the Nxt2 promoter recapitulated its 
expression levels. It was gradually decreased when Mll2 was inactivated in 
EpiS cells and more if Mll2 was removed before differentiation in ES cells 
(Fig. 27 C). Stable H3K4 trimethylation on the Paf1 promoter served as 
control (Fig. 27 D).  
 




Figure 27 Nxt2 expression and epigenetic regulation in EpiS cells. All experiments were 
conducted with uninduced EpiS cells (F/F) as control and two different time points of 
knockout induction (see Fig. 20) to inactivate endogenous Mll2 (B-D) or Mll1 and Mll2 (A) 
alleles: The knockout was induced either in ES cells (4OHT-ES) by treatment with 4OHT for 
2 days following 2 days recovery and differentiation to homogenous EpiS cell lines by 
passaging in N2B27 with ActA and FGF2 for 21-35 days. Or the knockout was induced by 
4OHT in established EpiS cells (4OHT-EpiS) for 2 days and cells were analyzed after 5-7 
days recovery. (A) ChIP-qPCR of the Nxt2 promoter in EpiS cells. Binding of Mll1-YFP was 
determined using a GFP antibody for ChIP from cells expressing full-length tagged Mll1 or in 
cells without a GFP tag (mock). The occupancy of Mll1-YFP was compared in EpiS cells with 
and without expression from endogenous Mll1 and Mll2 alleles. Please note that the value 
for Mll1-YFP in Mll1F/F Mll2F/F EpiS cells is identical to the one in Figure 26 A because it is 
the same sample. Values are plotted relative to input DNA. (B) qRT-PCR analysis of Nxt2 
ex3-4 in Mll2 knockout and control EpiS cells. Expression levels are plotted relative to the 
expression of the housekeeping gene Actb. (C-D) ChIP-qPCR of the Nxt2 (C) promoter and 
Paf1 (D) promoter (serving as control) in Mll2 knockout and control EpiS cells using 
H3K27me3 or H3K4me3 specific antibodies. Values are plotted as enrichment against no 
antibody control. Data is represented as mean of triplicate analysis +/- SD. 
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4.1.3.8 Expression of Mll2 target genes and neural markers in vivo 
In order to determine if these in vitro observations could also apply in vivo, 
the expression of Mll2 target genes were analyzed in E9.5 mouse embryos. 
At this time point in development Mll2 knockout embryos were already 
growth retarded but not yet dead. Indeed, Nxt2 and Scml2 expression was 
strongly reduced in Mll2 knockout embryos (A/A) compared to their 
heterozygous or wild type littermates (Fig. 28 A). However, Bcl2 was only 
mildly downregulated. Hence, there might be additional compensation 
mechanisms to ensure its expression in vivo. Pax6 and Nestin expression 
served as readout for neural differentiation in the embryos (Fig. 28 B). The 
mRNA levels of both genes were reduced in Mll2 knockout embryos. This 
was probably not the cause but a consequence of failed neural 
differentiation, since Nestin and Pax6 were not among the 954 genes that 
lost H3K4 trimethylation at their promoters in ES cells upon conditional Mll2 





Figure 28 Expression of 
Mll2 target genes and 
neural markers in vivo. (A-
B) qRT-PCR analysis of 
Mll2 knockout (A/A) and 
heterozygous (A/+) control 
embryos at E9.5 for 
expression of Mll2 target 
genes Nxt2 (ex3-4), Scml2 
and Bcl2 (A) and of neural 
markers Pax6 and Nestin 
(B). Two embryos per 
genotype are shown. 
Expression levels were 
normalized to Actb and 
plotted as fold change 
relative to the expression 
in a wild type (+/+) 
embryo. Data is re-
presented as mean of 
triplicate analysis +/- SD. 
 
 Results  
 114 
4.2 Opposing functions of Mll1 and Mll2 during somatic cell 
reprogramming 
The complex interplay of Mll1 and Mll2 in neural differentiation and NS cells 
prompted us to wonder if these proteins might be similarly involved in the 
reverse process. Playing important roles for epigenetic regulation during 
differentiation might make them potent inhibitors or supporters of 
reprogramming to induced pluripotency, a process during which the whole 
epigenome must be reset. 
 
4.2.1 Establishing the PiggyBac transposase system for reprogramming 
of mNS cells 
4.2.1.1 Isolation of NS cells from fetal telencephalon 
The use of NS cells as original cell source offered several advantages. First, 
NS cells are a more defined cell type than the commonly used MEFs that 
represent a heterogeneous cell population. Second, they can be theoretically 
expanded indefinitely in vitro under defined conditions and are better 
amenable to genetic manipulation. Third, being multipotent and 
endogenously expressing one of four reprogramming factors (Sox2) they are 
easier to reprogramm than terminally differentiated cells. NS cells from 
telencephalon were used for all reprogramming experiments to avoid any 
traces of ES cells that might possibly be left in the culture when using ES cell 
derived NS cells.  
In order to establish a reliable reprogramming system we used the Oct4-GFP 
reporter mouse line (Szabo et al., 2002) where GFP is expressed from a 
transgene under the control of the Oct4 enhancer and promoter. In E15.5 
mouse embryos the reporter was expressed in the primordial germ cells that 
have migrated to the genital ridges. In male embryos the germ cells formed a 
striped pattern whereas in females it was punctate (Fig. 29 A). The fetal 
forebrain was triturated to single cells and cultured in suspension culture to 
allow the formation of neurospheres (Fig. 29 B). Seeding of these spheres to 
laminin in EGF and FGF containing NS medium generated NS cell lines that 
grew in adherent conditions (Fig. 29 C) with a similar morphology to NS cells 
generated from ES cells. Flow cytometry analysis for CD44 surface antigen 
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(Fig. 29 D) was used to ascertain the homogeneity of each NS cell line 
isolated from fetal forebrain since CD44 is highly expressed by NS cells and 




Figure 29 Isolation of NS cells from fetal telencephalon. (A) Merged image of phase contrast 
and fluorescent microscopy of genital ridges dissected from male and female E15.5 mouse 
embryos carrying the Oct4 promoter driven GFP (Oct4-GFP) transgene. Scale bar 500 µm. 
(B) Phase contrast image of neurospheres formed at day 4 of suspension culture of cells 
isolated from E15.5 mouse telencephalon. Scale bar 500 µm. (C) Phase contrast image of 
NS cells isolated from E15.5 mouse telencephalon in monolayer culture on laminin (passage 
5). Scale bar 100 µm. (D) Histograms showing FACS analysis of Oct4-GFP NS cells 
(passage 7) with Phycoerythrin coupled CD44 specific antibody (CD44-PE) or isotype control 
antibody. Intensity of PE signal is displayed in arbitrary units. 
 
 
4.2.1.2 NS cell reprogramming with constitutive factor expression 
The PiggyBac system from Alan Bradley’s laboratory (Yusa et al., 2009) that 
was originally applied for reprogramming of MEFs was established for NS 
cells. It consists of two plasmids that were cotransfected into cells (Fig. 30 A). 
One plasmid encodes the PiggyBac (PB) transposase that mediates insertion 
of the DNA lying between the 5’ and 3’ PB terminal repeats into the genome. 
PiggyBac integration duplicates the TTAA target sequence but later excision 
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removes the additional bases leaving no footprint (Fraser et al., 1996). The 
integrated plasmid part contains a strong CAG promoter that drives 
expression of a polycistronic mRNA consisting of the open reading frames of 
Oct4, Sox2, Klf4 and c-Myc (OSKM) separated by T2A and F2A sequences 
that prevent formation of the peptide bond creating single, fully functional 
proteins. This OSKM cassette was shown to express a better reprogramming 
factor stoichiometry resulting in a higher percentage of bona fide iPS cells 
that are germ line competent than the similar OKSM cassette (Carey et al., 
2011). Additionally, the integrating part of the PB-CAG-OSKM plasmid 
contains a puromycin resistance gene fused to thymidine kinase under the 
control of a PGK promoter to allow for positive selection of transfected cells 
by puromycin or to select against cells with integrations by adding 
Ganciclovir. The latter is important for excision from the genome since this 
transposition event is rather inefficient.  
NS cells were transfected at day 0 of reprogramming with an equimolar ratio 
(700 ng/kb) of circular PB-OSKM reprogramming and transposase plasmids 
using nucleofection since this method exhibited the highest transfection 
efficiency for this cell type (30% for 600 ng/kb or 4.2 µg of CAG-GFP 
plasmid, data not shown). Transfected NS cells were seeded onto a feeder 
layer of Mitomycin C-treated MEFs and cultured for two days in NS medium 
for recovery before the medium was changed to FCS-based ES medium (Fig. 
30 B). No selection for PB-CAG-OSKM was applied since reprogramming 
itself selects for the integration event. Non-transfected cells differentiated to 
astrocytes in FCS-containing medium and could then act as additional feeder 
cells. In contrast to most other studies the cells were not passaged during 
reprogramming to distinguish between two possible experimental readouts – 
treatments that change the efficiency of reprogramming (percentage of 
original cells that give rise to iPS cells) would result in differences in the 
number of colonies while treatments influencing only the proliferation of 
intermediate cells or iPS cells would lead to different colony sizes. 




Figure 30 NS cell reprogramming with constitutive factor expression. (A) Schematic 
representation of PiggyBac reprogramming factor and transposase plasmids. The 
transposase (PBase) mediates integration of the reprogramming cassette located between 
the terminal repeats (PB 5’, PB 3’) into the genome thereby doublicating the TTAA target 
sequence. CMV, cytomegalovirus promoter; CAG, CMV early enhancer/chicken β actin 
promoter; PGK, phosphoglycerate kinase promoter; AmpR, prokaryotic Ampicillin resistence 
gene; PuroRΔTK, Puromycin resistance fused to thymidine kinase ORF; ori, prokaryotic 
origin of replication; T2A, Thosea asigna virus 2A translational cleavage site; F2A, Foot-and-
mouth disease virus 2A translational cleavage site. (B) Schematic representation of the 
experimental outline to reprogram mouse NS cells from fetal telencephalon to iPS cells by 
constitutive factor expression. AP, Alkaline Phosphatase. (C) Top view of 6 well of iPS cell 
colonies stained for Alkaline Phosphatase activity at day 14 after nucleofection of PB-CAG-
OSKM and CMV-PBase plasmids to NS cells. (D) Phase contrast image of iPS cell colonies 
in (C). Scale bars, 500 µm. (E) Oct4-GFP iPS cell line generated by picking a single colony 
at day 14 after NS cell nucleofection. After picking the iPS cells were and grown in ES cell 
medium for 7 more days and passaged twice on feeder cells. Scale bar, 100 µm. 
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After 14 days of reprogramming two single iPS cell colonies per well were 
picked, passaged and expanded to evaluate their quality. The cell lines 
usually adopted a mouse ES cell-like colony morphology and turned on the 
Oct4-GFP reporter if present (Fig. 30 E). The residual plate at day 14 was 
stained for Alkaline Phosphatase activity for easy and fast assessment of iPS 
cell colonies (Fig. 30 D). The established reprogramming protocol reliably 
resulted in 50-250 Alkaline Phosphatase positive colonies per 6-well (Fig. 30 
C) from wild type NS cells or from uninduced control cells. Taking into 
account that only around 30% of the initial 8x106 NS cells were successfully 
transfected and that each nucleofection was distributed to two wells, the 
reprogramming efficiency reaches 0.004-0.02%. Thus, the performance is 
lower than viral factor delivery but suitable for our purpose. 
 
4.2.1.3 Evaluation of induced pluripotent stem cell lines 
Several of the established iPS cell lines were stained with an antibody 
against Nanog (Fig. 31 A) that was not encoded by the PB-CAG-OSKM 
reprogramming cassette. Positive Nanog staining proved that NS cells 
reprogrammed with PB-CAG-OSKM had indeed rearranged their epigenome 
and reactivated the expression of this endogenous transcription factor. 
Similarly, the cells had reactivated the Oct4-GFP reporter. The presence of 
stage specific embryonic antigen 1 (Ssea-1, synthesized by Fut4 and Fut9) 
on iPS cell membranes (Fig. 31 B) as a marker of murine pluripotent cells 
further confirmed full reprogramming. Another criterion of bona fine iPS cells 
is the silencing of the reprogramming transgenes. To distinguish between 
expression of endogenous and exogenous pluripotency genes, the antisense 
primer for qRT-PCR was designed complementary to either the 3’ 
untranslated region (UTR) that is only present in endogenous Oct4 mRNA or 
to the T2A sequence downstream of Oct4 cDNA in the OSKM cassette. Both 
qRT-PCRs used the same sense primer placed into the coding region of the 
last (fifth) Oct4 exon. Eight of ten iPS cell lines examined and displayed here 
as representative examples (Fig. 31 C) expressed endogenous Oct4 and 
Nanog at reasonable levels compared to the ES cell control. Two iPS cell 
lines (#1 and #2) showed very low Nanog and endogenous Oct4 expression 
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and seemed to rely mainly or partially on the expression from the OSKM 
cassette. However, also the eight PB-CAG-OSKM reprogrammed cell lines 
with otherwise good endogenous expression all showed basal levels of 
expression from the reprogramming transgenes. This might be due to the 
early passage number (P3-5) of iPS cells or it could represent an intrinsic 




Figure 31 Evaluation of induced pluripotent stem cell lines. (A-B) Established Oct4-GFP iPS 
cell lines were evaluated at day 28-35 after NS cell nucleofection with PB-CAG-OSKM and 
CMV-PBase (see Fig. 30) by staining with Nanog (A) or Ssea-1 (B) specific antibodies. The 
green fluorescence in (A) shows expression of GFP driven from the Oct4 promoter 
transgene. Nuclei were counterstained with DAPI. Scale bars, 100 µm. (C) qRT-PCR 
analysis of 10 iPS cell lines generated by PB-CAG-OSKM reprogramming as outlined in 
Figure 30 B. Mouse ES cells serve as control. Expression levels of endogenous Oct4, 
exogenous Oct4 (expression from PB-CAG-OSKM) and Nanog are plotted relative to the 
expression of the housekeeping gene Gapdh. Data is represented as mean of triplicate 
analysis +/- SD. 
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4.2.1.4 NS cell reprogramming with inducible factor expression 
To circumvent problems that might arise from incomplete silencing of the 
OSKM reprogramming cassette, the CAG promoter was replaced with 
tetCMV. The CMV minimal promoter is preceded by tetracyclin response 
elements (TRE) to render it Doxycyclin (Dox) inducible (Fig. 32 A). In order to 
establish the Tet-On system in NS cells they were stably transfected with a 
linearized plasmid encoding the reverse tetracyclin repressor fused to the 
VP16 transactivation domain (rtTA). Cells were selected for successful 
integration via IRES-neomycin and clones were tested for functionality by 
transient transfection with a circular plasmid expressing Gaussian Luciferase 
under a tetCMV promoter (data not shown). The best Dox responsive clones 
of each NS cell line were transfected a second time with circular PB 
transposase and the PB-tetCMV-OSKM plasmids and cells with the 
integrated cassette were selected with puromycin. The whole resistant 
population was expanded and used for reprogramming experiments to 
balance position effects and the influence of copy numbers. MEFs were 
reported to require at least two integrations of the original PB-CAG-OSKM 
cassette for successful reprogramming (Yusa et al., 2009). The double 
transgene NS cells were seeded onto feeder cells and Dox was added to the 
medium at day 0 to start reprogramming (Fig. 32 B). Dox is bound by rtetR 
that in turn binds to the TRE bringing the TA in close proximity to the CMV 
and transcription of the reprogramming factors is induced. Importantly, no 
iPS colonies were formed without Dox (see Fig. 35 E, right column). The 
expression of exogenous factors in the reprogramming culture steadily 
increased until day 12 of Dox treatment when endogenous Oct4 expression 
rose sufficiently and silencing of the transgenes started (Fig. 32 C). After 14 
days of Dox treatment, numerous compact iPS cell colonies had formed from 
approximately half of the tested CAG-rtTA-IRES-neo NS cell clones (n=13). 
The other cell lines were not able to generate iPS cells at a reasonable 
efficiency. The prolonged in vitro culture caused by the double transfection 
strategy supposedly led to irreversible genetic or epigenetic changes in half 
of the clones that impeded reprogramming.  




Figure 32 NS cell reprogramming with inducible factor expression. (A) Schematic 
representation of the Tet-On system to control the expression of reprogramming factors. The 
CAG promoter of the PiggyBac reprogramming plasmid was exchanged to tetCMV that is 
controlled by tetracycline response elements (TRE). rtTA, reverse tetracycline repressor 
fused to transactivator domain of Herpes simplex virion protein 16; IRES, internal ribosomal 
entry site; Neo, neomycin. Dox, Doxycyclin. Also see Figure 30 for more abbreviations. (B) 
Schematic representation of the experimental outline to reprogram mouse NS cells from fetal 
telencephalon to iPS cells by inducible factor expression. (C) qRT-PCR analysis of NS cells 
with integrated CAG-rtetR-TA and PB-tetCMV-OSKM undergoing reprogramming to iPS 
cells according to the experimental outline in (B) and splitting of the whole population at day 
14. Expression levels of endogenous Oct4, exogenous Oct4 and Nanog are plotted relative 
to the expression of the housekeeping gene Actb. (D) qRT-PCR analysis of 12 iPS cell lines 
generated by the experimental outline depicted in (B) and picking of single colonies at day 
14. Mouse ES cells serve as control. Expression levels of endogenous Oct4, exogenous 
Oct4 and Nanog are plotted relative to the expression of the housekeeping gene Gapdh. 
Data is represented as mean of triplicate analysis +/- SD. 
 Results  
 122 
This problem was not caused by silencing of the CAG-rtTA-IRES-neo. The 
same effect was observed in the affected NS clones when trying to 
reprogramm them with PB-CAG-OSKM that is not dependent on the Tet-On 
system (data not shown).  
Dox was kept on the cells for three more days after single iPS colonies were 
picked on day 14 or the whole population was passaged 1:5 to avoid 
overgrowing. When Dox was finally removed on day 17, approximately 80% 
of the colonies grew independently of Dox after a short crisis of two to four 
days and gave rise to iPS cell lines that relied only on the expression of 
endogenous pluripotency genes (Fig. 32 D). Nanog expression was not 
considerably elevated until four days after Dox removal (Fig. 32 C) and it was 
still much lower expressed in eight out of twelve iPS cell clones analyzed at 
passages 3-5 (Fig. 32 D). The impact of this finding is not clear since Nanog 
expression is known to fluctuate a lot within pluripotent cell populations 
(Chambers et al., 2007). However, none of the iPS cell clones showed any 
expression from the OSKM cassette and all but one (#4) expressed 
endogenous Oct4 in a much more comparable manner to ES cells than the 
PB-CAG-OSKM iPS cells (see Fig. 31 C). 
 
4.2.2 Inactivation of Mll1 and Mll2 during reprogramming 
NS cells with conditional alleles were isolated from fetal forebrain and 
reprogrammed by constitutive and inducible factor expression as described 
above. The beginning of reprogramming was defined as day 0 when 
exogenous factor expression started. In the case of constitutive PB-CAG-
OSKM, this was the day of nucleofection and for inducible PB-tetCMV-OSKM 
the day of Doxycyclin addition (Fig. 33). The same time course of knockout 
induction was applied to all conditional cell lines in reprogramming 
experiments. Cells were either left uninduced as control or the knockout of 
conditional alleles was induced by treating cells for two days with 4OHT 
following two days recovery without 4OHT one passage (P-1) before start of 
reprogramming. Additionally, the knockout was induced during iPS cell 
generation at early (d0-3), mid (d5-8) or late (d10-13) stages. The resulting 
Alkaline Phosphatase positive iPS cell colonies at day 14 were counted and 
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sorted into two different categories: Colonies with strong staining that are 
compact and round were supposed to be fully reprogrammed. The second 
category had either weaker Alkaline Phosphatase activity or frayed edges 
and might thus be partially reprogrammed pre-iPS cells or colonies that are 





Figure 33 Schematic representation of the experimental outline to determine the effect of 
Mll1 or Mll2 inactivation on reprogramming efficiency using constitutive or inducible factor 
expression. The conditional knockout of Mll1 or Mll2 was achieved by 4OHT treatment for 3 
consecutive days at different time points before or during reprogramming or cells were left 
uninduced as control. 
 
 
4.2.2.1 Knockout of Mll2 has mild effects on NS cell reprogramming 
efficiency 
Applying the above mentioned time course to Mll2 conditional NS cells while 
reprogramming them with PB-CAG-OSKM showed that the number of iPS 
cell colonies decreased the earlier the knockout was induced (Fig. 34 A and 
C). When Mll2 was inactivated before start of reprogramming (P-1) the 
efficiency of iPS cell generation was reduced by more than 50%. Removal of 
only one allele of Mll2 did not influence reprogramming efficiency (Fig. 34 B 
and D). Interestingly, a subclone of the same homozygous Mll2 NS cell line 
showed the same reprogramming efficiencies like uninduced control when 
Mll2 was inactivated prior to reprogramming with PB-tetCMV-OSKM (Fig. 34 
E). The efficiency was only mildly reduced upon Mll2 knockout if it was 
induced at mid (d5-8) or late (d10-13) stages. This discrepancy might be due 
to timing differences of the two reprogramming systems. 
 




Figure 34 Knockout of Mll2 has mild effects on NS cell reprogramming efficiency. (A-B) Top 
view of 6 wells (upper row) and phase contrast images (lower row) of iPS cell colonies 
stained for Alkaline Phosphatase (AP) activity at day 14 of PB-CAG-OSKM reprogramming 
by the experimental outline depicted in Figure 33. NS cells were either homozygous for the 
Mll2 conditional allele (A) or heterozygous (B). Scale bars, 1 mm. (C-F) Colony counts at day 
14 of reprogramming. NS cells homozygous (C, E) or heterozygous (D, F) for the Mll2 
conditional allele were reprogrammed by constitutive (PB-CAG-OSKM) or inducible (PB-
tetCMV-OSKM) factor expression. Colonies were counted and sorted into two categories 
according to appearance – round colonies with strong AP staining (red) and more frayed 
colonies or colonies with frayed edges (orange). Values are shown as fold change relative to 
the number of round colonies with strong AP staining in the untreated control well (no). 
Graphs show values of one out of two independent technical replicates carried out for each 
experiment that produced similar outcomes. 
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4.2.2.2 Early Mll1 inactivation improves reprogramming efficiency of NS 
cells 
While the Mll2 knockout had neutral or slightly negative consequences for 
reprogramming, inactivation of Mll1 showed the opposite effect. 
Reprogramming efficiency was enhanced if Mll1 was removed in NS cells (p-
1) or early (d0-3) during PB-CAG-OSKM reprogramming (Fig. 35 A-C). The 
extend of the improvement seemed to be quite variable depending on the NS 
cell line used. It varied between threefold (Fig. 35 A-B) and 12-fold (Fig. 35 
C) in two NS cell lines isolated independently from different litters. Again, 
inactivation of only one conditional Mll1 allele did not influence 
reprogramming efficiency (Fig. 35 D). Reprogramming with inducible factor 
expression produced the same result like PB-CAG-OSKM reprogramming. A 
subclone of the NS cell line NS 1 with 12-fold reprogramming improvement 
with PB-CAG-OSKM revealed a fourfold higher efficiency with PB-tetCMV-
OSKM (Fig. 35 E-F). 
 
 




Figure 35 Early Mll1 inactivation improves reprogramming efficiency of NS cells. (A, E) Top 
view of 6 wells (upper row) and phase contrast images (lower row) of iPS cell colonies 
stained for Alkaline Phosphatase (AP) activity at day 14 of PB-CAG-OSKM (A) or PB-
tetCMV-OSKM (E) reprogramming by the experimental outline depicted in Figure 33. Two 
different NS cell lines (NS 1 and NS 2) homozygous for the Mll1 conditional allele were used 
that were generated from fetal telencephalon of mice from different litters. Scale bars, 1 mm. 
(B-D, F) Colony counts at day 14 of reprogramming. NS cells homozygous (B, C, F) or 
heterozygous (D) for the Mll1 conditional allele were reprogrammed by constitutive (PB-
CAG-OSKM) or inducible (PB-tetCMV-OSKM) factor expression. Values are shown as fold 
change relative to the number of round colonies with strong AP staining in the untreated 
control well (no). Graphs show values of one out of two independent technical replicates 
carried out for each experiment that produced similar outcomes. 
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4.2.2.3 Overlapping effects of Mll1 and Mll2 inactivation on 
reprogramming 
The opposing roles of Mll1 and Mll2 during reprogramming became 
especially obvious when both were inactivated together during 
reprogramming (Fig. 36 A-B). The reprogramming efficiency was generally 
decreased, partially probably due to the proliferation defect of NS cells 
without Mll1 and Mll2. However, the extend differed depending on the time 
point of knockout induction and the NS cell line used. One of the two lines 
(NS2, Fig. 36 B) even showed an improvement of reprogramming efficiency 
when Mll1 and Mll2 were inactivated in early (d0-3) compared to mid (d5-8) 
stages. This could probably be accounted to the beneficial effects of Mll1 
knockout in the early phase. Even heterozygous inactivation of only one 
allele of both Mll1 and Mll2 led to fluctuations in reprogramming efficiency 
(Fig. 36 C). Subclones of the same NS cell lines showed similar overlapping 
effects when they were reprogrammed using the inducible PB-tetCMV-OSKM 
(Fig. 36 D-H). 
 




Figure 36 Overlapping effects of Mll1 and Mll2 inactivation on reprogramming. (B-C, F-H) 
Colony counts at day 14 of reprogramming. NS cells homozygous (A-B, F-G) or 
heterozygous (C, H) for the Mll1 and Mll2 conditional alleles were reprogrammed by 
constitutive (A-C) or inducible (F-H) factor expression. Two different homozygous NS cell 
lines (NS 1 and NS 2) were used that were generated from fetal telencephalon of mice from 
different litters. Values are shown as fold change relative to the number of round colonies 
with strong AP staining in the untreated control well (no). Graphs show values of one out of 
two independent technical replicates carried out for each experiment that produced similar 
outcomes. (D-E) Top view of 6 wells (upper row) and phase contrast images (lower row) of 
iPS cell colonies stained for Alkaline Phosphatase (AP) activity at day 14 of PB-tetCMV-
OSKM reprogramming by the experimental outline depicted in Figure 33. Scale bars, 1 mm.  
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4.2.2.4 esiRNA knockdown of Mll1 during NS cell reprogramming 
Since the Mll1 knockout was only effective when carried out in a short phase 
early during reprogramming, we speculated that a transient knockdown might 
produce the same outcome. Thus, Oct4-GFP NS cells were nucleofected not 
only with PB-CAG-OSKM and transposase plasmids for reprogramming but 
additionally with endoribonuclease prepared siRNA (esiRNA). EsiRNA 
directed against exons four to six of the Mll1 transcript was mixed with mock 
esiRNA in varying proportions to keep the total amount of esiRNA per 
nucleofection equal. This proved to be important to rule out the influence of 
increased nucleic acid concentration on cell survival and thus experimental 
outcome. The reprogramming efficiency increased slightly when the 
proportion of Mll1 esiRNA was enhanced (Fig. 37). With 250 ng Mll1 esiRNA 
the reprogramming efficiency could be increased by 60%. This is especially 
remarkable since heterozygous inactivation of Mll1 caused hardly any effect 
as shown above (see Fig. 35 D). The penetrance of the knockdown was 
probably very high due to the experimental setup. Every NS cell that was 
able to reprogramm must have been successfully transfected with the large 
reprogramming plasmids and thus very likely obtained a sufficient amount of 
the small esiRNA as well. 
 
 
Figure 37 esiRNA knockdown of Mll1 during NS cells reprogramming. (A) Top view of 6 
wells (upper row) and phase contrast images (lower row) of iPS cell colonies stained for 
Alkaline Phosphatase (AP) activity at day 14 of reprogramming. Oct4-GFP NS cells were 
nucleofected at day 0 with the PB-CAG-OSKM and PBase plasmids together with esiRNA. 
EsiRNA was directed against mouse Mll1 or GFP (mock) and the indicated amounts were 
mixed to a total of 250 ng. Scale bar, 1 mm. (B) Colony counts of the wells depicted in (A). 
Values are shown as fold change relative to the number of round colonies with strong AP 
staining in the control well (250 ng mock). Graphs show values of one out of two 
independent technical replicates that produced similar outcomes. 
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4.2.2.5 Reprogramming efficiency of MEFs is not affected by Mll1 
Several studies on Mll1 function utilized MEFs as experimental system 
(Takeda et al., 2006; Yokoyama et al., 2013) and MEFs are widely used as 
starting cell type for reprogramming experiments. Thus, the effect of Mll1 
inactivation on the reprogramming efficiency of this cell type was tested (Fig. 
38). Surprisingly, no consistent effect could be observed in two Mll1 
conditional MEF lines isolated from different litters. Thus, Mll1 seems to carry 






Figure 38 Reprogramming efficiency of MEFs is not affected by Mll1. (A-B) Top view of 6 
wells (upper row) and phase contrast images (lower row) of iPS cell colonies stained for 
Alkaline Phosphatase (AP) activity at day 14 of PB-CAG-OSKM reprogramming. E 13.5 
MEFs (mouse embryonic fibroblasts) homozygous (A) or heterozygous (B) for the conditional 
Mll1 allele were lipofected at passage 2 with PB-CAG-OSKM and PBase plasmids and 
subjected to the same 4OHT induction time course as outlined in Figure 33 for NS cells. 
Scale bars, 1 mm. (C-E) Colony counts at day 14 of reprogramming of MEFs homozygous 
(C-D) or heterozygous (E) for the Mll1 conditional allele. Two different homozygous MEF 
lines (MEF 1 and MEF 2) were used that were derived from embryos of different litters. 
Values are shown as fold change relative to the number of round colonies with strong AP 
staining in the untreated control well (no). 
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4.2.3 Mll1 stabilizes the NS cell state 
4.2.3.1 Identification of Mll1 target genes in NS cells 
In order to understand why and how Mll1 impedes NS cell reprogramming it 
is essential to identify its NS cell specific target genes. RNA-sequencing of 
two independent Mll1 conditional NS cell lines isolated from fetal 
telencephalon of mice from different litters revealed a very high variability in 
gene expression. Considering only genes with FPKM above 4 in at least one 
of the two lines before Mll1 inactivation revealed 712 genes that were 
downregulated by at least twofold in NS cell line 1 and 278 in NS cell line 2 
after Mll1 knockout (Fig. 39 A). The overlap between both cell lines was 
minimal with only 21 genes being at least twofold downregulated in both cell 
lines. The same held true for genes at least twofold upregulated upon Mll1 
knockout. Here, both lines had only 30 genes in common. This discrepancy 
was mainly due to a high general variation in gene expression between the 
two lines. Most genes that were reasonably high expressed in one NS cell 
line and thus could show differential expression were not expressed at all in 
the other line (data not shown). However, since both NS cells lines showed 
increased reprogramming efficiencies without Mll1, we reasoned that the 
target genes responsible for the effect must be found within the commonly 
regulated genes. With Mll1 being a transcriptional activator, we decided to 
focus on the 21 commonly downregulated genes that had been selected for 
certain criteria as described above (Fig. 39 B). 15 of them with annotated 
functions were tested by qRT-PCR and 4 genes whose differential 
expression could not be confirmed were removed. The 17 residual potential 
Mll1 targets in NS cells are listed in table 6 in the appendix. Foxg1 and 
Adamts19 were very differentially expressed between both NS cell lines and 
hardly bound by Mll1 (data not shown). Their differential expression is likely 
due to secondary changes and not responsible for the observed phenotype. 
The gene with the strongest decrease in expression (more than tenfold) that 
was reasonably expressed (FPKM ≥ 4) in both NS cell lines was 
Orthodenticle homologue 2 (Otx2).  




Figure 39 Identification of Mll1 target genes in NS cells. RNA-sequencing analysis was 
performed with two different NS cells lines (NS 1 and NS 2) homozygous for the Mll1 
conditional allele that were generated from fetal telencephalon of mice from different litters. 
The knockout of Mll1 was induced by 4OHT treatment for 2 days and RNA samples were 
collected after 4 or 6 days of recovery without 4OHT or NS cells were left uninduced as 
control. (B) Venn diagram illustrating the number of genes downregulated or upregulated by 
at least two fold in Mll1FC/FC NS cells for both cell lines. FPKM values were calculated 
using DESeq2. (A) Flow chart explaining selection of Mll1 target genes in NS cells. Numbers 
in brackets state how many genes fulfill each criterion. See table 6 (appendix) for details. (C) 
qRT-PCR analysis of Otx2 in both NS cell lines. The expression level of Otx2 relative to the 
housekeeping gene Actb is shown for Mll1 knockout (Mll1FC/FC) and control (Mll1F/F) NS 
cells using primers in exon 2 and 3 to capture all transcript variants. Data is represented as 
mean of triplicate analysis +/- SD. 
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Otx2 is a key transcription factor involved in brain development making it a 
good candidate to counteract early steps of reprogramming. Despite the 
diverge FPKM values in RNA-sequencing analysis, its mRNA expression 
measured by qRT-PCR was similar in both NS cell lines used in this study 
(Fig. 39 C). However, RNA-sequencing analysis of the two NS cell lines was 
not done in parallel and in different institutes, possibly explaining this 
discrepancy. NS cell line 1 with the higher increase in reprogramming 
efficiency upon Mll1 knockout (see Fig. 35 B-C) showed a 24-fold reduction 
of Otx2 expression while NS 2 had slightly more Otx2 transcript left (15-fold 
reduction) after removal of Mll1. 
Besides Otx2 we found few more signaling molecules and transcription 
factors downregulated after Mll1 knockdown that might stabilize the NS cells 
state. Dlx1 and Wnt4 are other good candidates that will be further discussed 
below. Kcnip1 as potassium channel might rather be a downstream target of 
Otx2 and was likely only expressed in some spontaneously differentiated 
neurons in the cultures. A2m, Barx2, Skida and all non-characterized 
transcripts were excluded from consideration as their gene ontology terms 
revealed no connection to the neural lineage. Moreover B3gnt5 and Bcar3 
are neural genes but the fold change is likely not big enough to explain a 
direct dependence on Mll1. Thus, we concentrated on Otx2 as most 
important Mll1 target gene for further analysis. 
 
4.2.3.2 Otx2 in NS cell reprogramming 
If the Mll1 knockout effect on NS cell reprogramming was caused by the 
decrease in Otx2 expression alone, an Otx2 knockdown should reproduce it. 
The esiRNA was directed against the 3’UTR of Otx2 and should therefore 
target all transcript variants. Since transfection efficiency in NS cells was too 
low the esiRNA was tested by lipofection of ES cells and could reduce Otx2 
mRNA to below 30% of its usual level (Fig. 40 A). Different ratios of Otx2 and 
mock esiRNA were nucleofected together with circular PB-CAG-OSKM and 
transposase plasmids into NS cells at the start of reprogramming. In contrast 
to Mll1 esiRNA that slightly increased reprogramming efficiency (see Fig. 37) 
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the Otx2 esiRNA did not yield more iPS cell colonies in a quantity-dependent 





Figure 40 Otx2 in NS cell reprogramming. (A) qRT-PCR analysis of Otx2 ex2-3 in ES cells 2 
days after lipofection with varying amounts of Otx2 esiRNA. The expression level of Otx2 
was normalized to the housekeeping gene Actb and displayed as fold change relative to the 
expression of ES cells lipofected with mock. Data is represented as mean of triplicate 
analysis +/- SD. (B) Top view of 6 wells (upper row) and phase contrast images (lower row) 
of iPS cell colonies stained for Alkaline Phosphatase (AP) activity at day 14 of 
reprogramming. Oct4-GFP NS cells were nucleofected at day 0 with the PB-CAG-OSKM and 
PBase plasmids together with esiRNA. EsiRNA was directed against mouse Otx2 or GFP 
(mock) and the indicated amounts were mixed to a total of 250 ng. Scale bar, 1 mm. (C) 
Colony counts of the wells depicted in (B). Values are shown as fold change relative to the 
number of round colonies with strong AP staining in the control well (250 ng mock).  
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4.2.3.3 Epigenetic regulation of the Otx2 promoter 
Otx2 has three transcript variants that differ in their promoter usage and 
5’UTR and code for two different protein isoforms due to the use of an 
alternative in-frame splice site at the 5’ end of exon 2 (Fig. 41 A). The slightly 
shorter isoform b (289 amino acids) is expressed from the middle (42 CpG) 
or the proximal (21 CpG) promoter. The latter one was shown to be 
preferably used in mouse ES cells (Fossat et al., 2005). The longer isoform a 
(297 amino acids) is supposedly expressed from the distal promoter (55 
CpG) being especially active in the developing brain (Fossat et al., 2005). 
qRT-PCR analysis was carried out to test if this holds true for the in vitro 
differentiation of ES to NS cells. Expression of total Otx2 mRNA was 
measured with primers spanning from exon two to three that captured all 
transcript variants (Fig. 41 B). Otx2 was expressed in wild type ES cells and 
throughout differentiation with highest expression in N2B27 d7 followed by 
EpiS cells. To distinguish the different transcript variants, individual sense 
primers in the distinct first exons were combined with a common antisense 
primer in exon 2 (Fig. 41 C). The transcript variant with exon 1B produced 
from the middle (42 CpG) promoter was expressed at a very low level in all 
differentiation steps. Exon 1A with the supposedly ES specific proximal 
promoter was used highest in ES cells, but dropped rapidly once cells were 
differentiated to EpiS cells. The second peak of expression in N2B27 d7 is 
probably not due to expression in neural rosettes but rather specifically in the 
few cells with germ cell like identity also produced at this stage (see section 
4.1.3.4). The transcript variant with exons 1A1 and 1A2 expressed from the 
neural distal promoter was indeed the prevalent one in NS cells. However, it 
was also already expressed in ES cells at similar levels like 1C and was the 
main variant in EpiS cells. Interestingly, all primer combinations produced an 
equal ratio of two products in all cell types examined with a size difference of 
24 bp corresponding to the alternative 5’ splicing of exon two distinguishing 
protein isoform a from b (data not shown). Thus, no certain 5’ UTR of any of 
the alternative first exons is specifically linked to one protein isoform as the 
Ensemble Genome Browser annotation might imply. 
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Figure 41 Epigenetic regulation of the Otx2 promoter. (A) Schematic representation of Otx2 
genomic organization, transcripts, protein isoforms and promoters adjusted from Ensemble 
Genome Browser. Thin lines with arrows indicate introns and direction of transcription. 
Compact blue lines display exons with thicker areas between start and end of translation. 
Green boxes represent CpG islands. (B-C) qRT-PCR analysis of Otx2 expression relative to 
the housekeeping gene Actb in ES cells differentiated to homogenous EpiS cells and 
differentiated further in N2B27 for 2 and 7 days and finally to NS cells. Otx2 primers either 
amplified a product ranging from exon 2 to exon 3 thus recognizing all transcript variants (B) 
or were specific for each variant by using sense primers in the individual first exons and a 
common antisense primer in the second exon (C). (D-E) ChIP-qPCR of both Otx2 promoters 
during differentiation of ES cells to NS cells as described in (B-C) using H3K4me3 (green) or 
H3K27me3 (red) specific antibodies. Values are plotted as enrichment against no antibody 
control. (F-G) ChIP-qPCR of both Otx2 promoters in ES, EpiS and NS cells. Binding of Mll2-
GFP or Mll1-YFP was determined using a GFP antibody for ChIP from cells expressing full-
length tagged Mll1 or Mll2 from a BAC transgene or in cells without a GFP tag (mock). 
Values are plotted relative to input DNA. (H-I) ChIP-qPCR of both Otx2 promoters in Mll1 
knockout and control NS cells using H3K27me3, H3K4me3, H3K4me2 or H3K4me1 specific 
antibodies. NS cells were induced for 2 days with 4OHT following 3 days of recovery before 
analysis. Values are plotted as enrichment against no antibody control. Data is represented 
as mean of triplicate analysis +/- SD. 
 
 
The H3K4 trimethylation changes during neural differentiation largely 
reflected promoter usage (Fig. 41 D-E). No enrichment could be detected for 
the middle (42 CpG) promoter (data not shown) corresponding to the very 
low expression level of the 1B transcript variant. Both the proximal (21 CpG) 
and the distal (55 CpG) Otx2 promoters were H3K4 trimethylated in ES cells 
and transcription started from both of them. The distal promoter showed an 
H3K4me3 increase in EpiS cells where the corresponding transcript variant 
1A was the prevalent one. In NS cells only the distal promoter was still H3K4 
trimethylated in agreement with its preferable use in NS cells while no 
H3K4me3 could be detected on the proximal promoter (21 CpG) any more. 
H3K27 trimethylation on both promoters was highest in ES cells on both 
promoters and reduced when cells differentiated to EpiS cells (Fig. 41 D-E).  
The binding of Mll1 and Mll2 to the different Otx2 promoters was evaluated 
by ChIP-qPCR. Mll2 was bound to both the proximal and the distal promoter 
in ES cells, the binding decreased in EpiS cells and was absent in NS cells 
(Fig. 41 F-G). In contrast, Mll1 was not significantly bound to both promoters 
in ES cells, but showed highest binding in EpiS and NS cells. Thus, the 
binding dynamics in different cell types resemble the ones on the Nxt2 
promoter (see Fig. 26 C) with the exception that a low amount of Mll2 is still 
bound to the Nxt2 promoter in NS cells while the Otx2 promoters are solely 
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bound by Mll1 in this cell type. Surprisingly, there was no obvious difference 
in Mll1 and Mll2 binding between the supposedly ES cell specific proximal 
promoter (21 CpG) and the neural-specific distal promoter (55 CpG).  
In order to determine how Mll1 controls expression of Otx2 in NS cells the 
promoter histone methylation was examined by ChIP-qPCR before and after 
inactivation of Mll1 (Fig. 41 H-I). As expected, H3K4me3 on the neural-
specific distal promoter (55 CpG) was higher than on the proximal one (21 
CpG) but there was no change upon removal of Mll1. However, H3K4 di- and 
monomethylation were higher than trimethylation, especially on the distal 
promoter (55 CpG) and H3K4 monomethylation was reduced by 
approximately threefold after Mll1 knockout. Simultaneously, H3K27me3 was 
increased on both promoters by two- to threefold after Mll1 inactivation 
possibly explaining the decrease in expression levels (see Fig. 39 C). 
H3K27me3 on both Otx2 promoters was much higher already in the 
uninduced conditional Mll1 NS cells as compared to the wild type NS cells 
used for ChIP-qPCR above (Fig. 41 D-E). This might be a cell line-specific 
variation or due to technical differences since differentiation to NS cells and 
the ChIPs were not done in parallel.  
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5 Discussion 
Mammals have six H3K4 methyltransferase complexes organized in three 
pairs of sister genes. This implies a certain specialization or division of labor 
between the enzymes. The present study examined the function of the 
paralogs Mll1 and Mll2 during neural differentiation and reprogramming of NS 
cells to induced pluripotency. 
 
5.1 Distinct roles of Mll1 and Mll2 in neural differentiation and 
reprogramming 
Despite the high homology between Mll1 and Mll2 both proteins have 
different functions during differentiation of ES cells to NS cells and the 
reversion of this process. Their divergency is reflected in the sequential cell 
type-specific binding to certain target genes and in the consequences of their 
depletion from promoters. The present study showed that Mll2 but not Mll1 is 
essential for neural differentiation. Mll2 activity is required in ES cells until 
they reach the EpiS cell state for subsequent neural differentiation. From the 
EpiS cell state on Mll1 is able to substitute for Mll2 absence. Finally, Mll1 
stabilizes the NS cell state by regulating the Otx2 promoter and thus it 
impedes reprogramming to induced pluripotency. In contrast, the importance 
of Mll2 for neural differentiation is mainly based on its ability to prime the 
Nxt2 promoter in ES cells and to prevent apoptosis by regulating Bcl2. 
Therefore, Mll2 carries out a pioneer role and exerts an epigenetic task that 
will not be required until later during differentiation. Mll1 on the other hand is 
dispensable for early differentiation events but gains influence during further 
development. This is in consistency with the earlier lethality of Mll2 knockout 
mice (E10.5) as compared to Mll1 (E13.5). Developmental retardation and 
widespread apoptosis of embryos deficient for Mll2 made it difficult to 
determine cell type-specific effects (Glaser et al., 2006). However, there is 
evidence for a neural phenotype since the expression of not only Nxt2 but 
also the neural markers Pax6 and Nestin was diminished in Mll2 knockout 
embryos. Thus, the in vitro phenotype corresponds well with observations 
made in mice. This also holds true for the finding that Mll2 is dispensable for 
later in vitro differentiation events as Mll2 inactivation in adult mice causes no 
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obvious phenotype except for sterility (Glaser et al., 2009). Hence, 
differentiation of ES cells to NS cells emerges as reliable method to mimic 
early neural development in vivo. 
 
5.2 Interplay of H3K4 methyltransferases during development 
Despite the distinct knockout phenotypes in mice and corresponding cell 
type- and developmental time point-specific functions, there is also evidence 
for a high degree of redundancy among the six H3K4 methyltransferases. It 
appears that several of them bind to common target genes and thus can 
compensate or replace each other in certain cases but not in others. In ES 
cells, for example, active promoters are bound by Setd1 and Mll2 complexes 
while bivalent genes are bound by Mll2 but not Setd1. Thus, many bivalent 
genes rely on Mll2 for their H3K4 trimethylation and loose significant levels 
upon Mll2 knockout while almost all active genes are unaffected (Hu et al., 
2013b; Denissov et al., 2014). On the other hand, if Setd1a is inactivated in 
ES cells global H3K4 trimethylation decreases causing proliferation arrest 
and apoptosis (Bledau et al., 2014). Mll2 is not able to compensate for 
Setd1a despite their corporate binding to most active promoters. It is 
conceivable that methyltransferases bind to promoters without being 
catalytically active but rather awaiting additional signals. Indeed, there are 
indications implying a functional separation between methyltransferase 
recruitment and activity. For instance, the intact structure of the 3rd PHD 
finger of Mll1 is indispensable for its recruitment to target genes, but 
transcriptional maintenance depends additionally on binding of this PHD 
finger to H3K4me3 (Chang et al., 2010).  
Comparing Mll1 and Mll2 the degree of redundancy might be more 
pronounced due to the high homology between the paralogs. Considering the 
higher severity of the double knockout, Mll1 and Mll2 indeed seem to conduct 
a redundant yet essential function that increases with developmental 
progression. While Mll1 and Mll2 double knockout ES cells were almost 
unaffected, EpiS cells showed reduced proliferation and NS displayed a 
severe growth arrest (see Fig. 15 D). Several publications claim a role for 
Mll1 in cell cycle progression (Takeda et al., 2006; Liu et al., 2010; Ali et al., 
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2014) either due to the regulation of cell cycle associated genes or even 
independent of its H3K4 methyltransferase function. However, all studies so 
far utilized MEFs or immortalized human cell lines and cell type specificity 
appears to play an important role in the context of Mll1 and Mll2. 
Nevertheless, we cannot exclude a redundant function of the two histone 
methyltransferases in cell cycle progression in our experimental setup. One 
argument in favor of this hypothesis is provided by the mutant Mll1 BAC 
missing a PHD finger and the Bromo-like domain. This mutant BAC was not 
able to rescue the neural differentiation defect after removal of endogenous 
Mll1 and Mll2 in EpiS cells and did not show efficient chromatin binding. 
However, it was able to reestablish the proliferation during differentiation to 
the same extent like the full-length Mll1 BAC (see Fig. 20 D and E). 
In addition to the high degree of redundancy, Mll1 and Mll2 also acquired 
very diverge functions in some cell types or developmental stages despite 
their close homology. This might be explained by a large fraction of 
overlapping target genes (Denissov et al., 2014) with only few genes 
representing an exception by specifically relying on only one H3K4 
methyltransferase in certain cell types. Examples for these exceptions for 
Mll2 are Magohb in ES cells (Glaser et al., 2009; Ladopoulos et al., 2013), 
Pigp in macrophages (Austenaa et al., 2012) and Nxt2 and Scml2 in our 
neural differentiation assay. Other exceptions from the redundancy can occur 
if only one of the paralogous H3K4 methyltransferases is expressed as it is 
the case in spermatogonia where the severity of the Mll2 knockout cannot be 
compensated due to absence of Mll1 transcript (Glaser et al., 2009). 
 
5.3 Comparing immediate and long-term knockout effects and systems 
In a previous report using constitutive Mll2 knockout ES cells (Lubitz et al., 
2007) we showed that mesoderm and ectoderm differentiation was inefficient 
without Mll2 due to delayed induction of key differentiation markers. In 
contrast, the conditional Mll2 knockout ES cells examined here displayed a 
more severe phenotype not being able to differentiate to neural precursors 
under any circumstances (see Fig. 16). The discrepancy might be explained 
by the use of two different protocols for differentiation. While the previous 
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report utilized a strategy via embryoid bodies that led directly to neurons, the 
present defined monolayer differentiation protocol generates neural 
precursors. Besides these technical differences the more severe phenotype 
was probably caused by the acute nature of the conditional knockout strategy 
that prevents adaptation of cells during long in vitro culture. This explanation 
is supported by expression profiling data, which revealed more down- than 
upregulated genes in the conditional knockout while the constitutive one had 
equal numbers (Glaser et al., 2009). As H3K4 methyltransferases are 
supposedly transcriptional activators, their direct target genes will show 
reduced expression. Hence, more down- than upregulated genes were 
expected upon their inactivation. The increased number of upregulated 
genes in the constitutive Mll2 knockout might be mainly due to secondary 
effects or adaptations. On the other hand, prolonged culture after the 
knockout might also decrease the number of downregulated genes, like it 
occurred in the present study. Several Mll2 target genes that were 
downregulated in ES cells shortly after the knockout reversed to normal 
expression levels after prolonged culture as EpiS cells (see Fig. 24). This 
underlines the importance of inducible knockout systems. 
Even more useful than inducible knockout systems that can be only applied 
once and unidirectional might be switchable strategies like the tagging of 
endogenous genes with the Auxin-induced degron (AID) (Nishimura et al., 
2009; Holland et al., 2012). If both alleles are tagged one can degrade the 
protein by simply adding Auxin to the cells. Applying this strategy to Mll2 one 
could degrade the protein in ES cells and differentiate them to EpiS cells 
before allowing cells to re-express Mll2 protein after Auxin withdrawal. If this 
rescues the neural differentiation defect it would prove that Mll2 is not 
needed in ES cells but only briefly in EpiS cells to H3K4 methylate the Nxt2 
promoter for subsequent transcriptional upregulation. In contrast, if cells were 
still not able to differentiate to NS cells, one could conclude that Mll2 is also 
needed at the ES cell state, probably because the Nxt2 promoter cannot be 
reactivated later due to irrevocable silencing. 
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5.4 Potential Mll2 target genes essential for neural differentiation 
More than 900 bivalent genes loose significant amounts of H3K4me3 upon 
conditional knockout of Mll2 in ES cells (Denissov et al., 2014). Thus, one 
would expect a rather severe transcriptional failure during differentiation in 
the absence of Mll2. This was not the case as most early developmental 
genes were induced during retinoic acid differentiation and increased their 
H3K4 trimethylation and expression levels (Hu et al., 2013b; Denissov et al., 
2014). Obviously, Mll1 might be able to substitute for Mll2 on most 
developmental genes or even the Setd1 complex might be recruited when 
expression is being activated. The key expression program of neural 
differentiation in the present study was also induced regularly after Mll2 
inactivation. Despite the acute phenotype a surprisingly low number of 
significantly downregulated genes were identified. This might be in part due 
to the high background noise in the analysis. It was caused first by the 
diversity between the biological replicates since both ES cell lines were 
derived from different blastocysts and litters and their neural differentiation 
efficiency and speed was rather diverse. Secondly, the cell populations 
analyzed were heterogeneous with some cells faster progressing in 
differentiation than others. Third, while the majority of cells progressed 
towards the neural lineage, there are always smaller percentages of cells 
from other lineages evolving as well. Thus, there might be more Mll2 target 
genes involved in this process that could not be identified by expression 
profiling. The partial rescue by Nxt2 and Bcl2 overexpression could also be 
explained by the requirement for more Mll2 target genes. 
Besides Nxt2 whose deficiency apparently makes up a big portion of the Mll2 
knockout effect, we identified Scml2 as Mll2 dependent gene with a similar 
neural-specific expression pattern. It was recently shown that the longer 
isoform SCML2A in human cells associates with Polycomb Repressive 
Complex 1 (PRC1) while the shorter isoform SCML2B does not bind to 
chromatin but is regulating the cell cycle (Lecona et al., 2013). Interestingly, 
in mice there is only the b isoform annotated. Knockdown of SCML2 
accelerated G1 progression and thus has no obvious correlation with the 
observed phenotype during neural differentiation of Mll2 knockout cells. 
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5.5 Mll2 regulates Nxt2 and Bcl2 during neural differentiation 
Mll2 is essential for neural differentiation because it prevents apoptosis, 
probably by regulating Bcl2 levels. The anti-apoptotic gene was identified as 
Mll2 target in ES cells in a previous study (Lubitz et al., 2007). However, 
mouse ES cells contained hardly any Bcl2 protein (see Fig. 21 B). Thus, Bcl2 
could also be categorized as developmental gene. It was shown to be 
upregulated during mouse ES cell differentiation promoting neural 
commitment (Trouillas et al., 2008). The exact role of Bcl2 in our neural 
differentiation assay and its regulation by Mll2 still have to be addressed in 
further studies. Notably, Nxt2 could only rescue Mll2 inactivation in 
cooperation with Bcl2 (see Fig. 25 B). Presumably, endogenous Bcl2 
transcription depends on Mll2 and thus Bcl2 overexpression directly replaced 
this aspect of Mll2 function. Apart from this most plausible explanation there 
might be other reasons for the necessity of Bcl2 overexpression for the 
rescue to take place. Excess Bcl2 could have an indirect effect leading to a 
general improvement of differentiation efficiency that is needed for the Nxt2 
overexpression to show an enhancement. Our data from mouse embryos 
argues in favor of the second explanation. At least in mice there seem to be 
additional mechanisms preserving Bcl2 expression even if Mll2 is absent 
(see Fig. 28 A). Additionally, Bcl2 was not identified as downregulated gene 
by expression profiling during neural differentiation. Thus, Bcl2 rather falls 
into the category of genes where Mll2 can be replaced by another H3K4 
methyltransferase when cells leave the ES cell stage. 
Preventing apoptosis of Mll2 knockout cells by overexpression of Bcl2 was 
not sufficient to reestablish neural differentiation capacity. The second 
important task of Mll2 was to H3K4 methylate the Nxt2 promoter in ES and 
EpiS cells in order to allow for its increased expression later in neural 
precursors. Apart from being a nuclear export factor, remarkably few data 
exist about Nxt2. It mediates mRNA or protein export and the longer isoform 
b is important for heart development in zebrafish (Huang et al., 2005). The 
importance of Nxt2 for neural differentiation was demonstrated by partially 
rescuing together with Bcl2 the phenotype caused by Mll2 deletion. However, 
the exact function of Nxt2 in neural progenitors will be subject of further 
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studies. Isoform a seemed to be preferably expressed in NS cells (see Fig. 
26 B) and was thus used for the overexpression construct in rescue 
experiments. Nevertheless, we cannot exclude that the partial nature of the 
rescue effect might be due to the isoform chosen. It remains to be seen if 
isoform b or the only recently annotated short isoform c or a combination of 
all three isoforms could improve the rescue effect. 
Due to the very low amount of H3K27me3 on its promoter in ES cells, Nxt2 is 
usually not categorized as bivalent gene. However, the low transcription level 
in ES cells and its upregulation in neural cells could classify it as 
developmental gene. Despite removal of the low H3K27me3 when cells left 
the ES cell state there was no transcriptional upregulation in EpiS cells. 
Similarly, H3K4me3 at the Nxt2 promoter was already high in ES cells and 
did not increase when cells differentiated to NS cells. In spite of the 
apparently open chromatin state Nxt2 was not highly transcribed until the 
neural rosette stage. Thus, it might require a specific transcription factor or 
cofactor that is not present earlier in development. Interestingly, this 
correlates with the finding of Mikkelsen and colleagues that promoters with 
low CpG content (like Nxt2) are usually tissue-specific with low expression in 
ES cells even if they are H3K4 trimethylated, but are transcriptional 
upregulated if H3K4 trimethylation remains in neural progenitors (Mikkelsen 
et al., 2007).  
 
5.6 Cooperation of Mll1 and Mll2 at the Nxt2 promoter 
Despite being the main H3K4 methyltransferase for most active genes in ES 
cells, Setd1a does not seem to be sufficiently active on the marginally 
expressed Nxt2 promoter. Like it was previously shown for Magohb (Glaser 
et al., 2009; Ladopoulos et al., 2013), Nxt2 represents an exception by 
specifically relying on Mll2 for its H3K4 methylation in ES cells. Once cells 
differentiated to EpiS cells, Mll1 was also recruited to the Nxt2 promoter and 
both paralogs were then redundantly keeping the chromatin accessible until 
transcription of Nxt2 was upregulated in neural progenitors, probably due to 
an additional transcriptional (co-) factor as discussed above (Fig. 42, 
Mll2F/F).  
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Mll2 presence until the EpiS cell state was essential for Mll1 to substitute for 
Mll2, but binding of Mll1 to the Nxt2 promoter in EpiS cells was not Mll2-
dependent. Mll1 could bind to the promoter even if Mll2 was absent already 
from the ES cell stage on (see Fig. 27 A). No evidence for a direct protein 
interaction between Mll1 and Mll2 complexes was reported so far. Thus, it is 
unlikely that Mll2 directly recruits Mll1 to the Nxt2 promoter.  
Mll2 presence until the EpiS cell state might rather be required to maintain a 
certain amount of H3K4 trimethylation at the Nxt2 promoter. The low 
transcription level of Nxt2 in EpiS cells was directly correlated with H3K4 
trimethylation at its promoter that gradually decreased the earlier Mll2 was 
inactivated (see Fig. 27 B and C). Despite its binding to the Nxt2 promoter in 
EpiS cells Mll1 was not able to maintain H3K4 trimethylation to the same 
extend as Mll2. Mll1 might rather function by recruiting transcription factors 
and preventing Polycomb silencing. One could speculate that the trancription 
factor(s) necessary to increase Nxt2 expression in neural precursors require 
not only Mll1 (or Mll2) but also a certain amount of H3K4 trimethylation at the 
promoter. This would explain the finding of Chang and colleagues that the 
third PHD finger of Mll1 has to bind trimethylated H3K4 for the protein to 
carry out its transcription promoting effects (Chang et al., 2010). If Mll2 was 
inactivated in EpiS cells (Fig. 42, Mll2FC/FC 4OHT-EpiS) the left-over H3K4 
trimethylation together with Mll1 presence allowed transcription factor binding 
in neural precursors and thus successful generation of NS cells. 
For unknown reasons, Mll1 was not able to sufficiently replace Mll2 earlier 
than in EpiS cells. There was hardly any Mll1 bound to the Nxt2 promoter in 
ES cells although the protein was expressed. If Mll2 was inactivated in ES 
cells, H3K4 trimethylation was greatly reduced rendering the Nxt2 promoter 
less accessible (Fig. 42, Mll2FC/FC 4OHT-ES). It is yet unclear if reduced 
H3K4 methylation was the sole cause for the defect or if additional silencing 
mechanisms were involved. H3K27 trimethylation at the Nxt2 promoter was 
apparently transient. It was only slightly increased after Mll2 knockout in ES 
cells and not maintained throughout further differentiation (see Fig. 26 H). 
Binding of Mll1 to the Nxt2 promoter in EpiS cells might prevent Polycomb 
group action like at the Otx2 promoter in NS cells. Alternatively, H3K27 
methylation might have been replaced by H3K9 methylation or DNA 
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methylation. The latter is less likely as Nxt2 has no CpG island at its 
promoter. However, the restricting chromatin state was inherited during 
following cell divisions. This in turn possibly prevented recruitment of 
transcription factors and thus upregulation of Nxt2 transcription in neural 
progenitors. Absence of Nxt2 and possibly other proteins essential for neural 
differentiation then probably caused a general cell-intrinsic catastrophe 





Figure 42 Model for the interplay of Mll1 and Mll2 at the Nxt2 promoter during differentiation 
of mouse ES cells over EpiS cells to NS cells. Grey circles represent nucleosomes around 
the Nxt2 promoter with two protruding H3 tails that can get trimethylated either at K4 (green 
dot) or K27 (red dot). The model illustrates the different outcomes with Mll2 being present 
(Mll2F/F, gray background) or when Mll2 is inactivated in ES cells (Mll2FC/FC 4OHT-ES, 
pink background) compared to the slightly more committed EpiS cell stage (Mll2FC/FC 
4OHT-EpiS, blue background) or in NS cells (Mll2FC/FC 4OHT-NS, green background). 
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5.7 Correlation of promoter H3K4 methylation and transcription of Nxt2 
After switching from Mll2 dependence in ES cells to requirement of either 
Mll1 or Mll2 in EpiS cells, the Nxt2 promoter was mainly bound by Mll1 in NS 
cells and only low levels of Mll2 were left (see Fig. 26 C). Nevertheless, most 
of the Nxt2 promoter H3K4 trimethylation relied on Mll2 since its removal led 
to a profound decrease comparable to the one observed in ES cells (see Fig. 
26 F). The discrepancy might be explained by Nxt2 being a rare exception by 
relying mostly on one H3K4 methyltransferase like it was already the case in 
ES cells. 
Despite the loss of H3K4 trimethylation, mRNA levels of Nxt2 were not 
reduced upon Mll2 knockout in NS cells (see Fig. 24). This finding challenges 
the widely approved correlation of promoter H3K4 methylation and 
transcriptional output (Mikkelsen et al., 2007). Highly expressed genes like 
Nxt2 at this developmental stage might be independent from H3K4 
methylation for their transcription since they already have all transcription 
factors bound to their promoters. A division of labor between the different 
methyltransferase complexes is also conceivable where one is responsible 
for most H3K4 methylation while others provide merely binding platforms for 
the transcription machinery. Highly expressed promoters might be 
maintained active by such redundant mechanisms.  
In contrast, the low basal expression of Nxt2 in ES cells is not sufficiently 
maintained without H3K4 methylation defining the promoter as such. Thus, 
the present study contributes to the ongoing debate whether chromatin 
modifications are a consequence of transcription or a prerequisite. Both 
might be true depending on the identity of the gene, the developmental stage 
and lineage examined and type of modification. Nxt2 presents an example 
where H3K4 methylation is required to prime the promoter for subsequent 
transcriptional upregulation but is irrelevant for transcriptional maintenance in 
NS cells. 
 
5.8 Mll2 domains that are crucial for neural differentiation 
Trithorax and Polycomb group proteins and many other chromatin modifying 
enzymes have domains that bind to the same histone mark they are 
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catalyzing. It was proposed that epigenetic modifications are reinforced by 
positive feedback loops providing stability and adaptability at the same time 
(for review see Schreiber and Bernstein, 2002). PHD fingers were shown to 
bind to methylated lysines in histone tails and Mll1 and Mll2 each contain four 
of them. The third PHD finger of Mll1 seems to be especially important as 
Mll1 activity depends on its binding to trimethylated H3K4 (Chang et al., 
2010). Thus, it is not surprising that the stretch of three PHD fingers and the 
Bromo-like domain appeared to be essential in our differentiation assay 
where the Mll2 mutant BAC missing this part was not able to rescue the 
endogenous knockout (see Fig. 14). Similarly, Mll1 possessing the 
corresponding mutation was not able to rescue from the EpiS cell stage on 
(see Fig. 20 E). Additionally, we could confirm the result from Chang et al. 
that this domain is essential for efficient chromatin binding since a large 
fraction of the mutant Mll1 and Mll2 proteins was localized in the cytoplasm 
(data not shown). Thus, the spreading and maintenance of H3K4 methylation 
on the Nxt2 promoter seems to be an important function of Mll2 in order to 
keep the chromatin accessible. The second essential feature of Mll2 for 
neural differentiation is directly associated with this task. The H3K4 
methylation activity of Mll2 was apparently essential since deletion of the 
catalytic SET domain together with post-Set and FYRC ablated the rescue 
effect of the Mll2 BAC. To clarify this hypothesis it will be necessary to point 
mutate the SET domain of Mll2. 
On the other hand, we found that deletion of the ePHD and the FYRN 
domain of Mll2 had only a mild effect on the differentiation efficiency. Thus, 
the binding of FYRN to FYRC responsible for heterodimerization of N- and C-
terminal half of Mll2 after Taspase 1 cleavage seemed to be dispensable for 
neural differentiation. Nevertheless, we cannot exclude that N- and C-
terminal parts can interact via other domains or are able to form functional 
heterodimers with Mll1. 
Intriguingly, we found that even the Taspase 1 cleavage site of Mll2 was 
abdicable in our experimental setup. The effects of Taspase 1 cleavage on 
protein activity are still under debate. Although it was reported that it is 
important for stabilization of the N-terminal part, correct subnuclear 
localization and activity of Mll1 (Takeda et al., 2006) this does not seem to 
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hold true for Mll2 in the context examined here. Similarly, a recent report 
showed that deletion of the Taspase 1 site of Mll1 had no phenotype in mice 
(Yokoyama et al., 2013).  
Interestingly, the two non-rescuing Mll2 BAC variants (see Fig. 13 C; Δex9-
20 and Δex30-37) appeared to be mainly existing as full-length proteins in 
the cells while all other mutant proteins and wild type Mll2 protein had equal 
ratios or slightly favored the cleaved product. This implies a certain 
correlation between Taspase 1 cleavage and the ability of the Mll2 mutants 
to rescue. One can probably exclude that Taspase 1 cleavage is necessary 
for enzymatic activity because enzyme activity of the non-cleavable Mll2 
mutant was not disturbed in our assay. Instead, cleavage could be a 
consequence of catalytic activity and not necessarily a prerequisite. If this 
holds true, Mll2 might be cleaved by Taspase 1 only after methylating a 
target gene. The non-rescuing mutants would largely remain full-length 
proteins. It is also conceivable that PHD fingers or bromo-like domain act in 
concert with FYRC or SET domain to recruit Taspase 1. Deletion of either 
domain would then lead to the low efficiency of cleavage observed for the 
mutant proteins. Alternatively, it is possible that Taspase 1 recognition or 
cleavage was disturbed by missfolding of these two Mll2 mutant proteins. A 
failure to fold correctly would also explain why the mutants were unable to 
rescue the inactivation of endogenous Mll2. Further, the stability of the N-
terminus might be influenced by the mutations. However, this seems less 
likely since one of the two affected deletions (Δex30-37) was located in the 
C- and not the N-terminus.  
In contrast to PHD fingers that confer interactions with histones and other 
proteins, the CxxC domain is a zinc finger that binds to DNA. It recognizes 
unmethylated CpG nucleotides thereby directing proteins to active CpG 
island promoters (Voo et al., 2000). In the context of leukemic fusion proteins 
the CxxC domains of Mll1 and Mll2 confer target gene specificity explaining 
why Mll2 fusion proteins miss the malignant transformation ability of Mll1 
fusions (Bach et al., 2009). CpG island genes were significantly 
overrepresented among genes with reduced transcription or H3K4me3 in Mll2 
knockout ES cells (Glaser et al., 2009; Denissov et al., 2014) and 21 out of 
 Discussion  
 151 
30 potential Mll2 target genes identified in this study harbor CpG islands. 
Nevertheless, the neural differentiation efficiency of ES cells was only slightly 
reduced when the CxxC domain of Mll2 was deleted. The absence of a CpG 
island in front of the Nxt2 and Scml2 promoters might explain why the ability 
of Mll2 to bind to unmethylated CpG islands was less important for neural 
differentiation. Having various domains that are able to bind to DNA or 
chromatin, Mll2 might rely on one or the other depending on the genes 
examined, as well as on the cellular and developmental context or on other 
complex members and transient interactors.  
Interestingly, out of 15 Mll2 target genes whose expression was tested by 
qRT-PCR in the context of this study, there were five (Sohlh2, Rpl10l, 
Slc39a8, Scml2, Nxt2) whose expression stayed low even long after Mll2 
inactivation and only two of them (Rpl10l, Slc39a8) had a CpG island at their 
promoters (see Fig. 24). In contrast, eight out of ten Mll2 target genes whose 
expression returned to normal levels after long-term culture were preceded 
by CpG islands. Most promoters with high CpG content are thought to be 
active by default because they are H3K4 trimethylated in many cell types 
(Mikkelsen et al., 2007). Thus, CpG island genes might easier recruit other 
H3K4 methyltransferases or transcription factors to restore their expression 
when cells adapt to the Mll2 knockout. Their promoters are well defined and 
recognizable by other proteins with CxxC domains including Mll1 and Cxxc1 
(Cfp1), a specific component of Setd1a and Setd1b complexes. On the other 
hand, promoters lacking CpG islands like Nxt2 might rather stay dependent 
on Mll2 for their H3K4 methylation throughout development. 
 
5.9 Role of H3K4 methylation for reprogramming to induced 
pluripotency 
The reprogramming of somatic cells to the induced pluripotent state involves 
a complete change of their transcriptional program and thus a resetting of the 
epigenome. Changes include silencing of somatic genes, reactivation of 
pluripotency genes and reestablishment of bivalent chromatin on 
developmental genes (for review see Apostolou and Hochedlinger, 2013). 
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H3K4 methyltransferases might influence all these processes depending on 
their target gene specificity.  
One of the earliest chromatin changes upon transfection of MEFs with 
reprogramming factors is the gain of H3K4 dimethylation at enhancers and 
promoters, even before transcriptional changes take place (Koche et al., 
2010). Thus, Mll3 or Mll4 might influence reprogramming efficiency as they 
were recently connected to enhancer mono- and dimethylation (Hu et al., 
2013a; Lee et al., 2013). Their histone methyltransferase complexes contain 
Utx (Lee et al., 2007), a H3K27 demethylase that might be required for 
simultaneously removing the silencing histone mark in order for genes to get 
activated. Indeed, it was reported that Utx knockout impedes reprogramming 
or reduces its efficiency (Mansour et al., 2012 and Neumann, unpublished 
data). 
The reestablishment of H3K4 trimethylation on endogenous pluripotency 
genes is crucial for iPS cells to get independent from the exogenously 
supplied reprogramming factors. Thus, it is not surprising that knockdown of 
WD repeat domain containing 5 (Wdr5), a core component of all H3K4 
methyltransferase complexes, reduces reprogramming efficiency of MEFs 
(Ang et al., 2011). Wdr5 is recruited by Oct4 in order to achieve target gene 
reactivation during reprogramming. Similarly, we showed that Setd1a is 
essential for the generation of iPS cells from NS cells while its sister gene 
Setd1b is not (Bledau et al., 2014). The Setd1 complex interacts with RNA 
Polymerase II via its specific component Wdr82 linking H3K4 methylation to 
the transcription machinery (Lee and Skalnik, 2008). Since Setd1a is the 
main H3K4 methyltransferase on active promoters in pluripotent cells, its 
knockout leads to a global reduction of H3K4 trimethylation (Bledau et al., 
2014), like it was also reported for the knockdown of Wdr5 (Ang et al., 2011). 
Thus, the requirement of Wdr5 and Setd1a for successful reprogramming 
might be due to cell intrinsic needs for preventing a general transcriptional 
failure in addition to a specific recruitment for gene reactivation. This is 
especially plausible as Setd1a is also required for proliferation of NS cells 
that were used as initial cell source for reprogramming (Bledau et al., 2014). 
Without proliferation not only the growth of iPS cells but also reprogramming 
in general might be impossible. MEFs, for instance, show greatly reduced 
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reprogramming efficiencies at late passages due to senescence and their 
immortalization eliminates this barrier (Utikal et al., 2009). Thus, it is 
surprising that Mll1 and Mll2 double knockout NS cells that stopped to 
proliferate could still generate iPS cells, although at a lower efficiency (see 
Fig. 36). The extent of the defect varied a lot between the two NS cell lines 
examined. These differences could be explained by the overlap of distinct 
functions of both proteins as well as their redundant features and how the 
influence of these effects changed during the different reprogramming 
phases. First, it might be critical how fast cells left the NS cell state since the 
proliferation defect after inactivation of both sister genes diminished in earlier 
developmental stages. On the other hand, the advantage of Mll1 inactivation 
during early phases of reprogramming might have compensated to different 
extents for the negative effects of the double knockout. This hints towards a 
complex interplay of Mll1 and Mll2 during iPS cell generation, similar to their 
cooperation during neural differentiation. 
The reestablishment of bivalent chromatin domains to silence lineage-
specific genes by H3K27 methylation is essential for reprogramming. This 
was first shown by fusing human B-lymphocytes to mouse ES cells deficient 
for different PRC2 components (Eed, Suz12). The absence of PRC2 activity 
prevented reprogramming in this experimental setup (Pereira et al., 2010). 
Due to its role on bivalent genes in ES cells, Mll2 might be also needed to 
reestablish bivalent chromatin in iPS cells. Two different categories of 
bivalent genes have to be considered that can be distinguished according to 
their chromatin state in the lineage from that the iPS cells were generated. 
First, there are active genes like neural lineage ones in the present study. 
They only have to maintain their H3K4 methylation and get silenced by 
H3K27 methyltransferases when NS cells are reprogrammed. Secondly, the 
genes from another lineage likely carry repressive H3K27, H3K9 or DNA 
methylation. While H3K27 methylation could be simply maintained, H3K9 or 
DNA methylation has to be removed and H3K4 has to get de novo 
methylated in iPS cells. Reestablishing bivalency at this second group might 
be a harder task to accomplish. This probably explains the effect of 
epigenetic memory in many iPS cell lines that often differentiate easier 
towards the lineage they were derived from (reviewed in Sullivan et al., 
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2010). The knockout of Mll2 at certain time points during reprogramming 
slightly reduced the number of iPS cells generated (see Fig. 34). However, 
while a failure to silence lineage genes hinders reprogramming (Pereira et 
al., 2010), the absence of H3K4 methylation on bivalent genes that are not 
expressed is unlikely to influence pluripotent cells themselves. The 
consequences of absent or reduced H3K4 methylation on developmental 
genes should not become obvious until differentiation of the resulting iPS 
cells. Therefore, the slight reduction of reprogramming efficiency without Mll2 
could also be related to other effects like the increased apoptosis of Mll2 
knockout cells (Lubitz et al., 2007).  
Contrary to Mll2, the inactivation of Mll1 only influenced early phases of NS 
cell reprogramming (see Fig. 35). Since the knockout of Mll1 had no effect on 
MEF reprogramming (see Fig. 38), it seems likely that it specifically regulates 
neural genes. Mll1 might stabilize the identity and chromatin state of NS cells 
thereby impeding early reprogramming stages. These first steps are most 
likely the most sensitive ones and susceptible to disturbances because cells 
express somatic genes together with exogenous reprogramming factors. This 
likely generates protein combinations that would not exist in the same cell 
during normal development. Mll1 presence might tip this delicate balance 
toward the differentiated state by keeping neural genes longer active. 
 
5.10 Mll1 target genes in NS cells 
Expression profiling revealed potential Mll1 target genes in NS cells that 
might impede reprogramming. Besides Orthodenticle homolog 2 (Otx2) we 
found Distal-less homeobox 1 (Dlx1) and Wingless-related MMTV integration 
site 4 (Wnt4) to be differentially expressed genes that might explain the 
observed increase in reprogramming efficiency. 
Wnt inhibition in early phases of MEF reprogramming was shown to enhance 
efficiency while it is detrimental during later stages (Ho et al., 2013). The 
reduction of Wnt signaling in Mll1 knockout NS cells might explain their 
higher reprogramming efficiency. However, this cannot explain why the effect 
was restricted to NS cells and not observed in Mll1 knockout MEFs. 
Additionally, Wnt4 was the only Wnt gene being downregulated upon Mll1 
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inactivation in NS cells. Wnt5a, Wnt7a and Wnt7b were also expressed at 
high levels in this cell type (FPKM 10-40) but their expression did not depend 
upon Mll1. Moreover, preliminary data indicates that the Wnt4 promoter is not 
even bound by Mll1 in NS cells (Singh and Neumann, data not shown). Thus, 
its downregulation might rather be a secondary effect. 
Dlx1 on the other hand was bound by Mll1 in NS cells. It is located on mouse 
chromosome two directly besides its paralog Dlx2 that was previously 
reported to be a Mll1 target essential for neurogenesis (Lim et al., 2009). This 
is contradictory to our finding that Mll1 knockout NS cells were able to 
generate neurons without any obvious defects (see Fig. 16). The discrepancy 
might be due to the use of adult subventricular zone NS cells by Lim et al. in 
contrast to the fetal NS cells used here. They probably produce different 
neuronal subtypes that depend on other transcription factors. Dlx2 was not 
expressed at reasonable levels (FPKM < 4) in the NS cells used in the 
present study and thus was not classified as potential Mll1 target gene.  
Mll1 presence retaining Otx2 or Dlx1 expression might explain the resistance 
of NS cells to reprogramming. Both are neural transcription factors thus 
influencing the expression of many downstream genes. While Otx2 is 
involved in early neural differentiation, Dlx1 is apparently responsible for 
differentiation towards postmitotic interneurons (Cobos et al., 2005). Thus, 
Dlx1 might act downstream of Otx2 or at least later in development. 
Therefore, the present study focused on Otx2 as the most influential Mll1 
target gene in NS cells.  
Otx2 is well known to be essential for normal brain development (for reviews 
see Boncinelli and Morgan, 2001; Simeone et al., 2002). Despite its 
expression from the blastocyst stage on it was only recently reported to be 
important during this early developmental stage as well. Otx2 antagonizes 
ground state pluripotency and stabilizes the epiblast stem cell state 
(Acampora et al., 2013). It was suggested that Otx2 recruits Oct4 to neural 
enhancers (Yang et al., 2014). A similar cooperation might occur in Otx2 
expressing NS cells when they are transfected with the four reprogramming 
factors including Oct4. The combination of both transcription factors during 
early reprogramming stages might drive cells towards differentiation instead 
of inducing pluripotency (Fig. 43). The reduced Otx2 expression in Mll1 
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knockout NS cells could favor reprogramming because Oct4 can then 
preferably bind to different target sites to induce pluripotency, probably in 
coordination with the other factors. The absence of Otx2 expression in MEFs 
explains why this effect is restricted to NS cell reprogramming. 
Unfortunately, the Otx2 esiRNA did not enhance NS cell reprogramming 
efficiency (see Fig. 40) like the Mll1 knockdown (see Fig. 37). This could 
imply that Mll1 conducts its reprogramming inhibiting role by regulating other 
genes like Dlx1 as well or by mechanisms more complex or independent of 
its role as transcriptional activator. Due to the cell type-specific regulation of 
Otx2 expression and its different transcripts, one could also speculate that 
the Otx2 esiRNA that seemed to function well in ES cells might not be 
efficient enough in NS cells to produce a phenotype. The esiRNA target 
region in the 3’UTR contains a conserved element that is essential for Otx2 
mRNA nuclear export and translation in epiblast and neuroectoderm but not 
in visceral endoderm (Boyl et al., 2001). Interestingly, EpiS and NS cells 
preferably express the isoform starting from the distal promoter while ES 
cells express the one from the proximal promoter as well. Although the 
3’UTRs of all Otx2 transcript isoforms are identical, cell type-specific 
secondary structures, interactions of 5’ with 3’UTR or of the 3’UTR with 
protein complexes might impair binding of RNA-induced silencing complex 
(RISC) and thus impede efficient knockdown of one isoform but not the other. 
It might be beneficial to test if another Otx2 esiRNA that targets a different 
region in the mRNA, maybe in combination with knockdown of Dlx1, is able 
to copy the effect of Mll1 knockdown on NS cell reprogramming. 
 
5.11 Epigenetic regulation of the Otx2 promoter 
When ES cells differentiated to EpiS and finally NS cells the expression of 
Otx2 shifted from its proximal to the distal promoter (see Fig. 41 C). This 
switch was reflected in the H3K4 methylation level of both promoters but not 
in terms of Mll1 and Mll2 binding. Again, this hints toward a separation of 
H3K4 methyltransferase binding and catalytic activity. Despite their cell type-
specific usage the binding profiles of both Otx2 promoters were very similar 
to each other and even very alike to the Nxt2 promoter. Both Otx2 promoters 
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were first bound by Mll2 but not Mll1 in ES cells. In EpiS cells Mll1 was 
recruited while Mll2 binding decreased. Finally in NS cells only Mll1 was 
bound to both Otx2 promoters in contrast to Nxt2 where a little Mll2 binding 
remained. Thus, it is comprehensible that Otx2 expression in NS cells is 
dependent on Mll1. After inactivation of Mll1 H3K4 di- and trimethylation did 
not change significantly but monomethylation was reduced and repressive 
H3K27 trimethylation increased (Fig. 43). The latter is probably responsible 
for the transcriptional failure or a direct consequence of it. Thus, the main 
role of Mll1 is to maintain Otx2 expression by recruiting the transcription 
machinery or to block Polycomb Repressive Complex 2. Interestingly, Lim et 
al. could show that the Dlx2 promoter becomes H3K27 trimethylated in the 
absence of Mll1 (Lim et al., 2009) suggesting a similar mechanism like for the 
Otx2 promoter. Additionally, it was shown that mice with homozygously 
mutated SET domains of Mll1 are viable in contrast to Mll1 knockout mice 
and thus, an essential amount of Mll1 function indeed seems to be 
independent of its catalytic activity (Terranova et al., 2006).  
 




Figure 43 Model for the role of Mll1 and its target gene Otx2 in NS 
cells and early reprogramming steps. The model illustrates how Mll1 
ensures Otx2 expression by H3K4 mono-methylation and preventing 
trimethylation of H3K27 by Polycomb repressive complex 2 (PRC2). 
Otx2 recruits Oct4 to neural enhancers and thus acts in favor of 
keeping cells in the NS cell state impeding reprogramming to iPS 
cells. 
 
 Conclusion and outlook  
 159 
6 Conclusion and Outlook 
In the present study we could show that Mll1 and Mll2 have very specific and 
distinct functions despite their high degree of redundancy and that their 
respective influences change during development. Mll2 primed the Nxt2 
promoter by H3K4 methylating it in ES and EpiS cells for later transcription 
upregulation during differentiation. In contrast, Mll1 did not seem to play an 
essential role in ES cells, but it was recruited to the Nxt2 promoter in EpiS 
cells. During further neural differentiation, Mll1 could replace Mll2 from this 
crucial EpiS cell state on. Although Mll1 binding to the Nxt2 promoter in EpiS 
cells was independent of Mll2 presence, the ability to substitute during neural 
differentiation was not. Thus, the Nxt2 promoter might require a certain 
amount of H3K4 trimethylation besides Mll1 (or Mll2) binding to become 
active. Finally, Mll1 stabilized the NS cell state by regulating the Otx2 
promoter thus impeding reprogramming to induced pluripotency. The 
promoters of both, Nxt2 and Otx2, were mainly or only bound by Mll1 in NS 
cells, showing that it is probably more important for later development as 
compared to its paralog Mll2. 
Not only the sequential binding to promoters but also the modes of action 
distinguished both histone methyltransferases from each other. Mll2 seemed 
to be mainly responsible for H3K4 trimethylation while Mll1 ensured 
transcription of its target genes by H3K4 monomethylation and preventing 
H3K27 methylation. Thus, it might be possible to sort genes into different 
categories depending on which H3K4 methyltransferases bind to them and in 
which cell types. This could help to predict the effects of Mll1 or Mll2 
knockout on these genes. Genes that are only bound by Mll2, like Nxt2 in ES 
cells, will probably loose H3K4 trimethylation when Mll2 is inactivated and 
transcription will fail. Genes like Otx2 in NS cells that are only bound by Mll1 
should have only little H3K4 trimethylation. Their H3K4 monomethylation will 
likely be reduced after Mll1 knockout but expression probably fails due to 
silencing by H3K27 methylation. Finally, genes like Nxt2 in NS cells that are 
bound by both histone methyltransferases could rely on either of them. Even 
if their H3K4 trimethylation is reduced after Mll2 inactivation, Mll1 could still 
ensure their transcription.  
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Nxt2 switches from being solely dependent on Mll2 in ES cells to a target 
gene of both Mll1 and Mll2 during further development. This confirms our 
previously suggested bimodal recruit and maintain model (Glaser et al., 
2009). Mll2 is required to establish certain epigenetic decisions that are later 
maintained by redundant mechanisms. It remains to be seen if Nxt2 is merely 
an exception or if this concept or part of it can be applied more generally. 
Genome wide ChIP-sequencing for binding sites of H3K4 methyltransferases 
in the different cell types combined with ChIP-sequencing for H3K4 and 
H3K27 methylation in wild type cells and in the corresponding conditional 
knockout cell lines will help to understand the complex relations. Besides 
Mll1 and Mll2, the presence and binding of the other four H3K4 
methyltransferases will be of great importance. Especially Setd1a appears to 
play an essential role for active promoters and thus all genes also bound by 
this complex will probably suffer no transcriptional consequences if Mll1 or 
Mll2 are inactivated. The molecular processes underlying the transition of 
Mll2 target genes to Mll1 or other H3K4 methyltransferases later in 
development will also be subject of these further studies. 
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